id	sid	tid	token	lemma	pos
eshr-12641	1	1	epidemiology	epidemiology	NOUN
eshr-12641	1	2	and	and	CCONJ
eshr-12641	1	3	society	society	NOUN
eshr-12641	1	4	health	health	PROPN
eshr-12641	1	5	review|	review|	PROPN
eshr-12641	1	6	eshr	eshr	PROPN
eshr-12641	1	7	vol	vol	NOUN
eshr-12641	1	8	.	.	PROPN
eshr-12641	2	1	7	7	NUM
eshr-12641	2	2	,	,	PUNCT
eshr-12641	2	3	no	no	INTJ
eshr-12641	2	4	.	.	NOUN
eshr-12641	2	5	2	2	NUM
eshr-12641	2	6	,	,	PUNCT
eshr-12641	2	7	2025	2025	NUM
eshr-12641	2	8	,	,	PUNCT
eshr-12641	2	9	pp	pp	ADJ
eshr-12641	2	10	.	.	PUNCT
eshr-12641	3	1	87	87	NUM
eshr-12641	3	2	-	-	SYM
eshr-12641	3	3	95	95	NUM
eshr-12641	3	4	issn	issn	PROPN
eshr-12641	3	5	2656	2656	NUM
eshr-12641	3	6	-	-	SYM
eshr-12641	3	7	6052	6052	NUM
eshr-12641	3	8	(	(	PUNCT
eshr-12641	3	9	online	online	NOUN
eshr-12641	3	10	)	)	PUNCT
eshr-12641	3	11	|	|	ADV
eshr-12641	3	12	2656	2656	NUM
eshr-12641	3	13	-	-	SYM
eshr-12641	3	14	1107	1107	NUM
eshr-12641	3	15	(	(	PUNCT
eshr-12641	3	16	print	print	NOUN
eshr-12641	3	17	)	)	PUNCT
eshr-12641	3	18	http://journal2.uad.ac.id/index.php/eshr/index	http://journal2.uad.ac.id/index.php/eshr/index	NOUN
eshr-12641	3	19	eshr@ikm.uad.ac.id	eshr@ikm.uad.ac.id	X
eshr-12641	3	20	10.26555	10.26555	NUM
eshr-12641	3	21	/	/	SYM
eshr-12641	3	22	eshr.v7i2.12641	eshr.v7i2.12641	PROPN
eshr-12641	3	23	87	87	NUM
eshr-12641	3	24	research	research	NOUN
eshr-12641	3	25	article	article	NOUN
eshr-12641	3	26	prevalence	prevalence	NOUN
eshr-12641	3	27	of	of	ADP
eshr-12641	3	28	metabolic	metabolic	NOUN
eshr-12641	3	29	syndrome	syndrome	NOUN
eshr-12641	3	30	among	among	ADP
eshr-12641	3	31	patients	patient	NOUN
eshr-12641	3	32	with	with	ADP
eshr-12641	3	33	type	type	NOUN
eshr-12641	3	34	2	2	NUM
eshr-12641	3	35	diabetes	diabetes	NOUN
eshr-12641	3	36	at	at	ADP
eshr-12641	3	37	the	the	DET
eshr-12641	3	38	bon	bon	PROPN
eshr-12641	3	39	samaritain	samaritain	PROPN
eshr-12641	3	40	university	university	NOUN
eshr-12641	3	41	hospital	hospital	NOUN
eshr-12641	3	42	complex	complex	NOUN
eshr-12641	3	43	in	in	ADP
eshr-12641	3	44	n’djamena	n’djamena	PROPN
eshr-12641	3	45	,	,	PUNCT
eshr-12641	3	46	chad	chad	PROPN
eshr-12641	3	47	suitombaye	suitombaye	VERB
eshr-12641	3	48	noubaramadji	noubaramadji	PROPN
eshr-12641	3	49	yamti*1,2	yamti*1,2	NOUN
eshr-12641	3	50	,	,	PUNCT
eshr-12641	3	51	abel	abel	PROPN
eshr-12641	3	52	dafogo	dafogo	VERB
eshr-12641	3	53	djibagaou1,2,6	djibagaou1,2,6	PROPN
eshr-12641	3	54	,	,	PUNCT
eshr-12641	3	55	koutaya	koutaya	PROPN
eshr-12641	3	56	dezoumbe1,2,6	dezoumbe1,2,6	PROPN
eshr-12641	3	57	,	,	PUNCT
eshr-12641	3	58	amine	amine	PROPN
eshr-12641	3	59	akouya1,2	akouya1,2	PROPN
eshr-12641	3	60	,	,	PUNCT
eshr-12641	3	61	zita	zita	PROPN
eshr-12641	3	62	aleyo	aleyo	PROPN
eshr-12641	3	63	nodjikouambaye1	nodjikouambaye1	PROPN
eshr-12641	3	64	,	,	PUNCT
eshr-12641	3	65	andrillene	andrillene	PROPN
eshr-12641	3	66	laure	laure	PROPN
eshr-12641	3	67	deutou	deutou	PROPN
eshr-12641	3	68	wondeu1,2	wondeu1,2	PROPN
eshr-12641	3	69	,	,	PUNCT
eshr-12641	3	70	brahim	brahim	PROPN
eshr-12641	3	71	boy	boy	NOUN
eshr-12641	3	72	otchom4	otchom4	PROPN
eshr-12641	3	73	,	,	PUNCT
eshr-12641	3	74	sabrina	sabrina	PROPN
eshr-12641	3	75	atturo1	atturo1	PROPN
eshr-12641	3	76	,	,	PUNCT
eshr-12641	3	77	giulia	giulia	PROPN
eshr-12641	3	78	cappelli1,5	cappelli1,5	PROPN
eshr-12641	3	79	,	,	PUNCT
eshr-12641	3	80	vittorio	vittorio	PROPN
eshr-12641	3	81	colizzi1,6	colizzi1,6	PROPN
eshr-12641	3	82	1	1	NUM
eshr-12641	3	83	laboratoire	laboratoire	PROPN
eshr-12641	3	84	des	des	PROPN
eshr-12641	3	85	grandes	grandes	PROPN
eshr-12641	3	86	épidémies	épidémie	VERB
eshr-12641	3	87	tropicales	tropicale	NOUN
eshr-12641	3	88	,	,	PUNCT
eshr-12641	3	89	bon	bon	PROPN
eshr-12641	3	90	samaritain	samaritain	PROPN
eshr-12641	3	91	university	university	NOUN
eshr-12641	3	92	hospital	hospital	NOUN
eshr-12641	3	93	complex	complex	NOUN
eshr-12641	3	94	,	,	PUNCT
eshr-12641	3	95	n’djamena	n’djamena	PROPN
eshr-12641	3	96	,	,	PUNCT
eshr-12641	3	97	chad	chad	VERB
eshr-12641	3	98	2	2	NUM
eshr-12641	3	99	faculty	faculty	NOUN
eshr-12641	3	100	of	of	ADP
eshr-12641	3	101	sciences	science	NOUN
eshr-12641	3	102	and	and	CCONJ
eshr-12641	3	103	technologies	technology	NOUN
eshr-12641	3	104	of	of	ADP
eshr-12641	3	105	the	the	DET
eshr-12641	3	106	evangelical	evangelical	ADJ
eshr-12641	3	107	university	university	NOUN
eshr-12641	3	108	of	of	ADP
eshr-12641	3	109	cameroon	cameroon	PROPN
eshr-12641	3	110	,	,	PUNCT
eshr-12641	3	111	mbouobandjoun	mbouobandjoun	PROPN
eshr-12641	3	112	,	,	PUNCT
eshr-12641	3	113	cameroon	cameroon	PROPN
eshr-12641	3	114	3	3	NUM
eshr-12641	3	115	university	university	PROPN
eshr-12641	3	116	of	of	ADP
eshr-12641	3	117	tor	tor	PROPN
eshr-12641	3	118	vergata	vergata	PROPN
eshr-12641	3	119	,	,	PUNCT
eshr-12641	3	120	rome	rome	PROPN
eshr-12641	3	121	,	,	PUNCT
eshr-12641	3	122	italy	italy	PROPN
eshr-12641	3	123	4	4	NUM
eshr-12641	3	124	toumaï	toumaï	PROPN
eshr-12641	3	125	university	university	NOUN
eshr-12641	3	126	,	,	PUNCT
eshr-12641	3	127	n’djamena	n’djamena	PROPN
eshr-12641	3	128	,	,	PUNCT
eshr-12641	3	129	chad	chad	VERB
eshr-12641	3	130	5	5	NUM
eshr-12641	3	131	laboratory	laboratory	NOUN
eshr-12641	3	132	of	of	ADP
eshr-12641	3	133	immunology	immunology	NOUN
eshr-12641	3	134	,	,	PUNCT
eshr-12641	3	135	national	national	PROPN
eshr-12641	3	136	research	research	PROPN
eshr-12641	3	137	council	council	PROPN
eshr-12641	3	138	,	,	PUNCT
eshr-12641	3	139	rome	rome	PROPN
eshr-12641	3	140	,	,	PUNCT
eshr-12641	3	141	italy	italy	PROPN
eshr-12641	3	142	6	6	NUM
eshr-12641	3	143	faculty	faculty	NOUN
eshr-12641	3	144	of	of	ADP
eshr-12641	3	145	medicine	medicine	NOUN
eshr-12641	3	146	,	,	PUNCT
eshr-12641	3	147	bon	bon	PROPN
eshr-12641	3	148	samaritain	samaritain	PROPN
eshr-12641	3	149	university	university	NOUN
eshr-12641	3	150	hospital	hospital	NOUN
eshr-12641	3	151	complex	complex	NOUN
eshr-12641	3	152	,	,	PUNCT
eshr-12641	3	153	n’djamena	n’djamena	PROPN
eshr-12641	3	154	,	,	PUNCT
eshr-12641	3	155	chad	chad	PROPN
eshr-12641	3	156	*	*	PROPN
eshr-12641	3	157	correspondence	correspondence	NOUN
eshr-12641	3	158	:	:	PUNCT
eshr-12641	3	159	noubaramadji.yamti@gmail.com	noubaramadji.yamti@gmail.com	X
eshr-12641	3	160	.	.	PROPN
eshr-12641	3	161	received	receive	VERB
eshr-12641	3	162	20	20	NUM
eshr-12641	3	163	january	january	NOUN
eshr-12641	3	164	2025	2025	NUM
eshr-12641	3	165	;	;	PUNCT
eshr-12641	3	166	accepted	accept	VERB
eshr-12641	3	167	02	02	NUM
eshr-12641	3	168	september	september	PROPN
eshr-12641	3	169	2025	2025	NUM
eshr-12641	3	170	;	;	PUNCT
eshr-12641	3	171	published	publish	VERB
eshr-12641	3	172	02	02	NUM
eshr-12641	3	173	september	september	PROPN
eshr-12641	3	174	2025	2025	NUM
eshr-12641	3	175	abstract	abstract	ADJ
eshr-12641	3	176	introduction	introduction	NOUN
eshr-12641	3	177	:	:	PUNCT
eshr-12641	3	178	the	the	DET
eshr-12641	3	179	metabolic	metabolic	NOUN
eshr-12641	3	180	syndrome	syndrome	NOUN
eshr-12641	3	181	(	(	PUNCT
eshr-12641	3	182	ms	ms	NOUN
eshr-12641	3	183	)	)	PUNCT
eshr-12641	3	184	is	be	AUX
eshr-12641	3	185	characterized	characterize	VERB
eshr-12641	3	186	by	by	ADP
eshr-12641	3	187	the	the	DET
eshr-12641	3	188	presence	presence	NOUN
eshr-12641	3	189	of	of	ADP
eshr-12641	3	190	at	at	ADV
eshr-12641	3	191	least	least	ADV
eshr-12641	3	192	three	three	NUM
eshr-12641	3	193	of	of	ADP
eshr-12641	3	194	the	the	DET
eshr-12641	3	195	following	follow	VERB
eshr-12641	3	196	five	five	NUM
eshr-12641	3	197	factors	factor	NOUN
eshr-12641	3	198	:	:	PUNCT
eshr-12641	3	199	abdominal	abdominal	ADJ
eshr-12641	3	200	obesity	obesity	NOUN
eshr-12641	3	201	,	,	PUNCT
eshr-12641	3	202	hypertriglyceridemia	hypertriglyceridemia	NOUN
eshr-12641	3	203	,	,	PUNCT
eshr-12641	3	204	low	low	ADJ
eshr-12641	3	205	hdl	hdl	NOUN
eshr-12641	3	206	-	-	PUNCT
eshr-12641	3	207	cholesterol	cholesterol	NOUN
eshr-12641	3	208	,	,	PUNCT
eshr-12641	3	209	glucose	glucose	NOUN
eshr-12641	3	210	intolerance	intolerance	NOUN
eshr-12641	3	211	or	or	CCONJ
eshr-12641	3	212	type	type	NOUN
eshr-12641	3	213	2	2	NUM
eshr-12641	3	214	diabetes	diabetes	NOUN
eshr-12641	3	215	,	,	PUNCT
eshr-12641	3	216	hypertension	hypertension	NOUN
eshr-12641	3	217	.	.	PUNCT
eshr-12641	4	1	it	it	PRON
eshr-12641	4	2	is	be	AUX
eshr-12641	4	3	relatively	relatively	ADV
eshr-12641	4	4	common	common	ADJ
eshr-12641	4	5	with	with	ADP
eshr-12641	4	6	a	a	DET
eshr-12641	4	7	prevalence	prevalence	NOUN
eshr-12641	4	8	that	that	PRON
eshr-12641	4	9	increases	increase	VERB
eshr-12641	4	10	with	with	ADP
eshr-12641	4	11	age	age	NOUN
eshr-12641	4	12	and	and	CCONJ
eshr-12641	4	13	predisposes	predispose	NOUN
eshr-12641	4	14	to	to	ADP
eshr-12641	4	15	the	the	DET
eshr-12641	4	16	occurrence	occurrence	NOUN
eshr-12641	4	17	of	of	ADP
eshr-12641	4	18	cardiovascular	cardiovascular	ADJ
eshr-12641	4	19	complications	complication	NOUN
eshr-12641	4	20	,	,	PUNCT
eshr-12641	4	21	hence	hence	ADV
eshr-12641	4	22	the	the	DET
eshr-12641	4	23	motivation	motivation	NOUN
eshr-12641	4	24	of	of	ADP
eshr-12641	4	25	this	this	DET
eshr-12641	4	26	study	study	NOUN
eshr-12641	4	27	,	,	PUNCT
eshr-12641	4	28	the	the	DET
eshr-12641	4	29	aim	aim	NOUN
eshr-12641	4	30	of	of	ADP
eshr-12641	4	31	which	which	PRON
eshr-12641	4	32	was	be	AUX
eshr-12641	4	33	to	to	PART
eshr-12641	4	34	determine	determine	VERB
eshr-12641	4	35	its	its	PRON
eshr-12641	4	36	prevalence	prevalence	NOUN
eshr-12641	4	37	in	in	ADP
eshr-12641	4	38	a	a	DET
eshr-12641	4	39	chadian	chadian	ADJ
eshr-12641	4	40	population	population	NOUN
eshr-12641	4	41	.	.	PUNCT
eshr-12641	5	1	method	method	NOUN
eshr-12641	5	2	:	:	PUNCT
eshr-12641	5	3	we	we	PRON
eshr-12641	5	4	conducted	conduct	VERB
eshr-12641	5	5	a	a	DET
eshr-12641	5	6	prospective	prospective	ADJ
eshr-12641	5	7	study	study	NOUN
eshr-12641	5	8	involving	involve	VERB
eshr-12641	5	9	115	115	NUM
eshr-12641	5	10	subjects	subject	NOUN
eshr-12641	5	11	aged	age	VERB
eshr-12641	5	12	20	20	NUM
eshr-12641	5	13	to	to	PART
eshr-12641	5	14	80	80	NUM
eshr-12641	5	15	received	receive	VERB
eshr-12641	5	16	at	at	ADP
eshr-12641	5	17	the	the	DET
eshr-12641	5	18	biochemistry	biochemistry	NOUN
eshr-12641	5	19	laboratory	laboratory	NOUN
eshr-12641	5	20	as	as	ADP
eshr-12641	5	21	part	part	NOUN
eshr-12641	5	22	of	of	ADP
eshr-12641	5	23	a	a	DET
eshr-12641	5	24	monthly	monthly	ADJ
eshr-12641	5	25	visit	visit	NOUN
eshr-12641	5	26	.	.	PUNCT
eshr-12641	6	1	the	the	DET
eshr-12641	6	2	anthropometric	anthropometric	ADJ
eshr-12641	6	3	and	and	CCONJ
eshr-12641	6	4	clinical	clinical	ADJ
eshr-12641	6	5	data	datum	NOUN
eshr-12641	6	6	were	be	AUX
eshr-12641	6	7	recorded	record	VERB
eshr-12641	6	8	,	,	PUNCT
eshr-12641	6	9	and	and	CCONJ
eshr-12641	6	10	the	the	DET
eshr-12641	6	11	biochemical	biochemical	ADJ
eshr-12641	6	12	parameters	parameter	NOUN
eshr-12641	6	13	were	be	AUX
eshr-12641	6	14	analyzed	analyze	VERB
eshr-12641	6	15	on	on	ADP
eshr-12641	6	16	the	the	DET
eshr-12641	6	17	pentra	pentra	PROPN
eshr-12641	6	18	c400	c400	PROPN
eshr-12641	6	19	automaton	automaton	NOUN
eshr-12641	6	20	.	.	PUNCT
eshr-12641	7	1	the	the	DET
eshr-12641	7	2	ms	ms	PROPN
eshr-12641	7	3	was	be	AUX
eshr-12641	7	4	defined	define	VERB
eshr-12641	7	5	according	accord	VERB
eshr-12641	7	6	to	to	ADP
eshr-12641	7	7	the	the	DET
eshr-12641	7	8	criteria	criterion	NOUN
eshr-12641	7	9	of	of	ADP
eshr-12641	7	10	the	the	DET
eshr-12641	7	11	ncep	ncep	PROPN
eshr-12641	7	12	-	-	PUNCT
eshr-12641	7	13	atp	atp	PROPN
eshr-12641	7	14	iii	iii	PROPN
eshr-12641	7	15	(	(	PUNCT
eshr-12641	7	16	2001	2001	NUM
eshr-12641	7	17	)	)	PUNCT
eshr-12641	7	18	.	.	PUNCT
eshr-12641	8	1	all	all	PRON
eshr-12641	8	2	of	of	ADP
eshr-12641	8	3	these	these	DET
eshr-12641	8	4	data	datum	NOUN
eshr-12641	8	5	were	be	AUX
eshr-12641	8	6	analyzed	analyze	VERB
eshr-12641	8	7	using	use	VERB
eshr-12641	8	8	excel	excel	NOUN
eshr-12641	8	9	2013	2013	NUM
eshr-12641	8	10	and	and	CCONJ
eshr-12641	8	11	ibm	ibm	PROPN
eshr-12641	8	12	spss	spss	PROPN
eshr-12641	8	13	software	software	NOUN
eshr-12641	8	14	.	.	PUNCT
eshr-12641	9	1	results	result	NOUN
eshr-12641	9	2	:	:	PUNCT
eshr-12641	9	3	in	in	ADP
eshr-12641	9	4	our	our	PRON
eshr-12641	9	5	study	study	NOUN
eshr-12641	9	6	the	the	DET
eshr-12641	9	7	prevalence	prevalence	NOUN
eshr-12641	9	8	of	of	ADP
eshr-12641	9	9	ms	ms	PROPN
eshr-12641	9	10	is	be	AUX
eshr-12641	9	11	72.2	72.2	NUM
eshr-12641	9	12	%	%	NOUN
eshr-12641	9	13	of	of	ADP
eshr-12641	9	14	cases	case	NOUN
eshr-12641	9	15	with	with	ADP
eshr-12641	9	16	a	a	DET
eshr-12641	9	17	female	female	ADJ
eshr-12641	9	18	predominance	predominance	NOUN
eshr-12641	9	19	of	of	ADP
eshr-12641	9	20	86.15	86.15	NUM
eshr-12641	9	21	%	%	NOUN
eshr-12641	9	22	and	and	CCONJ
eshr-12641	9	23	it	it	PRON
eshr-12641	9	24	increases	increase	VERB
eshr-12641	9	25	with	with	ADP
eshr-12641	9	26	age	age	NOUN
eshr-12641	9	27	.	.	PUNCT
eshr-12641	10	1	the	the	DET
eshr-12641	10	2	most	most	ADV
eshr-12641	10	3	frequent	frequent	ADJ
eshr-12641	10	4	components	component	NOUN
eshr-12641	10	5	of	of	ADP
eshr-12641	10	6	the	the	DET
eshr-12641	10	7	metabolic	metabolic	NOUN
eshr-12641	10	8	syndrome	syndrome	NOUN
eshr-12641	10	9	were	be	AUX
eshr-12641	10	10	abdominal	abdominal	ADJ
eshr-12641	10	11	obesity	obesity	NOUN
eshr-12641	10	12	(	(	PUNCT
eshr-12641	10	13	71	71	NUM
eshr-12641	10	14	%	%	NOUN
eshr-12641	10	15	)	)	PUNCT
eshr-12641	10	16	,	,	PUNCT
eshr-12641	10	17	arterial	arterial	NOUN
eshr-12641	10	18	hypertension	hypertension	NOUN
eshr-12641	10	19	(	(	PUNCT
eshr-12641	10	20	45	45	NUM
eshr-12641	10	21	%	%	NOUN
eshr-12641	10	22	)	)	PUNCT
eshr-12641	10	23	,	,	PUNCT
eshr-12641	10	24	hypo	hypo	PROPN
eshr-12641	10	25	hdl	hdl	PROPN
eshr-12641	10	26	-	-	PUNCT
eshr-12641	10	27	cholesterol	cholesterol	NOUN
eshr-12641	10	28	.	.	PUNCT
eshr-12641	11	1	conclusion	conclusion	NOUN
eshr-12641	11	2	:	:	PUNCT
eshr-12641	11	3	our	our	PRON
eshr-12641	11	4	results	result	NOUN
eshr-12641	11	5	show	show	VERB
eshr-12641	11	6	a	a	DET
eshr-12641	11	7	high	high	ADJ
eshr-12641	11	8	prevalence	prevalence	NOUN
eshr-12641	11	9	of	of	ADP
eshr-12641	11	10	ms	ms	NOUN
eshr-12641	11	11	and	and	CCONJ
eshr-12641	11	12	its	its	PRON
eshr-12641	11	13	main	main	ADJ
eshr-12641	11	14	components	component	NOUN
eshr-12641	11	15	which	which	PRON
eshr-12641	11	16	are	be	AUX
eshr-12641	11	17	abdominal	abdominal	ADJ
eshr-12641	11	18	obesity	obesity	NOUN
eshr-12641	11	19	,	,	PUNCT
eshr-12641	11	20	arterial	arterial	ADJ
eshr-12641	11	21	hypertension	hypertension	NOUN
eshr-12641	11	22	,	,	PUNCT
eshr-12641	11	23	hypo	hypo	ADJ
eshr-12641	11	24	hdl	hdl	PROPN
eshr-12641	11	25	-	-	PUNCT
eshr-12641	11	26	cholesterol	cholesterol	NOUN
eshr-12641	11	27	,	,	PUNCT
eshr-12641	11	28	explaining	explain	VERB
eshr-12641	11	29	in	in	ADP
eshr-12641	11	30	parallel	parallel	NOUN
eshr-12641	11	31	a	a	DET
eshr-12641	11	32	high	high	ADJ
eshr-12641	11	33	level	level	NOUN
eshr-12641	11	34	of	of	ADP
eshr-12641	11	35	cardiovascular	cardiovascular	ADJ
eshr-12641	11	36	risk	risk	NOUN
eshr-12641	11	37	.	.	PUNCT
eshr-12641	12	1	management	management	NOUN
eshr-12641	12	2	should	should	AUX
eshr-12641	12	3	be	be	AUX
eshr-12641	12	4	multidisciplinary	multidisciplinary	ADJ
eshr-12641	12	5	to	to	PART
eshr-12641	12	6	optimize	optimize	VERB
eshr-12641	12	7	the	the	DET
eshr-12641	12	8	risk	risk	NOUN
eshr-12641	12	9	of	of	ADP
eshr-12641	12	10	chronic	chronic	ADJ
eshr-12641	12	11	complications	complication	NOUN
eshr-12641	12	12	.	.	PUNCT
eshr-12641	13	1	keywords	keyword	NOUN
eshr-12641	13	2	:	:	PUNCT
eshr-12641	13	3	metabolic	metabolic	NOUN
eshr-12641	13	4	syndrome	syndrome	NOUN
eshr-12641	13	5	;	;	PUNCT
eshr-12641	13	6	abdominal	abdominal	ADJ
eshr-12641	13	7	obesity	obesity	NOUN
eshr-12641	13	8	;	;	PUNCT
eshr-12641	13	9	hypertension	hypertension	NOUN
eshr-12641	13	10	;	;	PUNCT
eshr-12641	13	11	chad	chad	PROPN
eshr-12641	13	12	http://journal2.uad.ac.id/index.php/eshr/index	http://journal2.uad.ac.id/index.php/eshr/index	NUM
eshr-12641	13	13	mailto:eshr@ikm.uad.ac.id	mailto:eshr@ikm.uad.ac.id	PROPN
eshr-12641	13	14	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	13	15	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	13	16	mailto:noubaramadji.yamti@gmail.com	mailto:noubaramadji.yamti@gmail.com	X
eshr-12641	13	17	noubaramadji	noubaramadji	NOUN
eshr-12641	13	18	yamti	yamti	PROPN
eshr-12641	13	19	et	et	PROPN
eshr-12641	13	20	al	al	PROPN
eshr-12641	13	21	.	.	PUNCT
eshr-12641	14	1	(	(	PUNCT
eshr-12641	14	2	prevalence	prevalence	NOUN
eshr-12641	14	3	of	of	ADP
eshr-12641	14	4	metabolic	metabolic	NOUN
eshr-12641	14	5	syndrome	syndrome	NOUN
eshr-12641	14	6	among	among	ADP
eshr-12641	14	7	patients	patient	NOUN
eshr-12641	14	8	with	with	ADP
eshr-12641	14	9	type	type	NOUN
eshr-12641	14	10	2	2	NUM
eshr-12641	14	11	diabetes	diabetes	NOUN
eshr-12641	14	12	…	…	PUNCT
eshr-12641	14	13	)	)	PUNCT
eshr-12641	14	14	vol	vol	NOUN
eshr-12641	14	15	.	.	PROPN
eshr-12641	15	1	7	7	NUM
eshr-12641	15	2	,	,	PUNCT
eshr-12641	15	3	no	no	INTJ
eshr-12641	15	4	.	.	NOUN
eshr-12641	15	5	2	2	NUM
eshr-12641	15	6	,	,	PUNCT
eshr-12641	15	7	2025	2025	NUM
eshr-12641	15	8	,	,	PUNCT
eshr-12641	15	9	pp	pp	ADJ
eshr-12641	15	10	.	.	PUNCT
eshr-12641	16	1	87	87	NUM
eshr-12641	16	2	-	-	SYM
eshr-12641	16	3	95	95	NUM
eshr-12641	16	4	88	88	NUM
eshr-12641	16	5	10.26555	10.26555	NUM
eshr-12641	16	6	/	/	SYM
eshr-12641	16	7	eshr.v7i2.12641	eshr.v7i2.12641	PROPN
eshr-12641	16	8	introduction	introduction	NOUN
eshr-12641	16	9	metabolic	metabolic	NOUN
eshr-12641	16	10	syndrome	syndrome	NOUN
eshr-12641	16	11	(	(	PUNCT
eshr-12641	16	12	ms	ms	NOUN
eshr-12641	16	13	)	)	PUNCT
eshr-12641	16	14	is	be	AUX
eshr-12641	16	15	characterized	characterize	VERB
eshr-12641	16	16	by	by	ADP
eshr-12641	16	17	the	the	DET
eshr-12641	16	18	presence	presence	NOUN
eshr-12641	16	19	of	of	ADP
eshr-12641	16	20	several	several	ADJ
eshr-12641	16	21	metabolic	metabolic	NOUN
eshr-12641	16	22	abnormalities	abnormality	NOUN
eshr-12641	16	23	including	include	VERB
eshr-12641	16	24	at	at	ADV
eshr-12641	16	25	least	least	ADV
eshr-12641	16	26	three	three	NUM
eshr-12641	16	27	of	of	ADP
eshr-12641	16	28	the	the	DET
eshr-12641	16	29	five	five	NUM
eshr-12641	16	30	associated	associated	ADJ
eshr-12641	16	31	factors	factor	NOUN
eshr-12641	16	32	in	in	ADP
eshr-12641	16	33	the	the	DET
eshr-12641	16	34	same	same	ADJ
eshr-12641	16	35	individual	individual	NOUN
eshr-12641	16	36	(	(	PUNCT
eshr-12641	16	37	abdominal	abdominal	ADJ
eshr-12641	16	38	obesity	obesity	NOUN
eshr-12641	16	39	,	,	PUNCT
eshr-12641	16	40	hypertriglyceridemia	hypertriglyceridemia	NOUN
eshr-12641	16	41	,	,	PUNCT
eshr-12641	16	42	low	low	ADJ
eshr-12641	16	43	hdl	hdl	NOUN
eshr-12641	16	44	-	-	PUNCT
eshr-12641	16	45	cholesterol	cholesterol	NOUN
eshr-12641	16	46	,	,	PUNCT
eshr-12641	16	47	glucose	glucose	NOUN
eshr-12641	16	48	intolerance	intolerance	NOUN
eshr-12641	16	49	or	or	CCONJ
eshr-12641	16	50	type	type	NOUN
eshr-12641	16	51	2	2	NUM
eshr-12641	16	52	diabetes	diabetes	NOUN
eshr-12641	16	53	,	,	PUNCT
eshr-12641	16	54	hypertension	hypertension	NOUN
eshr-12641	16	55	)	)	PUNCT
eshr-12641	16	56	.	.	PUNCT
eshr-12641	17	1	it	it	PRON
eshr-12641	17	2	is	be	AUX
eshr-12641	17	3	a	a	DET
eshr-12641	17	4	major	major	ADJ
eshr-12641	17	5	risk	risk	NOUN
eshr-12641	17	6	factor	factor	NOUN
eshr-12641	17	7	for	for	ADP
eshr-12641	17	8	cardiovascular	cardiovascular	ADJ
eshr-12641	17	9	disease	disease	NOUN
eshr-12641	17	10	and	and	CCONJ
eshr-12641	17	11	type	type	NOUN
eshr-12641	17	12	2	2	NUM
eshr-12641	17	13	diabetes	diabetes	NOUN
eshr-12641	17	14	(	(	PUNCT
eshr-12641	17	15	t2	t2	NOUN
eshr-12641	17	16	dm	dm	PROPN
eshr-12641	17	17	)	)	PUNCT
eshr-12641	17	18	.	.	PUNCT
eshr-12641	18	1	added	add	VERB
eshr-12641	18	2	to	to	ADP
eshr-12641	18	3	this	this	PRON
eshr-12641	18	4	is	be	AUX
eshr-12641	18	5	the	the	DET
eshr-12641	18	6	risk	risk	NOUN
eshr-12641	18	7	of	of	ADP
eshr-12641	18	8	chronic	chronic	ADJ
eshr-12641	18	9	pro	pro	ADJ
eshr-12641	18	10	-	-	ADJ
eshr-12641	18	11	inflammatory	inflammatory	ADJ
eshr-12641	18	12	,	,	PUNCT
eshr-12641	18	13	pro	pro	ADJ
eshr-12641	18	14	-	-	ADJ
eshr-12641	18	15	thrombotic	thrombotic	ADJ
eshr-12641	18	16	conditions	condition	NOUN
eshr-12641	18	17	and	and	CCONJ
eshr-12641	18	18	nonalcoholic	nonalcoholic	NOUN
eshr-12641	18	19	fatty	fatty	NOUN
eshr-12641	18	20	liver	liver	NOUN
eshr-12641	18	21	disease.1	disease.1	AUX
eshr-12641	18	22	first	first	ADV
eshr-12641	18	23	called	call	VERB
eshr-12641	18	24	syndrome	syndrome	PROPN
eshr-12641	18	25	x	x	SYM
eshr-12641	18	26	,	,	PUNCT
eshr-12641	18	27	then	then	ADV
eshr-12641	18	28	insulin	insulin	NOUN
eshr-12641	18	29	resistance	resistance	NOUN
eshr-12641	18	30	syndrome	syndrome	NOUN
eshr-12641	18	31	,	,	PUNCT
eshr-12641	18	32	ms	ms	PROPN
eshr-12641	18	33	has	have	AUX
eshr-12641	18	34	had	have	VERB
eshr-12641	18	35	several	several	ADJ
eshr-12641	18	36	definitions	definition	NOUN
eshr-12641	18	37	during	during	ADP
eshr-12641	18	38	its	its	PRON
eshr-12641	18	39	evolution.1	evolution.1	PROPN
eshr-12641	18	40	in	in	ADP
eshr-12641	18	41	the	the	DET
eshr-12641	18	42	world	world	NOUN
eshr-12641	18	43	,	,	PUNCT
eshr-12641	18	44	its	its	PRON
eshr-12641	18	45	prevalence	prevalence	NOUN
eshr-12641	18	46	varies	vary	VERB
eshr-12641	18	47	according	accord	VERB
eshr-12641	18	48	to	to	ADP
eshr-12641	18	49	the	the	DET
eshr-12641	18	50	country	country	NOUN
eshr-12641	18	51	but	but	CCONJ
eshr-12641	18	52	also	also	ADV
eshr-12641	18	53	according	accord	VERB
eshr-12641	18	54	to	to	ADP
eshr-12641	18	55	the	the	DET
eshr-12641	18	56	definitions	definition	NOUN
eshr-12641	18	57	used	use	VERB
eshr-12641	18	58	.	.	PUNCT
eshr-12641	19	1	in	in	ADP
eshr-12641	19	2	europe	europe	PROPN
eshr-12641	19	3	,	,	PUNCT
eshr-12641	19	4	the	the	DET
eshr-12641	19	5	prevalence	prevalence	NOUN
eshr-12641	19	6	is	be	AUX
eshr-12641	19	7	around	around	ADV
eshr-12641	19	8	20	20	NUM
eshr-12641	19	9	%	%	NOUN
eshr-12641	19	10	,	,	PUNCT
eshr-12641	19	11	whereas	whereas	SCONJ
eshr-12641	19	12	in	in	ADP
eshr-12641	19	13	the	the	DET
eshr-12641	19	14	united	united	PROPN
eshr-12641	19	15	states	states	PROPN
eshr-12641	19	16	the	the	DET
eshr-12641	19	17	figures	figure	NOUN
eshr-12641	19	18	are	be	AUX
eshr-12641	19	19	higher.2	higher.2	PROPN
eshr-12641	19	20	in	in	ADP
eshr-12641	19	21	africa	africa	PROPN
eshr-12641	19	22	,	,	PUNCT
eshr-12641	19	23	there	there	PRON
eshr-12641	19	24	are	be	VERB
eshr-12641	19	25	few	few	ADJ
eshr-12641	19	26	data	datum	NOUN
eshr-12641	19	27	on	on	ADP
eshr-12641	19	28	ms	ms	PROPN
eshr-12641	19	29	apart	apart	ADV
eshr-12641	19	30	from	from	ADP
eshr-12641	19	31	a	a	DET
eshr-12641	19	32	few	few	ADJ
eshr-12641	19	33	countries	country	NOUN
eshr-12641	19	34	such	such	ADJ
eshr-12641	19	35	as	as	ADP
eshr-12641	19	36	tunisia	tunisia	PROPN
eshr-12641	19	37	,	,	PUNCT
eshr-12641	19	38	ivory	ivory	PROPN
eshr-12641	19	39	coast	coast	PROPN
eshr-12641	19	40	and	and	CCONJ
eshr-12641	19	41	burkina	burkina	PROPN
eshr-12641	19	42	where	where	SCONJ
eshr-12641	19	43	prevalence	prevalence	NOUN
eshr-12641	19	44	of	of	ADP
eshr-12641	19	45	about	about	ADV
eshr-12641	19	46	7	7	NUM
eshr-12641	19	47	%	%	NOUN
eshr-12641	19	48	have	have	AUX
eshr-12641	19	49	been	be	AUX
eshr-12641	19	50	reported.3	reported.3	ADJ
eshr-12641	19	51	several	several	ADJ
eshr-12641	19	52	studies	study	NOUN
eshr-12641	19	53	carried	carry	VERB
eshr-12641	19	54	out	out	ADP
eshr-12641	19	55	both	both	PRON
eshr-12641	19	56	in	in	ADP
eshr-12641	19	57	the	the	DET
eshr-12641	19	58	general	general	ADJ
eshr-12641	19	59	diabetic	diabetic	ADJ
eshr-12641	19	60	population	population	NOUN
eshr-12641	19	61	and	and	CCONJ
eshr-12641	19	62	among	among	ADP
eshr-12641	19	63	target	target	NOUN
eshr-12641	19	64	groups	group	NOUN
eshr-12641	19	65	have	have	AUX
eshr-12641	19	66	demonstrated	demonstrate	VERB
eshr-12641	19	67	the	the	DET
eshr-12641	19	68	increasing	increase	VERB
eshr-12641	19	69	frequency	frequency	NOUN
eshr-12641	19	70	of	of	ADP
eshr-12641	19	71	metabolic	metabolic	NOUN
eshr-12641	19	72	syndrome	syndrome	NOUN
eshr-12641	19	73	and	and	CCONJ
eshr-12641	19	74	its	its	PRON
eshr-12641	19	75	consistent	consistent	ADJ
eshr-12641	19	76	association	association	NOUN
eshr-12641	19	77	with	with	ADP
eshr-12641	19	78	diabetes4	diabetes4	ADJ
eshr-12641	19	79	and	and	CCONJ
eshr-12641	19	80	cardiovascular	cardiovascular	ADJ
eshr-12641	19	81	disease5	disease5	PROPN
eshr-12641	19	82	.	.	PUNCT
eshr-12641	20	1	worldwide	worldwide	ADV
eshr-12641	20	2	,	,	PUNCT
eshr-12641	20	3	its	its	PRON
eshr-12641	20	4	prevalence	prevalence	NOUN
eshr-12641	20	5	varies	vary	VERB
eshr-12641	20	6	not	not	PART
eshr-12641	20	7	only	only	ADV
eshr-12641	20	8	from	from	ADP
eshr-12641	20	9	country	country	NOUN
eshr-12641	20	10	to	to	ADP
eshr-12641	20	11	country	country	NOUN
eshr-12641	20	12	,	,	PUNCT
eshr-12641	20	13	but	but	CCONJ
eshr-12641	20	14	also	also	ADV
eshr-12641	20	15	according	accord	VERB
eshr-12641	20	16	to	to	ADP
eshr-12641	20	17	the	the	DET
eshr-12641	20	18	definitions	definition	NOUN
eshr-12641	20	19	used	use	VERB
eshr-12641	20	20	.	.	PUNCT
eshr-12641	21	1	diagnostic	diagnostic	ADJ
eshr-12641	21	2	criteria	criterion	NOUN
eshr-12641	21	3	for	for	ADP
eshr-12641	21	4	ms	ms	PROPN
eshr-12641	21	5	have	have	AUX
eshr-12641	21	6	been	be	AUX
eshr-12641	21	7	proposed	propose	VERB
eshr-12641	21	8	by	by	ADP
eshr-12641	21	9	many	many	ADJ
eshr-12641	21	10	groups	group	NOUN
eshr-12641	21	11	,	,	PUNCT
eshr-12641	21	12	including	include	VERB
eshr-12641	21	13	the	the	DET
eshr-12641	21	14	world	world	NOUN
eshr-12641	21	15	health	health	NOUN
eshr-12641	21	16	organization	organization	NOUN
eshr-12641	21	17	(	(	PUNCT
eshr-12641	21	18	who	who	PRON
eshr-12641	21	19	,	,	PUNCT
eshr-12641	21	20	1998	1998	NUM
eshr-12641	21	21	)	)	PUNCT
eshr-12641	21	22	,	,	PUNCT
eshr-12641	21	23	the	the	DET
eshr-12641	21	24	european	european	ADJ
eshr-12641	21	25	group	group	NOUN
eshr-12641	21	26	for	for	ADP
eshr-12641	21	27	the	the	DET
eshr-12641	21	28	study	study	NOUN
eshr-12641	21	29	of	of	ADP
eshr-12641	21	30	insulin	insulin	NOUN
eshr-12641	21	31	resistance	resistance	NOUN
eshr-12641	21	32	(	(	PUNCT
eshr-12641	21	33	egir	egir	PROPN
eshr-12641	21	34	,	,	PUNCT
eshr-12641	21	35	1999),6	1999),6	NUM
eshr-12641	21	36	the	the	DET
eshr-12641	21	37	american	american	PROPN
eshr-12641	21	38	association	association	PROPN
eshr-12641	21	39	of	of	ADP
eshr-12641	21	40	clinical	clinical	ADJ
eshr-12641	21	41	endocrinologists	endocrinologist	NOUN
eshr-12641	21	42	(	(	PUNCT
eshr-12641	21	43	aace	aace	NOUN
eshr-12641	21	44	,	,	PUNCT
eshr-12641	21	45	2003),7	2003),7	NUM
eshr-12641	21	46	the	the	DET
eshr-12641	21	47	national	national	ADJ
eshr-12641	21	48	cholesterol	cholesterol	PROPN
eshr-12641	21	49	education	education	NOUN
eshr-12641	21	50	program	program	NOUN
eshr-12641	21	51	adult	adult	NOUN
eshr-12641	21	52	treatment	treatment	NOUN
eshr-12641	21	53	panel	panel	NOUN
eshr-12641	21	54	iii	iii	PROPN
eshr-12641	21	55	(	(	PUNCT
eshr-12641	21	56	ncep	ncep	NOUN
eshr-12641	21	57	-	-	PUNCT
eshr-12641	21	58	atp	atp	PROPN
eshr-12641	21	59	iii	iii	PROPN
eshr-12641	21	60	,	,	PUNCT
eshr-12641	21	61	2001)8	2001)8	NUM
eshr-12641	21	62	,	,	PUNCT
eshr-12641	21	63	the	the	DET
eshr-12641	21	64	national	national	ADJ
eshr-12641	21	65	cholesterol	cholesterol	PROPN
eshr-12641	21	66	education	education	NOUN
eshr-12641	21	67	program	program	NOUN
eshr-12641	21	68	revised	revise	VERB
eshr-12641	21	69	adult	adult	NOUN
eshr-12641	21	70	treatment	treatment	NOUN
eshr-12641	21	71	panel	panel	NOUN
eshr-12641	21	72	iii	iii	PROPN
eshr-12641	21	73	(	(	PUNCT
eshr-12641	21	74	ncep	ncep	NOUN
eshr-12641	21	75	-	-	PUNCT
eshr-12641	21	76	atp	atp	PROPN
eshr-12641	21	77	iii	iii	PROPN
eshr-12641	21	78	revised	revise	VERB
eshr-12641	21	79	,	,	PUNCT
eshr-12641	21	80	2005)9	2005)9	NUM
eshr-12641	21	81	,	,	PUNCT
eshr-12641	21	82	the	the	DET
eshr-12641	21	83	international	international	ADJ
eshr-12641	21	84	diabetes	diabetes	PROPN
eshr-12641	21	85	federation	federation	PROPN
eshr-12641	21	86	(	(	PUNCT
eshr-12641	21	87	idf	idf	PROPN
eshr-12641	21	88	,	,	PUNCT
eshr-12641	21	89	2005),10	2005),10	NUM
eshr-12641	21	90	and	and	CCONJ
eshr-12641	21	91	a	a	DET
eshr-12641	21	92	consensus	consensus	NOUN
eshr-12641	21	93	between	between	ADP
eshr-12641	21	94	the	the	DET
eshr-12641	21	95	aha	aha	PROPN
eshr-12641	21	96	/	/	SYM
eshr-12641	21	97	nhlbi	nhlbi	PROPN
eshr-12641	21	98	and	and	CCONJ
eshr-12641	21	99	idf	idf	PROPN
eshr-12641	21	100	(	(	PUNCT
eshr-12641	21	101	joint	joint	ADJ
eshr-12641	21	102	interim	interim	ADJ
eshr-12641	21	103	statement	statement	NOUN
eshr-12641	21	104	,	,	PUNCT
eshr-12641	21	105	2009).11	2009).11	PROPN
eshr-12641	21	106	there	there	PRON
eshr-12641	21	107	is	be	VERB
eshr-12641	21	108	agreement	agreement	NOUN
eshr-12641	21	109	about	about	ADP
eshr-12641	21	110	the	the	DET
eshr-12641	21	111	various	various	ADJ
eshr-12641	21	112	components	component	NOUN
eshr-12641	21	113	of	of	ADP
eshr-12641	21	114	ms	ms	NOUN
eshr-12641	21	115	,	,	PUNCT
eshr-12641	21	116	but	but	CCONJ
eshr-12641	21	117	there	there	PRON
eshr-12641	21	118	are	be	VERB
eshr-12641	21	119	differences	difference	NOUN
eshr-12641	21	120	in	in	ADP
eshr-12641	21	121	the	the	DET
eshr-12641	21	122	details	detail	NOUN
eshr-12641	21	123	of	of	ADP
eshr-12641	21	124	the	the	DET
eshr-12641	21	125	criteria	criterion	NOUN
eshr-12641	21	126	used	use	VERB
eshr-12641	21	127	to	to	PART
eshr-12641	21	128	describe	describe	VERB
eshr-12641	21	129	them	they	PRON
eshr-12641	21	130	and	and	CCONJ
eshr-12641	21	131	their	their	PRON
eshr-12641	21	132	cut	cut	VERB
eshr-12641	21	133	-	-	PUNCT
eshr-12641	21	134	off	off	ADP
eshr-12641	21	135	values.12	values.12	NOUN
eshr-12641	21	136	several	several	ADJ
eshr-12641	21	137	studies	study	NOUN
eshr-12641	21	138	conducted	conduct	VERB
eshr-12641	21	139	both	both	PRON
eshr-12641	21	140	in	in	ADP
eshr-12641	21	141	the	the	DET
eshr-12641	21	142	general	general	ADJ
eshr-12641	21	143	diabetic	diabetic	ADJ
eshr-12641	21	144	population	population	NOUN
eshr-12641	21	145	and	and	CCONJ
eshr-12641	21	146	among	among	ADP
eshr-12641	21	147	target	target	NOUN
eshr-12641	21	148	groups	group	NOUN
eshr-12641	21	149	have	have	AUX
eshr-12641	21	150	demonstrated	demonstrate	VERB
eshr-12641	21	151	the	the	DET
eshr-12641	21	152	increasing	increase	VERB
eshr-12641	21	153	prevalence	prevalence	NOUN
eshr-12641	21	154	of	of	ADP
eshr-12641	21	155	metabolic	metabolic	NOUN
eshr-12641	21	156	syndrome	syndrome	NOUN
eshr-12641	21	157	and	and	CCONJ
eshr-12641	21	158	its	its	PRON
eshr-12641	21	159	consistent	consistent	ADJ
eshr-12641	21	160	association	association	NOUN
eshr-12641	21	161	with	with	ADP
eshr-12641	21	162	diabetes13,14	diabetes13,14	ADV
eshr-12641	21	163	and	and	CCONJ
eshr-12641	21	164	cardiovascular	cardiovascular	ADJ
eshr-12641	21	165	diseases	disease	NOUN
eshr-12641	21	166	.	.	PUNCT
eshr-12641	22	1	globally	globally	ADV
eshr-12641	22	2	,	,	PUNCT
eshr-12641	22	3	its	its	PRON
eshr-12641	22	4	prevalence	prevalence	NOUN
eshr-12641	22	5	varies	vary	VERB
eshr-12641	22	6	not	not	PART
eshr-12641	22	7	only	only	ADV
eshr-12641	22	8	between	between	ADP
eshr-12641	22	9	countries	country	NOUN
eshr-12641	22	10	but	but	CCONJ
eshr-12641	22	11	also	also	ADV
eshr-12641	22	12	according	accord	VERB
eshr-12641	22	13	to	to	ADP
eshr-12641	22	14	the	the	DET
eshr-12641	22	15	definitions	definition	NOUN
eshr-12641	22	16	used.15	used.15	INTJ
eshr-12641	22	17	none	none	NOUN
eshr-12641	22	18	of	of	ADP
eshr-12641	22	19	these	these	DET
eshr-12641	22	20	definitions	definition	NOUN
eshr-12641	22	21	have	have	AUX
eshr-12641	22	22	been	be	AUX
eshr-12641	22	23	established	establish	VERB
eshr-12641	22	24	on	on	ADP
eshr-12641	22	25	a	a	DET
eshr-12641	22	26	sample	sample	NOUN
eshr-12641	22	27	of	of	ADP
eshr-12641	22	28	african	african	ADJ
eshr-12641	22	29	,	,	PUNCT
eshr-12641	22	30	but	but	CCONJ
eshr-12641	22	31	mainly	mainly	ADV
eshr-12641	22	32	western	western	ADJ
eshr-12641	22	33	,	,	PUNCT
eshr-12641	22	34	individuals	individual	NOUN
eshr-12641	22	35	,	,	PUNCT
eshr-12641	22	36	making	make	VERB
eshr-12641	22	37	it	it	PRON
eshr-12641	22	38	difficult	difficult	ADJ
eshr-12641	22	39	to	to	PART
eshr-12641	22	40	choose	choose	VERB
eshr-12641	22	41	one	one	NUM
eshr-12641	22	42	of	of	ADP
eshr-12641	22	43	the	the	DET
eshr-12641	22	44	definitions	definition	NOUN
eshr-12641	22	45	for	for	ADP
eshr-12641	22	46	studies	study	NOUN
eshr-12641	22	47	done	do	VERB
eshr-12641	22	48	in	in	ADP
eshr-12641	22	49	africa.16	africa.16	PROPN
eshr-12641	22	50	this	this	PRON
eshr-12641	22	51	sometimes	sometimes	ADV
eshr-12641	22	52	justifies	justify	VERB
eshr-12641	22	53	the	the	DET
eshr-12641	22	54	use	use	NOUN
eshr-12641	22	55	of	of	ADP
eshr-12641	22	56	several	several	ADJ
eshr-12641	22	57	definitions	definition	NOUN
eshr-12641	22	58	.	.	PUNCT
eshr-12641	23	1	previously	previously	ADV
eshr-12641	23	2	thought	think	VERB
eshr-12641	23	3	to	to	PART
eshr-12641	23	4	be	be	AUX
eshr-12641	23	5	uncommon	uncommon	ADJ
eshr-12641	23	6	in	in	ADP
eshr-12641	23	7	africa	africa	PROPN
eshr-12641	23	8	,	,	PUNCT
eshr-12641	23	9	numerous	numerous	ADJ
eshr-12641	23	10	studies	study	NOUN
eshr-12641	23	11	have	have	AUX
eshr-12641	23	12	revealed	reveal	VERB
eshr-12641	23	13	higher	high	ADJ
eshr-12641	23	14	prevalence	prevalence	NOUN
eshr-12641	23	15	in	in	ADP
eshr-12641	23	16	various	various	ADJ
eshr-12641	23	17	sub	sub	ADJ
eshr-12641	23	18	-	-	ADJ
eshr-12641	23	19	saharan	saharan	ADJ
eshr-12641	23	20	african	african	ADJ
eshr-12641	23	21	countries	country	NOUN
eshr-12641	23	22	,	,	PUNCT
eshr-12641	23	23	most	most	ADV
eshr-12641	23	24	notably	notably	ADV
eshr-12641	23	25	in	in	ADP
eshr-12641	23	26	nigeria	nigeria	PROPN
eshr-12641	23	27	(	(	PUNCT
eshr-12641	23	28	23%)17	23%)17	NUM
eshr-12641	23	29	and	and	CCONJ
eshr-12641	23	30	ghana	ghana	PROPN
eshr-12641	23	31	(	(	PUNCT
eshr-12641	23	32	41.8%);18	41.8%);18	NUM
eshr-12641	23	33	and	and	CCONJ
eshr-12641	23	34	in	in	ADP
eshr-12641	23	35	north	north	ADJ
eshr-12641	23	36	african	african	ADJ
eshr-12641	23	37	countries	country	NOUN
eshr-12641	23	38	with	with	ADP
eshr-12641	23	39	prevalence	prevalence	NOUN
eshr-12641	23	40	of	of	ADP
eshr-12641	23	41	39.6	39.6	NUM
eshr-12641	23	42	%	%	NOUN
eshr-12641	23	43	and	and	CCONJ
eshr-12641	23	44	48.5	48.5	NUM
eshr-12641	23	45	%	%	NOUN
eshr-12641	23	46	observed	observe	VERB
eshr-12641	23	47	in	in	ADP
eshr-12641	23	48	tunisia	tunisia	PROPN
eshr-12641	23	49	and	and	CCONJ
eshr-12641	23	50	morocco	morocco	PROPN
eshr-12641	23	51	respectively.19,20	respectively.19,20	NOUN
eshr-12641	23	52	because	because	SCONJ
eshr-12641	23	53	of	of	ADP
eshr-12641	23	54	the	the	DET
eshr-12641	23	55	rapid	rapid	ADJ
eshr-12641	23	56	rise	rise	NOUN
eshr-12641	23	57	in	in	ADP
eshr-12641	23	58	ms	ms	PROPN
eshr-12641	23	59	,	,	PUNCT
eshr-12641	23	60	non	non	ADJ
eshr-12641	23	61	-	-	ADJ
eshr-12641	23	62	communicable	communicable	ADJ
eshr-12641	23	63	diseases	disease	NOUN
eshr-12641	23	64	(	(	PUNCT
eshr-12641	23	65	ncds	ncds	ADV
eshr-12641	23	66	)	)	PUNCT
eshr-12641	23	67	such	such	ADJ
eshr-12641	23	68	.	.	PUNCT
eshr-12641	24	1	due	due	ADP
eshr-12641	24	2	to	to	ADP
eshr-12641	24	3	the	the	DET
eshr-12641	24	4	dramatic	dramatic	ADJ
eshr-12641	24	5	increase	increase	NOUN
eshr-12641	24	6	in	in	ADP
eshr-12641	24	7	urbanization	urbanization	NOUN
eshr-12641	24	8	,	,	PUNCT
eshr-12641	24	9	smoking	smoking	NOUN
eshr-12641	24	10	,	,	PUNCT
eshr-12641	24	11	severe	severe	ADJ
eshr-12641	24	12	stress	stress	NOUN
eshr-12641	24	13	-	-	PUNCT
eshr-12641	24	14	related	relate	VERB
eshr-12641	24	15	problems	problem	NOUN
eshr-12641	24	16	of	of	ADP
eshr-12641	24	17	poverty	poverty	NOUN
eshr-12641	24	18	,	,	PUNCT
eshr-12641	24	19	nutrition	nutrition	NOUN
eshr-12641	24	20	transition	transition	NOUN
eshr-12641	24	21	,	,	PUNCT
eshr-12641	24	22	reduced	reduce	VERB
eshr-12641	24	23	physical	physical	ADJ
eshr-12641	24	24	activity	activity	NOUN
eshr-12641	24	25	,	,	PUNCT
eshr-12641	24	26	and	and	CCONJ
eshr-12641	24	27	over	over	ADP
eshr-12641	24	28	nutrition	nutrition	NOUN
eshr-12641	24	29	increasing	increase	VERB
eshr-12641	24	30	on	on	ADP
eshr-12641	24	31	top	top	NOUN
eshr-12641	24	32	of	of	ADP
eshr-12641	24	33	the	the	DET
eshr-12641	24	34	already	already	ADV
eshr-12641	24	35	high	high	ADJ
eshr-12641	24	36	prevalence	prevalence	NOUN
eshr-12641	24	37	of	of	ADP
eshr-12641	24	38	undernutrition	undernutrition	NOUN
eshr-12641	24	39	,	,	PUNCT
eshr-12641	24	40	sub	sub	ADJ
eshr-12641	24	41	-	-	ADJ
eshr-12641	24	42	saharan	saharan	ADJ
eshr-12641	24	43	africa	africa	PROPN
eshr-12641	24	44	is	be	AUX
eshr-12641	24	45	facing	face	VERB
eshr-12641	24	46	a	a	DET
eshr-12641	24	47	rapid	rapid	ADJ
eshr-12641	24	48	escalation	escalation	NOUN
eshr-12641	24	49	of	of	ADP
eshr-12641	24	50	ms	ms	NOUN
eshr-12641	24	51	and	and	CCONJ
eshr-12641	24	52	noncommunicable	noncommunicable	ADJ
eshr-12641	24	53	chronic	chronic	ADJ
eshr-12641	24	54	diseases	disease	NOUN
eshr-12641	24	55	and	and	CCONJ
eshr-12641	24	56	associated	associated	ADJ
eshr-12641	24	57	mortality21	mortality21	NOUN
eshr-12641	24	58	and	and	CCONJ
eshr-12641	24	59	particularly	particularly	ADV
eshr-12641	24	60	chad	chad	VERB
eshr-12641	24	61	,	,	PUNCT
eshr-12641	24	62	we	we	PRON
eshr-12641	24	63	have	have	AUX
eshr-12641	24	64	set	set	VERB
eshr-12641	24	65	ourselves	ourselves	PRON
eshr-12641	24	66	the	the	DET
eshr-12641	24	67	objective	objective	NOUN
eshr-12641	24	68	to	to	PART
eshr-12641	24	69	determine	determine	VERB
eshr-12641	24	70	the	the	DET
eshr-12641	24	71	prevalence	prevalence	NOUN
eshr-12641	24	72	of	of	ADP
eshr-12641	24	73	the	the	DET
eshr-12641	24	74	metabolic	metabolic	NOUN
eshr-12641	24	75	syndrome	syndrome	NOUN
eshr-12641	24	76	and	and	CCONJ
eshr-12641	24	77	its	its	PRON
eshr-12641	24	78	components	component	NOUN
eshr-12641	24	79	in	in	ADP
eshr-12641	24	80	type	type	NOUN
eshr-12641	24	81	2	2	NUM
eshr-12641	24	82	diabetics	diabetic	NOUN
eshr-12641	24	83	in	in	ADP
eshr-12641	24	84	a	a	DET
eshr-12641	24	85	chadian	chadian	ADJ
eshr-12641	24	86	population	population	NOUN
eshr-12641	24	87	.	.	PUNCT
eshr-12641	25	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	25	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	25	3	noubaramadji	noubaramadji	NOUN
eshr-12641	25	4	yamti	yamti	PROPN
eshr-12641	25	5	et	et	PROPN
eshr-12641	25	6	al	al	PROPN
eshr-12641	25	7	.	.	PUNCT
eshr-12641	26	1	(	(	PUNCT
eshr-12641	26	2	prevalence	prevalence	NOUN
eshr-12641	26	3	of	of	ADP
eshr-12641	26	4	metabolic	metabolic	NOUN
eshr-12641	26	5	syndrome	syndrome	NOUN
eshr-12641	26	6	among	among	ADP
eshr-12641	26	7	patients	patient	NOUN
eshr-12641	26	8	with	with	ADP
eshr-12641	26	9	type	type	NOUN
eshr-12641	26	10	2	2	NUM
eshr-12641	26	11	diabetes	diabetes	NOUN
eshr-12641	26	12	…	…	PUNCT
eshr-12641	26	13	)	)	PUNCT
eshr-12641	26	14	vol	vol	NOUN
eshr-12641	26	15	.	.	PROPN
eshr-12641	27	1	7	7	NUM
eshr-12641	27	2	,	,	PUNCT
eshr-12641	27	3	no	no	INTJ
eshr-12641	27	4	.	.	NOUN
eshr-12641	27	5	2	2	NUM
eshr-12641	27	6	,	,	PUNCT
eshr-12641	27	7	2025	2025	NUM
eshr-12641	27	8	,	,	PUNCT
eshr-12641	27	9	pp	pp	ADJ
eshr-12641	27	10	.	.	PUNCT
eshr-12641	28	1	87	87	NUM
eshr-12641	28	2	-	-	SYM
eshr-12641	28	3	95	95	NUM
eshr-12641	28	4	89	89	NUM
eshr-12641	28	5	10.26555	10.26555	NUM
eshr-12641	28	6	/	/	SYM
eshr-12641	28	7	eshr.v7i2.12641	eshr.v7i2.12641	PROPN
eshr-12641	28	8	method	method	NOUN
eshr-12641	28	9	type	type	NOUN
eshr-12641	28	10	,	,	PUNCT
eshr-12641	28	11	and	and	CCONJ
eshr-12641	28	12	study	study	VERB
eshr-12641	28	13	population	population	NOUN
eshr-12641	28	14	this	this	PRON
eshr-12641	28	15	was	be	AUX
eshr-12641	28	16	a	a	DET
eshr-12641	28	17	descriptive	descriptive	ADJ
eshr-12641	28	18	and	and	CCONJ
eshr-12641	28	19	analytical	analytical	ADJ
eshr-12641	28	20	cross	cross	ADJ
eshr-12641	28	21	-	-	ADJ
eshr-12641	28	22	sectional	sectional	ADJ
eshr-12641	28	23	study	study	NOUN
eshr-12641	28	24	involving	involve	VERB
eshr-12641	28	25	115	115	NUM
eshr-12641	28	26	subjects	subject	NOUN
eshr-12641	28	27	received	receive	VERB
eshr-12641	28	28	for	for	ADP
eshr-12641	28	29	monthly	monthly	ADJ
eshr-12641	28	30	diabetic	diabetic	ADJ
eshr-12641	28	31	follow	follow	NOUN
eshr-12641	28	32	-	-	PUNCT
eshr-12641	28	33	up	up	NOUN
eshr-12641	28	34	in	in	ADP
eshr-12641	28	35	the	the	DET
eshr-12641	28	36	laboratory	laboratory	NOUN
eshr-12641	28	37	of	of	ADP
eshr-12641	28	38	the	the	DET
eshr-12641	28	39	"	"	PUNCT
eshr-12641	28	40	le	le	X
eshr-12641	28	41	bon	bon	PROPN
eshr-12641	28	42	samaritain	samaritain	PROPN
eshr-12641	28	43	"	"	PUNCT
eshr-12641	28	44	university	university	NOUN
eshr-12641	28	45	hospital	hospital	NOUN
eshr-12641	28	46	complex	complex	NOUN
eshr-12641	28	47	(	(	PUNCT
eshr-12641	28	48	chu	chu	NOUN
eshr-12641	28	49	-	-	PUNCT
eshr-12641	28	50	bs	bs	NOUN
eshr-12641	28	51	)	)	PUNCT
eshr-12641	28	52	in	in	ADP
eshr-12641	28	53	n'djamena	n'djamena	PROPN
eshr-12641	28	54	,	,	PUNCT
eshr-12641	28	55	chad	chad	PROPN
eshr-12641	28	56	.	.	PROPN
eshr-12641	28	57	included	include	VERB
eshr-12641	28	58	in	in	ADP
eshr-12641	28	59	the	the	DET
eshr-12641	28	60	study	study	NOUN
eshr-12641	28	61	were	be	AUX
eshr-12641	28	62	all	all	PRON
eshr-12641	28	63	subjects	subject	NOUN
eshr-12641	28	64	who	who	PRON
eshr-12641	28	65	had	have	AUX
eshr-12641	28	66	undergone	undergo	VERB
eshr-12641	28	67	a	a	DET
eshr-12641	28	68	blood	blood	NOUN
eshr-12641	28	69	test	test	NOUN
eshr-12641	28	70	(	(	PUNCT
eshr-12641	28	71	glycaemia	glycaemia	NOUN
eshr-12641	28	72	)	)	PUNCT
eshr-12641	28	73	provided	provide	VERB
eshr-12641	28	74	for	for	ADP
eshr-12641	28	75	by	by	ADP
eshr-12641	28	76	this	this	DET
eshr-12641	28	77	monthly	monthly	ADJ
eshr-12641	28	78	medical	medical	ADJ
eshr-12641	28	79	check	check	NOUN
eshr-12641	28	80	-	-	PUNCT
eshr-12641	28	81	up	up	NOUN
eshr-12641	28	82	and	and	CCONJ
eshr-12641	28	83	who	who	PRON
eshr-12641	28	84	had	have	AUX
eshr-12641	28	85	consented	consent	VERB
eshr-12641	28	86	to	to	PART
eshr-12641	28	87	participate	participate	VERB
eshr-12641	28	88	in	in	ADP
eshr-12641	28	89	the	the	DET
eshr-12641	28	90	study	study	NOUN
eshr-12641	28	91	.	.	PUNCT
eshr-12641	29	1	a	a	DET
eshr-12641	29	2	questionnaire	questionnaire	NOUN
eshr-12641	29	3	prepared	prepare	VERB
eshr-12641	29	4	in	in	ADP
eshr-12641	29	5	advance	advance	NOUN
eshr-12641	29	6	was	be	AUX
eshr-12641	29	7	made	make	VERB
eshr-12641	29	8	available	available	ADJ
eshr-12641	29	9	to	to	ADP
eshr-12641	29	10	them	they	PRON
eshr-12641	29	11	in	in	ADP
eshr-12641	29	12	order	order	NOUN
eshr-12641	29	13	to	to	PART
eshr-12641	29	14	have	have	AUX
eshr-12641	29	15	information	information	NOUN
eshr-12641	29	16	on	on	ADP
eshr-12641	29	17	their	their	PRON
eshr-12641	29	18	socio	socio	NOUN
eshr-12641	29	19	-	-	ADJ
eshr-12641	29	20	demographic	demographic	ADJ
eshr-12641	29	21	data	datum	NOUN
eshr-12641	29	22	.	.	PUNCT
eshr-12641	30	1	then	then	ADV
eshr-12641	30	2	a	a	DET
eshr-12641	30	3	clinical	clinical	ADJ
eshr-12641	30	4	examination	examination	NOUN
eshr-12641	30	5	including	include	VERB
eshr-12641	30	6	anthropometric	anthropometric	ADJ
eshr-12641	30	7	measurements	measurement	NOUN
eshr-12641	30	8	was	be	AUX
eshr-12641	30	9	carried	carry	VERB
eshr-12641	30	10	out	out	ADP
eshr-12641	30	11	and	and	CCONJ
eshr-12641	30	12	at	at	ADP
eshr-12641	30	13	the	the	DET
eshr-12641	30	14	end	end	NOUN
eshr-12641	30	15	a	a	DET
eshr-12641	30	16	biochemical	biochemical	ADJ
eshr-12641	30	17	examination	examination	NOUN
eshr-12641	30	18	was	be	AUX
eshr-12641	30	19	carried	carry	VERB
eshr-12641	30	20	out	out	ADP
eshr-12641	30	21	.	.	PUNCT
eshr-12641	31	1	clinical	clinical	ADJ
eshr-12641	31	2	and	and	CCONJ
eshr-12641	31	3	anthropometric	anthropometric	ADJ
eshr-12641	31	4	data	datum	NOUN
eshr-12641	31	5	were	be	AUX
eshr-12641	31	6	collected	collect	VERB
eshr-12641	31	7	on	on	ADP
eshr-12641	31	8	survey	survey	NOUN
eshr-12641	31	9	forms	form	NOUN
eshr-12641	31	10	designed	design	VERB
eshr-12641	31	11	for	for	ADP
eshr-12641	31	12	this	this	DET
eshr-12641	31	13	purpose	purpose	NOUN
eshr-12641	31	14	.	.	PUNCT
eshr-12641	32	1	the	the	DET
eshr-12641	32	2	parameters	parameter	NOUN
eshr-12641	32	3	evaluated	evaluate	VERB
eshr-12641	32	4	were	be	AUX
eshr-12641	32	5	age	age	NOUN
eshr-12641	32	6	,	,	PUNCT
eshr-12641	32	7	sex	sex	NOUN
eshr-12641	32	8	,	,	PUNCT
eshr-12641	32	9	blood	blood	NOUN
eshr-12641	32	10	pressure	pressure	NOUN
eshr-12641	32	11	and	and	CCONJ
eshr-12641	32	12	waist	waist	NOUN
eshr-12641	32	13	circumference	circumference	NOUN
eshr-12641	32	14	.	.	PUNCT
eshr-12641	33	1	for	for	ADP
eshr-12641	33	2	the	the	DET
eshr-12641	33	3	biochemical	biochemical	ADJ
eshr-12641	33	4	analysis	analysis	NOUN
eshr-12641	33	5	,	,	PUNCT
eshr-12641	33	6	blood	blood	NOUN
eshr-12641	33	7	samples	sample	NOUN
eshr-12641	33	8	were	be	AUX
eshr-12641	33	9	taken	take	VERB
eshr-12641	33	10	by	by	ADP
eshr-12641	33	11	venipuncture	venipuncture	NOUN
eshr-12641	33	12	at	at	ADP
eshr-12641	33	13	the	the	DET
eshr-12641	33	14	bend	bend	NOUN
eshr-12641	33	15	of	of	ADP
eshr-12641	33	16	the	the	DET
eshr-12641	33	17	elbow	elbow	NOUN
eshr-12641	33	18	in	in	ADP
eshr-12641	33	19	subjects	subject	NOUN
eshr-12641	33	20	who	who	PRON
eshr-12641	33	21	had	have	AUX
eshr-12641	33	22	fasted	fast	VERB
eshr-12641	33	23	for	for	ADP
eshr-12641	33	24	at	at	ADV
eshr-12641	33	25	least	least	ADV
eshr-12641	33	26	12	12	NUM
eshr-12641	33	27	hours	hour	NOUN
eshr-12641	33	28	.	.	PUNCT
eshr-12641	34	1	for	for	ADP
eshr-12641	34	2	each	each	DET
eshr-12641	34	3	patient	patient	NOUN
eshr-12641	34	4	,	,	PUNCT
eshr-12641	34	5	blood	blood	NOUN
eshr-12641	34	6	was	be	AUX
eshr-12641	34	7	collected	collect	VERB
eshr-12641	34	8	in	in	ADP
eshr-12641	34	9	a	a	DET
eshr-12641	34	10	tube	tube	NOUN
eshr-12641	34	11	containing	contain	VERB
eshr-12641	34	12	citrate	citrate	NOUN
eshr-12641	34	13	.	.	PUNCT
eshr-12641	35	1	after	after	ADP
eshr-12641	35	2	centrifugation	centrifugation	NOUN
eshr-12641	35	3	,	,	PUNCT
eshr-12641	35	4	the	the	DET
eshr-12641	35	5	serum	serum	NOUN
eshr-12641	35	6	was	be	AUX
eshr-12641	35	7	used	use	VERB
eshr-12641	35	8	immediately	immediately	ADV
eshr-12641	35	9	for	for	ADP
eshr-12641	35	10	the	the	DET
eshr-12641	35	11	determination	determination	NOUN
eshr-12641	35	12	of	of	ADP
eshr-12641	35	13	biochemical	biochemical	ADJ
eshr-12641	35	14	parameters	parameter	NOUN
eshr-12641	35	15	including	include	VERB
eshr-12641	35	16	glycaemia	glycaemia	NOUN
eshr-12641	35	17	,	,	PUNCT
eshr-12641	35	18	triglycerides	triglyceride	NOUN
eshr-12641	35	19	and	and	CCONJ
eshr-12641	35	20	hdl	hdl	PROPN
eshr-12641	35	21	cholesterol	cholesterol	PROPN
eshr-12641	35	22	.	.	PUNCT
eshr-12641	36	1	these	these	DET
eshr-12641	36	2	assays	assay	NOUN
eshr-12641	36	3	were	be	AUX
eshr-12641	36	4	carried	carry	VERB
eshr-12641	36	5	out	out	ADP
eshr-12641	36	6	using	use	VERB
eshr-12641	36	7	suitable	suitable	ADJ
eshr-12641	36	8	enzymatic	enzymatic	ADJ
eshr-12641	36	9	methods	method	NOUN
eshr-12641	36	10	on	on	ADP
eshr-12641	36	11	the	the	DET
eshr-12641	36	12	pentra	pentra	PROPN
eshr-12641	36	13	c400	c400	PROPN
eshr-12641	36	14	automaton	automaton	NOUN
eshr-12641	36	15	.	.	PUNCT
eshr-12641	37	1	all	all	DET
eshr-12641	37	2	procedures	procedure	NOUN
eshr-12641	37	3	were	be	AUX
eshr-12641	37	4	conducted	conduct	VERB
eshr-12641	37	5	in	in	ADP
eshr-12641	37	6	accordance	accordance	NOUN
eshr-12641	37	7	with	with	ADP
eshr-12641	37	8	the	the	DET
eshr-12641	37	9	declaration	declaration	NOUN
eshr-12641	37	10	of	of	ADP
eshr-12641	37	11	helsinki	helsinki	PROPN
eshr-12641	37	12	.	.	PUNCT
eshr-12641	38	1	written	write	VERB
eshr-12641	38	2	informed	informed	ADJ
eshr-12641	38	3	consent	consent	NOUN
eshr-12641	38	4	was	be	AUX
eshr-12641	38	5	obtained	obtain	VERB
eshr-12641	38	6	from	from	ADP
eshr-12641	38	7	each	each	DET
eshr-12641	38	8	participant	participant	NOUN
eshr-12641	38	9	prior	prior	ADV
eshr-12641	38	10	to	to	ADP
eshr-12641	38	11	inclusion	inclusion	NOUN
eshr-12641	38	12	.	.	PUNCT
eshr-12641	39	1	the	the	DET
eshr-12641	39	2	study	study	NOUN
eshr-12641	39	3	protocol	protocol	NOUN
eshr-12641	39	4	was	be	AUX
eshr-12641	39	5	submitted	submit	VERB
eshr-12641	39	6	to	to	ADP
eshr-12641	39	7	and	and	CCONJ
eshr-12641	39	8	approved	approve	VERB
eshr-12641	39	9	by	by	ADP
eshr-12641	39	10	the	the	DET
eshr-12641	39	11	management	management	NOUN
eshr-12641	39	12	of	of	ADP
eshr-12641	39	13	the	the	DET
eshr-12641	39	14	bon	bon	PROPN
eshr-12641	39	15	samaritain	samaritain	PROPN
eshr-12641	39	16	university	university	NOUN
eshr-12641	39	17	hospital	hospital	NOUN
eshr-12641	39	18	(	(	PUNCT
eshr-12641	39	19	chu	chu	NOUN
eshr-12641	39	20	-	-	PUNCT
eshr-12641	39	21	bs	bs	NOUN
eshr-12641	39	22	)	)	PUNCT
eshr-12641	39	23	before	before	ADP
eshr-12641	39	24	the	the	DET
eshr-12641	39	25	start	start	NOUN
eshr-12641	39	26	of	of	ADP
eshr-12641	39	27	the	the	DET
eshr-12641	39	28	activities	activity	NOUN
eshr-12641	39	29	.	.	PUNCT
eshr-12641	40	1	the	the	DET
eshr-12641	40	2	metabolic	metabolic	NOUN
eshr-12641	40	3	syndrome	syndrome	NOUN
eshr-12641	40	4	has	have	AUX
eshr-12641	40	5	been	be	AUX
eshr-12641	40	6	defined	define	VERB
eshr-12641	40	7	according	accord	VERB
eshr-12641	40	8	to	to	ADP
eshr-12641	40	9	the	the	DET
eshr-12641	40	10	(	(	PUNCT
eshr-12641	40	11	national	national	ADJ
eshr-12641	40	12	cholesterol	cholesterol	NOUN
eshr-12641	40	13	education	education	NOUN
eshr-12641	40	14	program	program	NOUN
eshr-12641	40	15	)	)	PUNCT
eshr-12641	40	16	;	;	PUNCT
eshr-12641	40	17	adult	adult	NOUN
eshr-12641	40	18	treatment	treatment	NOUN
eshr-12641	40	19	panel	panel	NOUN
eshr-12641	40	20	iii	iii	PROPN
eshr-12641	40	21	(	(	PUNCT
eshr-12641	40	22	ncep	ncep	NOUN
eshr-12641	40	23	-	-	PUNCT
eshr-12641	40	24	atp	atp	PROPN
eshr-12641	40	25	iii	iii	NOUN
eshr-12641	40	26	)	)	PUNCT
eshr-12641	40	27	criteria	criterion	NOUN
eshr-12641	40	28	[	[	X
eshr-12641	40	29	10	10	NUM
eshr-12641	40	30	]	]	X
eshr-12641	40	31	:	:	PUNCT
eshr-12641	40	32	abdominal	abdominal	ADJ
eshr-12641	40	33	obesity	obesity	NOUN
eshr-12641	40	34	(	(	PUNCT
eshr-12641	40	35	waist	waist	NOUN
eshr-12641	40	36	circumference	circumference	NOUN
eshr-12641	40	37	>	>	X
eshr-12641	40	38	102	102	NUM
eshr-12641	40	39	cm	cm	NOUN
eshr-12641	40	40	(	(	PUNCT
eshr-12641	40	41	men	man	NOUN
eshr-12641	40	42	)	)	PUNCT
eshr-12641	40	43	;	;	PUNCT
eshr-12641	40	44	>	>	X
eshr-12641	40	45	88	88	NUM
eshr-12641	40	46	cm	cm	NOUN
eshr-12641	40	47	(	(	PUNCT
eshr-12641	40	48	women	woman	NOUN
eshr-12641	40	49	)	)	PUNCT
eshr-12641	40	50	,	,	PUNCT
eshr-12641	40	51	arterial	arterial	NOUN
eshr-12641	40	52	hypertension	hypertension	NOUN
eshr-12641	40	53	(	(	PUNCT
eshr-12641	40	54	ap	ap	PROPN
eshr-12641	40	55	≥	≥	NUM
eshr-12641	40	56	130/85	130/85	NUM
eshr-12641	40	57	mm	mm	NUM
eshr-12641	40	58	hg	hg	NOUN
eshr-12641	40	59	)	)	PUNCT
eshr-12641	40	60	,	,	PUNCT
eshr-12641	40	61	hypertriglycideremia	hypertriglycideremia	NOUN
eshr-12641	40	62	(	(	PUNCT
eshr-12641	40	63	≥	≥	NOUN
eshr-12641	40	64	1.50	1.50	NUM
eshr-12641	40	65	g	g	NOUN
eshr-12641	40	66	/	/	SYM
eshr-12641	40	67	l	l	NOUN
eshr-12641	40	68	)	)	PUNCT
eshr-12641	40	69	,	,	PUNCT
eshr-12641	40	70	decreased	decrease	VERB
eshr-12641	40	71	hdl	hdl	PROPN
eshr-12641	40	72	cholesterol	cholesterol	PROPN
eshr-12641	40	73	(	(	PUNCT
eshr-12641	40	74	<	<	X
eshr-12641	40	75	0.40	0.40	NUM
eshr-12641	40	76	g	g	NOUN
eshr-12641	40	77	/	/	SYM
eshr-12641	40	78	l	l	NOUN
eshr-12641	40	79	(	(	PUNCT
eshr-12641	40	80	men	man	NOUN
eshr-12641	40	81	)	)	PUNCT
eshr-12641	40	82	;	;	PUNCT
eshr-12641	40	83	<	<	X
eshr-12641	40	84	0.50	0.50	NUM
eshr-12641	40	85	g	g	NOUN
eshr-12641	40	86	/	/	SYM
eshr-12641	40	87	l	l	NOUN
eshr-12641	40	88	(	(	PUNCT
eshr-12641	40	89	women	woman	NOUN
eshr-12641	40	90	)	)	PUNCT
eshr-12641	40	91	and	and	CCONJ
eshr-12641	40	92	hyperglycemia	hyperglycemia	NOUN
eshr-12641	40	93	(	(	PUNCT
eshr-12641	40	94	≥	≥	NUM
eshr-12641	40	95	1.10	1.10	NUM
eshr-12641	40	96	g	g	NOUN
eshr-12641	40	97	/	/	SYM
eshr-12641	40	98	l	l	NOUN
eshr-12641	40	99	/l	/l	PUNCT
eshr-12641	40	100	)	)	PUNCT
eshr-12641	40	101	;	;	PUNCT
eshr-12641	40	102	subjects	subject	NOUN
eshr-12641	40	103	with	with	ADP
eshr-12641	40	104	at	at	ADV
eshr-12641	40	105	least	least	ADV
eshr-12641	40	106	three	three	NUM
eshr-12641	40	107	of	of	ADP
eshr-12641	40	108	these	these	DET
eshr-12641	40	109	criteria	criterion	NOUN
eshr-12641	40	110	were	be	AUX
eshr-12641	40	111	considered	consider	VERB
eshr-12641	40	112	to	to	PART
eshr-12641	40	113	have	have	VERB
eshr-12641	40	114	a	a	DET
eshr-12641	40	115	metabolic	metabolic	NOUN
eshr-12641	40	116	syndrome	syndrome	NOUN
eshr-12641	40	117	.	.	PUNCT
eshr-12641	41	1	statistical	statistical	ADJ
eshr-12641	41	2	analyzes	analyze	NOUN
eshr-12641	41	3	all	all	DET
eshr-12641	41	4	data	datum	NOUN
eshr-12641	41	5	was	be	AUX
eshr-12641	41	6	entered	enter	VERB
eshr-12641	41	7	and	and	CCONJ
eshr-12641	41	8	coded	code	VERB
eshr-12641	41	9	in	in	ADP
eshr-12641	41	10	windows	window	NOUN
eshr-12641	41	11	excel	excel	VERB
eshr-12641	41	12	2013	2013	NUM
eshr-12641	41	13	and	and	CCONJ
eshr-12641	41	14	then	then	ADV
eshr-12641	41	15	analyzed	analyze	VERB
eshr-12641	41	16	using	use	VERB
eshr-12641	41	17	ibm	ibm	PROPN
eshr-12641	41	18	spss	spss	PROPN
eshr-12641	41	19	statistics	statistic	NOUN
eshr-12641	41	20	21.0	21.0	NUM
eshr-12641	41	21	.	.	PUNCT
eshr-12641	42	1	the	the	DET
eshr-12641	42	2	comparison	comparison	NOUN
eshr-12641	42	3	of	of	ADP
eshr-12641	42	4	the	the	DET
eshr-12641	42	5	quantitative	quantitative	ADJ
eshr-12641	42	6	variables	variable	NOUN
eshr-12641	42	7	was	be	AUX
eshr-12641	42	8	made	make	VERB
eshr-12641	42	9	using	use	VERB
eshr-12641	42	10	the	the	DET
eshr-12641	42	11	student	student	NOUN
eshr-12641	42	12	's	's	PART
eshr-12641	42	13	t	t	NOUN
eshr-12641	42	14	test	test	NOUN
eshr-12641	42	15	,	,	PUNCT
eshr-12641	42	16	the	the	DET
eshr-12641	42	17	comparison	comparison	NOUN
eshr-12641	42	18	of	of	ADP
eshr-12641	42	19	the	the	DET
eshr-12641	42	20	percentages	percentage	NOUN
eshr-12641	42	21	required	require	VERB
eshr-12641	42	22	the	the	DET
eshr-12641	42	23	chi	chi	ADJ
eshr-12641	42	24	-	-	PUNCT
eshr-12641	42	25	square	square	ADJ
eshr-12641	42	26	test	test	NOUN
eshr-12641	42	27	.	.	PUNCT
eshr-12641	43	1	the	the	DET
eshr-12641	43	2	95	95	NUM
eshr-12641	43	3	%	%	NOUN
eshr-12641	43	4	confidence	confidence	NOUN
eshr-12641	43	5	interval	interval	NOUN
eshr-12641	43	6	(	(	PUNCT
eshr-12641	43	7	95	95	NUM
eshr-12641	43	8	%	%	NOUN
eshr-12641	43	9	ci	ci	NOUN
eshr-12641	43	10	)	)	PUNCT
eshr-12641	43	11	and	and	CCONJ
eshr-12641	43	12	a	a	DET
eshr-12641	43	13	p	p	NOUN
eshr-12641	43	14	value	value	NOUN
eshr-12641	43	15	<	<	NOUN
eshr-12641	43	16	0.05	0.05	NUM
eshr-12641	43	17	was	be	AUX
eshr-12641	43	18	considered	consider	VERB
eshr-12641	43	19	significant	significant	ADJ
eshr-12641	43	20	.	.	PUNCT
eshr-12641	44	1	results	result	VERB
eshr-12641	44	2	our	our	PRON
eshr-12641	44	3	study	study	NOUN
eshr-12641	44	4	included	include	VERB
eshr-12641	44	5	115	115	NUM
eshr-12641	44	6	subjects	subject	NOUN
eshr-12641	44	7	including	include	VERB
eshr-12641	44	8	50	50	NUM
eshr-12641	44	9	men	man	NOUN
eshr-12641	44	10	and	and	CCONJ
eshr-12641	44	11	65	65	NUM
eshr-12641	44	12	women	woman	NOUN
eshr-12641	44	13	.	.	PUNCT
eshr-12641	45	1	it	it	PRON
eshr-12641	45	2	follows	follow	VERB
eshr-12641	45	3	from	from	ADP
eshr-12641	45	4	table	table	NOUN
eshr-12641	45	5	1	1	NUM
eshr-12641	45	6	(	(	PUNCT
eshr-12641	45	7	appendix	appendix	X
eshr-12641	45	8	)	)	PUNCT
eshr-12641	45	9	presenting	present	VERB
eshr-12641	45	10	the	the	DET
eshr-12641	45	11	distribution	distribution	NOUN
eshr-12641	45	12	of	of	ADP
eshr-12641	45	13	participants	participant	NOUN
eshr-12641	45	14	according	accord	VERB
eshr-12641	45	15	to	to	ADP
eshr-12641	45	16	age	age	NOUN
eshr-12641	45	17	groups	group	NOUN
eshr-12641	45	18	and	and	CCONJ
eshr-12641	45	19	level	level	NOUN
eshr-12641	45	20	of	of	ADP
eshr-12641	45	21	education	education	NOUN
eshr-12641	45	22	that	that	SCONJ
eshr-12641	45	23	most	most	ADJ
eshr-12641	45	24	of	of	ADP
eshr-12641	45	25	the	the	DET
eshr-12641	45	26	participants	participant	NOUN
eshr-12641	45	27	were	be	AUX
eshr-12641	45	28	between	between	ADP
eshr-12641	45	29	50	50	NUM
eshr-12641	45	30	-	-	SYM
eshr-12641	45	31	60	60	NUM
eshr-12641	45	32	years	year	NOUN
eshr-12641	45	33	(	(	PUNCT
eshr-12641	45	34	33.9	33.9	NUM
eshr-12641	45	35	%	%	NOUN
eshr-12641	45	36	)	)	PUNCT
eshr-12641	45	37	and	and	CCONJ
eshr-12641	45	38	60	60	NUM
eshr-12641	45	39	-	-	SYM
eshr-12641	45	40	70	70	NUM
eshr-12641	45	41	years	year	NOUN
eshr-12641	45	42	(	(	PUNCT
eshr-12641	45	43	33.9	33.9	NUM
eshr-12641	45	44	%	%	NOUN
eshr-12641	45	45	)	)	PUNCT
eshr-12641	45	46	.	.	PUNCT
eshr-12641	46	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	46	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	46	3	noubaramadji	noubaramadji	NOUN
eshr-12641	46	4	yamti	yamti	PROPN
eshr-12641	46	5	et	et	PROPN
eshr-12641	46	6	al	al	PROPN
eshr-12641	46	7	.	.	PUNCT
eshr-12641	47	1	(	(	PUNCT
eshr-12641	47	2	prevalence	prevalence	NOUN
eshr-12641	47	3	of	of	ADP
eshr-12641	47	4	metabolic	metabolic	NOUN
eshr-12641	47	5	syndrome	syndrome	NOUN
eshr-12641	47	6	among	among	ADP
eshr-12641	47	7	patients	patient	NOUN
eshr-12641	47	8	with	with	ADP
eshr-12641	47	9	type	type	NOUN
eshr-12641	47	10	2	2	NUM
eshr-12641	47	11	diabetes	diabetes	NOUN
eshr-12641	47	12	…	…	PUNCT
eshr-12641	47	13	)	)	PUNCT
eshr-12641	47	14	vol	vol	NOUN
eshr-12641	47	15	.	.	PROPN
eshr-12641	48	1	7	7	NUM
eshr-12641	48	2	,	,	PUNCT
eshr-12641	48	3	no	no	INTJ
eshr-12641	48	4	.	.	NOUN
eshr-12641	48	5	2	2	NUM
eshr-12641	48	6	,	,	PUNCT
eshr-12641	48	7	2025	2025	NUM
eshr-12641	48	8	,	,	PUNCT
eshr-12641	48	9	pp	pp	ADJ
eshr-12641	48	10	.	.	PUNCT
eshr-12641	49	1	87	87	NUM
eshr-12641	49	2	-	-	SYM
eshr-12641	49	3	95	95	NUM
eshr-12641	49	4	90	90	NUM
eshr-12641	49	5	10.26555	10.26555	NUM
eshr-12641	49	6	/	/	SYM
eshr-12641	49	7	eshr.v7i2.12641	eshr.v7i2.12641	NOUN
eshr-12641	49	8	table	table	NOUN
eshr-12641	49	9	1	1	NUM
eshr-12641	49	10	.	.	PUNCT
eshr-12641	49	11	distribution	distribution	NOUN
eshr-12641	49	12	of	of	ADP
eshr-12641	49	13	participants	participant	NOUN
eshr-12641	49	14	by	by	ADP
eshr-12641	49	15	age	age	NOUN
eshr-12641	49	16	group	group	NOUN
eshr-12641	49	17	and	and	CCONJ
eshr-12641	49	18	level	level	NOUN
eshr-12641	49	19	of	of	ADP
eshr-12641	49	20	education	education	NOUN
eshr-12641	49	21	furthermore	furthermore	ADV
eshr-12641	49	22	,	,	PUNCT
eshr-12641	49	23	40	40	NUM
eshr-12641	49	24	%	%	NOUN
eshr-12641	49	25	of	of	ADP
eshr-12641	49	26	the	the	DET
eshr-12641	49	27	participants	participant	NOUN
eshr-12641	49	28	have	have	VERB
eshr-12641	49	29	a	a	DET
eshr-12641	49	30	higher	high	ADJ
eshr-12641	49	31	level	level	NOUN
eshr-12641	49	32	of	of	ADP
eshr-12641	49	33	education	education	NOUN
eshr-12641	49	34	,	,	PUNCT
eshr-12641	49	35	23.5	23.5	NUM
eshr-12641	49	36	%	%	NOUN
eshr-12641	49	37	have	have	VERB
eshr-12641	49	38	a	a	DET
eshr-12641	49	39	secondary	secondary	ADJ
eshr-12641	49	40	level	level	NOUN
eshr-12641	49	41	,	,	PUNCT
eshr-12641	49	42	6.1	6.1	NUM
eshr-12641	49	43	%	%	NOUN
eshr-12641	49	44	have	have	VERB
eshr-12641	49	45	a	a	DET
eshr-12641	49	46	primary	primary	ADJ
eshr-12641	49	47	level	level	NOUN
eshr-12641	49	48	of	of	ADP
eshr-12641	49	49	education	education	NOUN
eshr-12641	49	50	,	,	PUNCT
eshr-12641	49	51	and	and	CCONJ
eshr-12641	49	52	finally	finally	ADV
eshr-12641	49	53	30.4	30.4	NUM
eshr-12641	49	54	%	%	NOUN
eshr-12641	49	55	are	be	AUX
eshr-12641	49	56	unschooled	unschooled	ADJ
eshr-12641	49	57	.	.	PUNCT
eshr-12641	50	1	a	a	DET
eshr-12641	50	2	female	female	ADJ
eshr-12641	50	3	predominance	predominance	NOUN
eshr-12641	50	4	was	be	AUX
eshr-12641	50	5	observed	observe	VERB
eshr-12641	50	6	(	(	PUNCT
eshr-12641	50	7	figure	figure	NOUN
eshr-12641	50	8	1	1	NUM
eshr-12641	50	9	)	)	PUNCT
eshr-12641	50	10	.	.	PUNCT
eshr-12641	51	1	figure	figure	NOUN
eshr-12641	51	2	1	1	NUM
eshr-12641	51	3	.	.	PUNCT
eshr-12641	52	1	breakdown	breakdown	NOUN
eshr-12641	52	2	of	of	ADP
eshr-12641	52	3	study	study	NOUN
eshr-12641	52	4	participants	participant	NOUN
eshr-12641	52	5	by	by	ADP
eshr-12641	52	6	gender	gender	NOUN
eshr-12641	52	7	the	the	DET
eshr-12641	52	8	breakdown	breakdown	NOUN
eshr-12641	52	9	of	of	ADP
eshr-12641	52	10	participants	participant	NOUN
eshr-12641	52	11	by	by	ADP
eshr-12641	52	12	sex	sex	NOUN
eshr-12641	52	13	shows	show	VERB
eshr-12641	52	14	a	a	DET
eshr-12641	52	15	predominance	predominance	NOUN
eshr-12641	52	16	of	of	ADP
eshr-12641	52	17	women	woman	NOUN
eshr-12641	52	18	,	,	PUNCT
eshr-12641	52	19	with	with	ADP
eshr-12641	52	20	65	65	NUM
eshr-12641	52	21	women	woman	NOUN
eshr-12641	52	22	(	(	PUNCT
eshr-12641	52	23	56.5	56.5	NUM
eshr-12641	52	24	%	%	NOUN
eshr-12641	52	25	)	)	PUNCT
eshr-12641	52	26	and	and	CCONJ
eshr-12641	52	27	50	50	NUM
eshr-12641	52	28	men	man	NOUN
eshr-12641	52	29	(	(	PUNCT
eshr-12641	52	30	43.5	43.5	NUM
eshr-12641	52	31	%	%	NOUN
eshr-12641	52	32	)	)	PUNCT
eshr-12641	52	33	.	.	PUNCT
eshr-12641	53	1	this	this	DET
eshr-12641	53	2	predominance	predominance	NOUN
eshr-12641	53	3	is	be	AUX
eshr-12641	53	4	still	still	ADV
eshr-12641	53	5	feminine	feminine	ADJ
eshr-12641	53	6	in	in	ADP
eshr-12641	53	7	terms	term	NOUN
eshr-12641	53	8	of	of	ADP
eshr-12641	53	9	the	the	DET
eshr-12641	53	10	presence	presence	NOUN
eshr-12641	53	11	or	or	CCONJ
eshr-12641	53	12	absence	absence	NOUN
eshr-12641	53	13	of	of	ADP
eshr-12641	53	14	sm	sm	PROPN
eshr-12641	53	15	in	in	ADP
eshr-12641	53	16	this	this	DET
eshr-12641	53	17	population	population	NOUN
eshr-12641	53	18	(	(	PUNCT
eshr-12641	53	19	table	table	NOUN
eshr-12641	53	20	2	2	NUM
eshr-12641	53	21	)	)	PUNCT
eshr-12641	53	22	.	.	PUNCT
eshr-12641	54	1	table	table	NOUN
eshr-12641	54	2	2	2	NUM
eshr-12641	54	3	.	.	PUNCT
eshr-12641	55	1	distribution	distribution	NOUN
eshr-12641	55	2	of	of	ADP
eshr-12641	55	3	participants	participant	NOUN
eshr-12641	55	4	by	by	ADP
eshr-12641	55	5	gender	gender	NOUN
eshr-12641	55	6	and	and	CCONJ
eshr-12641	55	7	by	by	ADP
eshr-12641	55	8	presence	presence	NOUN
eshr-12641	55	9	or	or	CCONJ
eshr-12641	55	10	absence	absence	NOUN
eshr-12641	55	11	of	of	ADP
eshr-12641	55	12	sm	sm	PROPN
eshr-12641	55	13	.	.	PROPN
eshr-12641	55	14	sex	sex	PROPN
eshr-12641	55	15	n	n	CCONJ
eshr-12641	55	16	attendees	attendee	NOUN
eshr-12641	55	17	presence	presence	NOUN
eshr-12641	55	18	of	of	ADP
eshr-12641	55	19	sm	sm	NOUN
eshr-12641	55	20	%	%	NOUN
eshr-12641	55	21	presence	presence	NOUN
eshr-12641	55	22	of	of	ADP
eshr-12641	55	23	sm	sm	PROPN
eshr-12641	55	24	absence	absence	NOUN
eshr-12641	55	25	of	of	ADP
eshr-12641	55	26	sm	sm	NOUN
eshr-12641	55	27	%	%	NOUN
eshr-12641	55	28	absence	absence	NOUN
eshr-12641	55	29	of	of	ADP
eshr-12641	55	30	sm	sm	PROPN
eshr-12641	55	31	female	female	ADJ
eshr-12641	55	32	65	65	NUM
eshr-12641	55	33	(	(	PUNCT
eshr-12641	55	34	56.5	56.5	NUM
eshr-12641	55	35	%	%	NOUN
eshr-12641	55	36	)	)	PUNCT
eshr-12641	55	37	59	59	NUM
eshr-12641	55	38	51.3	51.3	NUM
eshr-12641	55	39	6	6	NUM
eshr-12641	55	40	5.2	5.2	NUM
eshr-12641	55	41	male	male	NOUN
eshr-12641	55	42	50	50	NUM
eshr-12641	55	43	(	(	PUNCT
eshr-12641	55	44	43.5	43.5	NUM
eshr-12641	55	45	%	%	NOUN
eshr-12641	55	46	)	)	PUNCT
eshr-12641	55	47	24	24	NUM
eshr-12641	55	48	20.9	20.9	NUM
eshr-12641	55	49	26	26	NUM
eshr-12641	55	50	22.6	22.6	NUM
eshr-12641	55	51	total	total	NOUN
eshr-12641	55	52	115	115	NUM
eshr-12641	55	53	(	(	PUNCT
eshr-12641	55	54	100	100	NUM
eshr-12641	55	55	%	%	NOUN
eshr-12641	55	56	)	)	PUNCT
eshr-12641	55	57	83	83	NUM
eshr-12641	55	58	72.2	72.2	NUM
eshr-12641	55	59	32	32	NUM
eshr-12641	55	60	27.8	27.8	NUM
eshr-12641	55	61	the	the	DET
eshr-12641	55	62	prevalence	prevalence	NOUN
eshr-12641	55	63	of	of	ADP
eshr-12641	55	64	ms	ms	PROPN
eshr-12641	55	65	in	in	ADP
eshr-12641	55	66	our	our	PRON
eshr-12641	55	67	study	study	NOUN
eshr-12641	55	68	population	population	NOUN
eshr-12641	55	69	is	be	AUX
eshr-12641	55	70	72.2	72.2	NUM
eshr-12641	55	71	%	%	NOUN
eshr-12641	55	72	,	,	PUNCT
eshr-12641	55	73	among	among	ADP
eshr-12641	55	74	the	the	DET
eshr-12641	55	75	elements	element	NOUN
eshr-12641	55	76	that	that	PRON
eshr-12641	55	77	compose	compose	VERB
eshr-12641	55	78	it	it	PRON
eshr-12641	55	79	,	,	PUNCT
eshr-12641	55	80	hyperglycemia	hyperglycemia	NOUN
eshr-12641	55	81	and	and	CCONJ
eshr-12641	55	82	hypo	hypo	ADJ
eshr-12641	55	83	hdl	hdl	PROPN
eshr-12641	55	84	-	-	PUNCT
eshr-12641	55	85	cholesterol	cholesterol	NOUN
eshr-12641	55	86	were	be	AUX
eshr-12641	55	87	the	the	DET
eshr-12641	55	88	two	two	NUM
eshr-12641	55	89	criteria	criterion	NOUN
eshr-12641	55	90	mainly	mainly	ADV
eshr-12641	55	91	present	present	ADJ
eshr-12641	55	92	with	with	ADP
eshr-12641	55	93	88	88	NUM
eshr-12641	55	94	%	%	NOUN
eshr-12641	55	95	for	for	ADP
eshr-12641	55	96	settings	setting	NOUN
eshr-12641	55	97	n	n	PRON
eshr-12641	55	98	percentage	percentage	NOUN
eshr-12641	55	99	(	(	PUNCT
eshr-12641	55	100	%	%	NOUN
eshr-12641	55	101	)	)	PUNCT
eshr-12641	55	102	age	age	NOUN
eshr-12641	55	103	range	range	VERB
eshr-12641	55	104	30	30	NUM
eshr-12641	55	105	-	-	SYM
eshr-12641	55	106	40	40	NUM
eshr-12641	55	107	9	9	NUM
eshr-12641	55	108	7.8	7.8	NUM
eshr-12641	55	109	40	40	NUM
eshr-12641	55	110	-	-	SYM
eshr-12641	55	111	50	50	NUM
eshr-12641	55	112	21	21	NUM
eshr-12641	55	113	18.3	18.3	NUM
eshr-12641	55	114	50	50	NUM
eshr-12641	55	115	-	-	SYM
eshr-12641	55	116	60	60	NUM
eshr-12641	55	117	39	39	NUM
eshr-12641	55	118	33.9	33.9	NUM
eshr-12641	55	119	60	60	NUM
eshr-12641	55	120	-	-	SYM
eshr-12641	55	121	70	70	NUM
eshr-12641	55	122	39	39	NUM
eshr-12641	55	123	33.9	33.9	NUM
eshr-12641	55	124	70	70	NUM
eshr-12641	55	125	-	-	SYM
eshr-12641	55	126	80	80	NUM
eshr-12641	55	127	7	7	NUM
eshr-12641	55	128	6.1	6.1	NUM
eshr-12641	55	129	level	level	NOUN
eshr-12641	55	130	of	of	ADP
eshr-12641	55	131	education	education	NOUN
eshr-12641	55	132	superior	superior	ADJ
eshr-12641	55	133	46	46	NUM
eshr-12641	55	134	40.0	40.0	NUM
eshr-12641	55	135	secondary	secondary	ADJ
eshr-12641	55	136	27	27	NUM
eshr-12641	55	137	23.5	23.5	NUM
eshr-12641	55	138	primary	primary	ADJ
eshr-12641	55	139	7	7	NUM
eshr-12641	55	140	6.1	6.1	NUM
eshr-12641	55	141	no	no	DET
eshr-12641	55	142	schooling	schooling	NOUN
eshr-12641	55	143	35	35	NUM
eshr-12641	55	144	30.4	30.4	NUM
eshr-12641	55	145	total	total	NOUN
eshr-12641	55	146	115	115	NUM
eshr-12641	55	147	100	100	NUM
eshr-12641	55	148	female	female	ADJ
eshr-12641	55	149	male	male	NOUN
eshr-12641	55	150	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	55	151	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	55	152	noubaramadji	noubaramadji	NOUN
eshr-12641	55	153	yamti	yamti	PROPN
eshr-12641	55	154	et	et	PROPN
eshr-12641	55	155	al	al	PROPN
eshr-12641	55	156	.	.	PUNCT
eshr-12641	56	1	(	(	PUNCT
eshr-12641	56	2	prevalence	prevalence	NOUN
eshr-12641	56	3	of	of	ADP
eshr-12641	56	4	metabolic	metabolic	NOUN
eshr-12641	56	5	syndrome	syndrome	NOUN
eshr-12641	56	6	among	among	ADP
eshr-12641	56	7	patients	patient	NOUN
eshr-12641	56	8	with	with	ADP
eshr-12641	56	9	type	type	NOUN
eshr-12641	56	10	2	2	NUM
eshr-12641	56	11	diabetes	diabetes	NOUN
eshr-12641	56	12	…	…	PUNCT
eshr-12641	56	13	)	)	PUNCT
eshr-12641	56	14	vol	vol	NOUN
eshr-12641	56	15	.	.	PROPN
eshr-12641	57	1	7	7	NUM
eshr-12641	57	2	,	,	PUNCT
eshr-12641	57	3	no	no	INTJ
eshr-12641	57	4	.	.	NOUN
eshr-12641	57	5	2	2	NUM
eshr-12641	57	6	,	,	PUNCT
eshr-12641	57	7	2025	2025	NUM
eshr-12641	57	8	,	,	PUNCT
eshr-12641	57	9	pp	pp	ADJ
eshr-12641	57	10	.	.	PUNCT
eshr-12641	58	1	87	87	NUM
eshr-12641	58	2	-	-	SYM
eshr-12641	58	3	95	95	NUM
eshr-12641	58	4	91	91	NUM
eshr-12641	58	5	10.26555	10.26555	NUM
eshr-12641	58	6	/	/	SYM
eshr-12641	58	7	eshr.v7i2.12641	eshr.v7i2.12641	NUM
eshr-12641	58	8	hyperglycemia	hyperglycemia	NOUN
eshr-12641	58	9	,	,	PUNCT
eshr-12641	58	10	81	81	NUM
eshr-12641	58	11	%	%	NOUN
eshr-12641	58	12	for	for	ADP
eshr-12641	58	13	hypo	hypo	ADJ
eshr-12641	58	14	hdl	hdl	PROPN
eshr-12641	58	15	-	-	PUNCT
eshr-12641	58	16	cholesterol	cholesterol	NOUN
eshr-12641	58	17	followed	follow	VERB
eshr-12641	58	18	by	by	ADP
eshr-12641	58	19	abdominal	abdominal	ADJ
eshr-12641	58	20	obesity	obesity	NOUN
eshr-12641	58	21	(	(	PUNCT
eshr-12641	58	22	71	71	NUM
eshr-12641	58	23	%	%	NOUN
eshr-12641	58	24	)	)	PUNCT
eshr-12641	58	25	,	,	PUNCT
eshr-12641	58	26	and	and	CCONJ
eshr-12641	58	27	arterial	arterial	ADJ
eshr-12641	58	28	hypertension	hypertension	NOUN
eshr-12641	58	29	(	(	PUNCT
eshr-12641	58	30	45	45	NUM
eshr-12641	58	31	%	%	NOUN
eshr-12641	58	32	)	)	PUNCT
eshr-12641	58	33	,	,	PUNCT
eshr-12641	58	34	in	in	ADP
eshr-12641	58	35	the	the	DET
eshr-12641	58	36	end	end	NOUN
eshr-12641	58	37	hypertriglyceridemia	hypertriglyceridemia	NOUN
eshr-12641	58	38	was	be	AUX
eshr-12641	58	39	noted	note	VERB
eshr-12641	58	40	in	in	ADP
eshr-12641	58	41	(	(	PUNCT
eshr-12641	58	42	25	25	NUM
eshr-12641	58	43	)	)	PUNCT
eshr-12641	58	44	%	%	NOUN
eshr-12641	58	45	(	(	PUNCT
eshr-12641	58	46	figure	figure	NOUN
eshr-12641	58	47	2	2	NUM
eshr-12641	58	48	)	)	PUNCT
eshr-12641	58	49	.	.	PUNCT
eshr-12641	59	1	metabolic	metabolic	NOUN
eshr-12641	59	2	syndrome	syndrome	NOUN
eshr-12641	59	3	,	,	PUNCT
eshr-12641	59	4	hta=	hta=	ADP
eshr-12641	59	5	arterial	arterial	ADJ
eshr-12641	59	6	hypertension	hypertension	NOUN
eshr-12641	59	7	,	,	PUNCT
eshr-12641	59	8	tg=	tg=	ADJ
eshr-12641	59	9	triglycerides	triglyceride	NOUN
eshr-12641	59	10	,	,	PUNCT
eshr-12641	59	11	gly	gly	NOUN
eshr-12641	59	12	=	=	NOUN
eshr-12641	59	13	blood	blood	NOUN
eshr-12641	59	14	sugar	sugar	NOUN
eshr-12641	59	15	,	,	PUNCT
eshr-12641	59	16	hdl	hdl	NOUN
eshr-12641	59	17	-	-	PUNCT
eshr-12641	59	18	c=	c=	NOUN
eshr-12641	59	19	high	high	ADJ
eshr-12641	59	20	density	density	NOUN
eshr-12641	59	21	lipoprotein	lipoprotein	ADJ
eshr-12641	59	22	cholesterol	cholesterol	NOUN
eshr-12641	59	23	figure	figure	NOUN
eshr-12641	59	24	2	2	NUM
eshr-12641	59	25	.	.	PUNCT
eshr-12641	60	1	prevalence	prevalence	NOUN
eshr-12641	60	2	of	of	ADP
eshr-12641	60	3	metabolic	metabolic	NOUN
eshr-12641	60	4	syndrome	syndrome	NOUN
eshr-12641	60	5	and	and	CCONJ
eshr-12641	60	6	its	its	PRON
eshr-12641	60	7	components	component	NOUN
eshr-12641	60	8	in	in	ADP
eshr-12641	60	9	the	the	DET
eshr-12641	60	10	study	study	NOUN
eshr-12641	60	11	population	population	NOUN
eshr-12641	60	12	of	of	ADP
eshr-12641	60	13	the	the	DET
eshr-12641	60	14	83	83	NUM
eshr-12641	60	15	patients	patient	NOUN
eshr-12641	60	16	identified	identify	VERB
eshr-12641	60	17	with	with	ADP
eshr-12641	60	18	metabolic	metabolic	NOUN
eshr-12641	60	19	syndrome	syndrome	NOUN
eshr-12641	60	20	(	(	PUNCT
eshr-12641	60	21	ms	ms	NOUN
eshr-12641	60	22	)	)	PUNCT
eshr-12641	60	23	,	,	PUNCT
eshr-12641	60	24	39	39	NUM
eshr-12641	60	25	(	(	PUNCT
eshr-12641	60	26	34	34	NUM
eshr-12641	60	27	%	%	NOUN
eshr-12641	60	28	)	)	PUNCT
eshr-12641	60	29	met	meet	VERB
eshr-12641	60	30	3	3	NUM
eshr-12641	60	31	diagnostic	diagnostic	ADJ
eshr-12641	60	32	criteria	criterion	NOUN
eshr-12641	60	33	,	,	PUNCT
eshr-12641	60	34	while	while	SCONJ
eshr-12641	60	35	27	27	NUM
eshr-12641	60	36	(	(	PUNCT
eshr-12641	60	37	23	23	NUM
eshr-12641	60	38	%	%	NOUN
eshr-12641	60	39	)	)	PUNCT
eshr-12641	60	40	fulfilled	fulfil	VERB
eshr-12641	60	41	4	4	NUM
eshr-12641	60	42	criteria	criterion	NOUN
eshr-12641	60	43	and	and	CCONJ
eshr-12641	60	44	17	17	NUM
eshr-12641	60	45	(	(	PUNCT
eshr-12641	60	46	15	15	NUM
eshr-12641	60	47	%	%	NOUN
eshr-12641	60	48	)	)	PUNCT
eshr-12641	60	49	met	meet	VERB
eshr-12641	60	50	all	all	DET
eshr-12641	60	51	5	5	NUM
eshr-12641	60	52	criteria	criterion	NOUN
eshr-12641	60	53	.	.	PUNCT
eshr-12641	61	1	in	in	ADP
eshr-12641	61	2	addition	addition	NOUN
eshr-12641	61	3	,	,	PUNCT
eshr-12641	61	4	17	17	NUM
eshr-12641	61	5	%	%	NOUN
eshr-12641	61	6	of	of	ADP
eshr-12641	61	7	the	the	DET
eshr-12641	61	8	study	study	NOUN
eshr-12641	61	9	population	population	NOUN
eshr-12641	61	10	presented	present	VERB
eshr-12641	61	11	2	2	NUM
eshr-12641	61	12	criteria	criterion	NOUN
eshr-12641	61	13	,	,	PUNCT
eshr-12641	61	14	indicating	indicate	VERB
eshr-12641	61	15	a	a	DET
eshr-12641	61	16	group	group	NOUN
eshr-12641	61	17	at	at	ADP
eshr-12641	61	18	high	high	ADJ
eshr-12641	61	19	risk	risk	NOUN
eshr-12641	61	20	of	of	ADP
eshr-12641	61	21	progression	progression	NOUN
eshr-12641	61	22	towards	towards	ADP
eshr-12641	61	23	full	full	ADJ
eshr-12641	61	24	ms	ms	PROPN
eshr-12641	61	25	(	(	PUNCT
eshr-12641	61	26	table	table	NOUN
eshr-12641	61	27	3	3	NUM
eshr-12641	61	28	)	)	PUNCT
eshr-12641	61	29	.	.	PUNCT
eshr-12641	62	1	table	table	NOUN
eshr-12641	62	2	3	3	NUM
eshr-12641	62	3	.	.	PUNCT
eshr-12641	63	1	clinico	clinico	ADJ
eshr-12641	63	2	-	-	PUNCT
eshr-12641	63	3	biochemical	biochemical	ADJ
eshr-12641	63	4	profile	profile	NOUN
eshr-12641	63	5	of	of	ADP
eshr-12641	63	6	participants	participant	NOUN
eshr-12641	63	7	according	accord	VERB
eshr-12641	63	8	to	to	ADP
eshr-12641	63	9	the	the	DET
eshr-12641	63	10	number	number	NOUN
eshr-12641	63	11	of	of	ADP
eshr-12641	63	12	metabolic	metabolic	NOUN
eshr-12641	63	13	syndrome	syndrome	NOUN
eshr-12641	63	14	criteria	criterion	NOUN
eshr-12641	63	15	settings	setting	NOUN
eshr-12641	63	16	n	n	PRON
eshr-12641	63	17	attendees	attendee	NOUN
eshr-12641	63	18	percentage	percentage	NOUN
eshr-12641	63	19	1	1	NUM
eshr-12641	63	20	criteria	criterion	NOUN
eshr-12641	63	21	13	13	NUM
eshr-12641	63	22	11	11	NUM
eshr-12641	63	23	%	%	NOUN
eshr-12641	63	24	2	2	NUM
eshr-12641	63	25	criteria	criterion	NOUN
eshr-12641	63	26	19	19	NUM
eshr-12641	63	27	17	17	NUM
eshr-12641	63	28	%	%	NOUN
eshr-12641	63	29	3	3	NUM
eshr-12641	63	30	criteria	criterion	NOUN
eshr-12641	63	31	39	39	NUM
eshr-12641	63	32	34	34	NUM
eshr-12641	63	33	%	%	NOUN
eshr-12641	63	34	4	4	NUM
eshr-12641	63	35	criteria	criterion	NOUN
eshr-12641	63	36	27	27	NUM
eshr-12641	63	37	23	23	NUM
eshr-12641	63	38	%	%	NOUN
eshr-12641	63	39	5	5	NUM
eshr-12641	63	40	criteria	criterion	NOUN
eshr-12641	63	41	17	17	NUM
eshr-12641	63	42	15	15	NUM
eshr-12641	63	43	%	%	NOUN
eshr-12641	63	44	total	total	NOUN
eshr-12641	63	45	115	115	NUM
eshr-12641	63	46	100	100	NUM
eshr-12641	63	47	%	%	NOUN
eshr-12641	63	48	41.7	41.7	NUM
eshr-12641	63	49	%	%	NOUN
eshr-12641	63	50	of	of	ADP
eshr-12641	63	51	the	the	DET
eshr-12641	63	52	study	study	NOUN
eshr-12641	63	53	population	population	NOUN
eshr-12641	63	54	practices	practice	NOUN
eshr-12641	63	55	at	at	ADP
eshr-12641	63	56	least	least	ADV
eshr-12641	63	57	one	one	NUM
eshr-12641	63	58	physical	physical	ADJ
eshr-12641	63	59	activity	activity	NOUN
eshr-12641	63	60	against	against	ADP
eshr-12641	63	61	58.3	58.3	NUM
eshr-12641	63	62	%	%	NOUN
eshr-12641	63	63	of	of	ADP
eshr-12641	63	64	those	those	PRON
eshr-12641	63	65	who	who	PRON
eshr-12641	63	66	do	do	AUX
eshr-12641	63	67	not	not	PART
eshr-12641	63	68	practice	practice	VERB
eshr-12641	63	69	any	any	DET
eshr-12641	63	70	physical	physical	ADJ
eshr-12641	63	71	activity	activity	NOUN
eshr-12641	63	72	(	(	PUNCT
eshr-12641	63	73	table	table	NOUN
eshr-12641	63	74	4	4	NUM
eshr-12641	63	75	)	)	PUNCT
eshr-12641	63	76	.	.	PUNCT
eshr-12641	64	1	discussion	discussion	NOUN
eshr-12641	64	2	the	the	DET
eshr-12641	64	3	prevalence	prevalence	NOUN
eshr-12641	64	4	of	of	ADP
eshr-12641	64	5	ms	ms	PROPN
eshr-12641	64	6	varies	vary	VERB
eshr-12641	64	7	greatly	greatly	ADV
eshr-12641	64	8	depending	depend	VERB
eshr-12641	64	9	on	on	ADP
eshr-12641	64	10	the	the	DET
eshr-12641	64	11	diagnostic	diagnostic	ADJ
eshr-12641	64	12	criteria	criterion	NOUN
eshr-12641	64	13	used	use	VERB
eshr-12641	64	14	.	.	PUNCT
eshr-12641	65	1	the	the	DET
eshr-12641	65	2	prevalence	prevalence	NOUN
eshr-12641	65	3	rates	rate	NOUN
eshr-12641	65	4	with	with	ADP
eshr-12641	65	5	who	who	PRON
eshr-12641	65	6	were	be	AUX
eshr-12641	65	7	44.8	44.8	NUM
eshr-12641	65	8	%	%	NOUN
eshr-12641	65	9	,	,	PUNCT
eshr-12641	65	10	39.7	39.7	NUM
eshr-12641	65	11	%	%	NOUN
eshr-12641	65	12	with	with	ADP
eshr-12641	65	13	revised	revise	VERB
eshr-12641	65	14	ncep	ncep	NOUN
eshr-12641	65	15	-	-	PUNCT
eshr-12641	65	16	atp	atp	PROPN
eshr-12641	65	17	,	,	PUNCT
eshr-12641	65	18	33.1	33.1	NUM
eshr-12641	65	19	%	%	NOUN
eshr-12641	65	20	with	with	ADP
eshr-12641	65	21	jis	ji	NOUN
eshr-12641	65	22	,	,	PUNCT
eshr-12641	65	23	and	and	CCONJ
eshr-12641	65	24	31.6	31.6	NUM
eshr-12641	65	25	%	%	NOUN
eshr-12641	65	26	with	with	ADP
eshr-12641	65	27	jis	ji	NOUN
eshr-12641	65	28	.	.	PUNCT
eshr-12641	66	1	ncep	ncep	PROPN
eshr-12641	66	2	-	-	PUNCT
eshr-12641	66	3	atp	atp	PROPN
eshr-12641	66	4	scored	score	VERB
eshr-12641	66	5	29.3	29.3	NUM
eshr-12641	66	6	%	%	NOUN
eshr-12641	66	7	,	,	PUNCT
eshr-12641	66	8	while	while	SCONJ
eshr-12641	66	9	idf	idf	PROPN
eshr-12641	66	10	scored	score	VERB
eshr-12641	66	11	29.3	29.3	NUM
eshr-12641	66	12	%	%	NOUN
eshr-12641	66	13	.	.	PUNCT
eshr-12641	67	1	although	although	SCONJ
eshr-12641	67	2	no	no	DET
eshr-12641	67	3	statistically	statistically	ADV
eshr-12641	67	4	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	ADJ
eshr-12641	67	5	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	67	6	noubaramadji	noubaramadji	NOUN
eshr-12641	67	7	yamti	yamti	PROPN
eshr-12641	67	8	et	et	PROPN
eshr-12641	67	9	al	al	PROPN
eshr-12641	67	10	.	.	PUNCT
eshr-12641	68	1	(	(	PUNCT
eshr-12641	68	2	prevalence	prevalence	NOUN
eshr-12641	68	3	of	of	ADP
eshr-12641	68	4	metabolic	metabolic	NOUN
eshr-12641	68	5	syndrome	syndrome	NOUN
eshr-12641	68	6	among	among	ADP
eshr-12641	68	7	patients	patient	NOUN
eshr-12641	68	8	with	with	ADP
eshr-12641	68	9	type	type	NOUN
eshr-12641	68	10	2	2	NUM
eshr-12641	68	11	diabetes	diabetes	NOUN
eshr-12641	68	12	…	…	PUNCT
eshr-12641	68	13	)	)	PUNCT
eshr-12641	68	14	vol	vol	NOUN
eshr-12641	68	15	.	.	PROPN
eshr-12641	69	1	7	7	NUM
eshr-12641	69	2	,	,	PUNCT
eshr-12641	69	3	no	no	INTJ
eshr-12641	69	4	.	.	NOUN
eshr-12641	69	5	2	2	NUM
eshr-12641	69	6	,	,	PUNCT
eshr-12641	69	7	2025	2025	NUM
eshr-12641	69	8	,	,	PUNCT
eshr-12641	69	9	pp	pp	ADJ
eshr-12641	69	10	.	.	PUNCT
eshr-12641	70	1	87	87	NUM
eshr-12641	70	2	-	-	SYM
eshr-12641	70	3	95	95	NUM
eshr-12641	70	4	92	92	NUM
eshr-12641	70	5	10.26555	10.26555	NUM
eshr-12641	70	6	/	/	SYM
eshr-12641	70	7	eshr.v7i2.12641	eshr.v7i2.12641	NOUN
eshr-12641	70	8	table	table	NOUN
eshr-12641	70	9	4	4	NUM
eshr-12641	70	10	.	.	PUNCT
eshr-12641	71	1	representation	representation	NOUN
eshr-12641	71	2	of	of	ADP
eshr-12641	71	3	study	study	NOUN
eshr-12641	71	4	participants	participant	NOUN
eshr-12641	71	5	according	accord	VERB
eshr-12641	71	6	to	to	ADP
eshr-12641	71	7	alcohol	alcohol	NOUN
eshr-12641	71	8	or	or	CCONJ
eshr-12641	71	9	tobacco	tobacco	NOUN
eshr-12641	71	10	consumption	consumption	NOUN
eshr-12641	71	11	and	and	CCONJ
eshr-12641	71	12	physical	physical	ADJ
eshr-12641	71	13	activity	activity	NOUN
eshr-12641	71	14	settings	setting	NOUN
eshr-12641	71	15	workforce	workforce	NOUN
eshr-12641	71	16	percentage	percentage	NOUN
eshr-12641	71	17	(	(	PUNCT
eshr-12641	71	18	%	%	INTJ
eshr-12641	71	19	)	)	PUNCT
eshr-12641	71	20	physical	physical	ADJ
eshr-12641	71	21	activity	activity	NOUN
eshr-12641	71	22	no	no	ADV
eshr-12641	71	23	67	67	NUM
eshr-12641	71	24	58.30	58.30	NUM
eshr-12641	71	25	%	%	NOUN
eshr-12641	72	1	yes	yes	INTJ
eshr-12641	72	2	48	48	NUM
eshr-12641	72	3	41.70	41.70	NUM
eshr-12641	72	4	%	%	NOUN
eshr-12641	72	5	total	total	NOUN
eshr-12641	72	6	115	115	NUM
eshr-12641	72	7	100.0	100.0	NUM
eshr-12641	72	8	%	%	NOUN
eshr-12641	72	9	significant	significant	ADJ
eshr-12641	72	10	difference	difference	NOUN
eshr-12641	72	11	was	be	AUX
eshr-12641	72	12	found	find	VERB
eshr-12641	72	13	,	,	PUNCT
eshr-12641	72	14	the	the	DET
eshr-12641	72	15	higher	high	ADJ
eshr-12641	72	16	prevalence	prevalence	NOUN
eshr-12641	72	17	obtained	obtain	VERB
eshr-12641	72	18	with	with	ADP
eshr-12641	72	19	idf	idf	PROPN
eshr-12641	72	20	definition	definition	NOUN
eshr-12641	72	21	in	in	ADP
eshr-12641	72	22	study	study	NOUN
eshr-12641	72	23	could	could	AUX
eshr-12641	72	24	be	be	AUX
eshr-12641	72	25	attributed	attribute	VERB
eshr-12641	72	26	to	to	ADP
eshr-12641	72	27	the	the	DET
eshr-12641	72	28	fact	fact	NOUN
eshr-12641	72	29	that	that	SCONJ
eshr-12641	72	30	,	,	PUNCT
eshr-12641	72	31	unlike	unlike	ADP
eshr-12641	72	32	the	the	DET
eshr-12641	72	33	other	other	ADJ
eshr-12641	72	34	definitions	definition	NOUN
eshr-12641	72	35	,	,	PUNCT
eshr-12641	72	36	this	this	DET
eshr-12641	72	37	definition	definition	NOUN
eshr-12641	72	38	includes	include	VERB
eshr-12641	72	39	bmi	bmi	NOUN
eshr-12641	72	40	as	as	ADP
eshr-12641	72	41	a	a	DET
eshr-12641	72	42	diagnostic	diagnostic	ADJ
eshr-12641	72	43	criterion	criterion	NOUN
eshr-12641	72	44	for	for	ADP
eshr-12641	72	45	ms	ms	PROPN
eshr-12641	72	46	,	,	PUNCT
eshr-12641	72	47	which	which	PRON
eshr-12641	72	48	is	be	AUX
eshr-12641	72	49	the	the	DET
eshr-12641	72	50	most	most	ADV
eshr-12641	72	51	important	important	ADJ
eshr-12641	72	52	risk	risk	NOUN
eshr-12641	72	53	factor	factor	NOUN
eshr-12641	72	54	in	in	ADP
eshr-12641	72	55	the	the	DET
eshr-12641	72	56	african	african	ADJ
eshr-12641	72	57	population.10	population.10	NOUN
eshr-12641	72	58	in	in	ADP
eshr-12641	72	59	chad	chad	PROPN
eshr-12641	72	60	,	,	PUNCT
eshr-12641	72	61	despite	despite	SCONJ
eshr-12641	72	62	the	the	DET
eshr-12641	72	63	seriousness	seriousness	NOUN
eshr-12641	72	64	of	of	ADP
eshr-12641	72	65	ms	ms	NOUN
eshr-12641	72	66	,	,	PUNCT
eshr-12641	72	67	we	we	PRON
eshr-12641	72	68	have	have	VERB
eshr-12641	72	69	little	little	ADJ
eshr-12641	72	70	data	datum	NOUN
eshr-12641	72	71	on	on	ADP
eshr-12641	72	72	its	its	PRON
eshr-12641	72	73	prevalence	prevalence	NOUN
eshr-12641	72	74	.	.	PUNCT
eshr-12641	73	1	we	we	PRON
eshr-12641	73	2	found	find	VERB
eshr-12641	73	3	in	in	ADP
eshr-12641	73	4	this	this	DET
eshr-12641	73	5	study	study	NOUN
eshr-12641	73	6	which	which	PRON
eshr-12641	73	7	aimed	aim	VERB
eshr-12641	73	8	to	to	PART
eshr-12641	73	9	determine	determine	VERB
eshr-12641	73	10	the	the	DET
eshr-12641	73	11	prevalence	prevalence	NOUN
eshr-12641	73	12	of	of	ADP
eshr-12641	73	13	ms	ms	NOUN
eshr-12641	73	14	a	a	DET
eshr-12641	73	15	rate	rate	NOUN
eshr-12641	73	16	of	of	ADP
eshr-12641	73	17	72.2	72.2	NUM
eshr-12641	73	18	%	%	NOUN
eshr-12641	73	19	(	(	PUNCT
eshr-12641	73	20	figure	figure	NOUN
eshr-12641	73	21	2	2	NUM
eshr-12641	73	22	)	)	PUNCT
eshr-12641	73	23	this	this	DET
eshr-12641	73	24	result	result	NOUN
eshr-12641	73	25	agrees	agree	VERB
eshr-12641	73	26	with	with	ADP
eshr-12641	73	27	the	the	DET
eshr-12641	73	28	data	datum	NOUN
eshr-12641	73	29	of	of	ADP
eshr-12641	73	30	the	the	DET
eshr-12641	73	31	literature	literature	NOUN
eshr-12641	73	32	.	.	PUNCT
eshr-12641	74	1	in	in	ADP
eshr-12641	74	2	burkina	burkina	PROPN
eshr-12641	74	3	,	,	PUNCT
eshr-12641	74	4	in	in	ADP
eshr-12641	74	5	a	a	DET
eshr-12641	74	6	study	study	NOUN
eshr-12641	74	7	by.11	by.11	ADP
eshr-12641	74	8	the	the	DET
eshr-12641	74	9	association	association	NOUN
eshr-12641	74	10	diabetes	diabetes	NOUN
eshr-12641	74	11	mellitus	mellitus	NOUN
eshr-12641	74	12	and	and	CCONJ
eshr-12641	74	13	metabolic	metabolic	NOUN
eshr-12641	74	14	syndrome	syndrome	NOUN
eshr-12641	74	15	was	be	AUX
eshr-12641	74	16	reported	report	VERB
eshr-12641	74	17	in	in	ADP
eshr-12641	74	18	48.9	48.9	NUM
eshr-12641	74	19	%	%	NOUN
eshr-12641	74	20	among	among	ADP
eshr-12641	74	21	type	type	NOUN
eshr-12641	74	22	2	2	NUM
eshr-12641	74	23	diabetic	diabetic	ADJ
eshr-12641	74	24	subjects	subject	NOUN
eshr-12641	74	25	.	.	PUNCT
eshr-12641	75	1	according	accord	VERB
eshr-12641	75	2	to,12	to,12	NUM
eshr-12641	75	3	the	the	DET
eshr-12641	75	4	prevalence	prevalence	NOUN
eshr-12641	75	5	of	of	ADP
eshr-12641	75	6	metabolic	metabolic	NOUN
eshr-12641	75	7	syndrome	syndrome	NOUN
eshr-12641	75	8	varies	vary	VERB
eshr-12641	75	9	from	from	ADP
eshr-12641	75	10	34	34	NUM
eshr-12641	75	11	%	%	NOUN
eshr-12641	75	12	to	to	PART
eshr-12641	75	13	80	80	NUM
eshr-12641	75	14	%	%	NOUN
eshr-12641	75	15	among	among	ADP
eshr-12641	75	16	diabetics	diabetic	NOUN
eshr-12641	75	17	,	,	PUNCT
eshr-12641	75	18	thus	thus	ADV
eshr-12641	75	19	reflecting	reflect	VERB
eshr-12641	75	20	the	the	DET
eshr-12641	75	21	importance	importance	NOUN
eshr-12641	75	22	of	of	ADP
eshr-12641	75	23	the	the	DET
eshr-12641	75	24	problem	problem	NOUN
eshr-12641	75	25	.	.	PUNCT
eshr-12641	76	1	our	our	PRON
eshr-12641	76	2	results	result	NOUN
eshr-12641	76	3	are	be	AUX
eshr-12641	76	4	much	much	ADV
eshr-12641	76	5	higher	high	ADJ
eshr-12641	76	6	than	than	ADP
eshr-12641	76	7	those	those	PRON
eshr-12641	76	8	reported	report	VERB
eshr-12641	76	9	in	in	ADP
eshr-12641	76	10	côte	côte	PROPN
eshr-12641	76	11	d'ivoire	d'ivoire	PROPN
eshr-12641	76	12	(	(	PUNCT
eshr-12641	76	13	4.94%).13	4.94%).13	NUM
eshr-12641	76	14	on	on	ADP
eshr-12641	76	15	the	the	DET
eshr-12641	76	16	other	other	ADJ
eshr-12641	76	17	hand	hand	NOUN
eshr-12641	76	18	,	,	PUNCT
eshr-12641	76	19	prevalence	prevalence	NOUN
eshr-12641	76	20	approaching	approach	VERB
eshr-12641	76	21	ours	ours	PRON
eshr-12641	76	22	were	be	AUX
eshr-12641	76	23	found	find	VERB
eshr-12641	76	24	in	in	ADP
eshr-12641	76	25	france	france	PROPN
eshr-12641	76	26	(	(	PUNCT
eshr-12641	76	27	20%)14	20%)14	NUM
eshr-12641	76	28	as	as	ADV
eshr-12641	76	29	well	well	ADV
eshr-12641	76	30	as	as	ADP
eshr-12641	76	31	in	in	ADP
eshr-12641	76	32	kuwait	kuwait	PROPN
eshr-12641	76	33	(	(	PUNCT
eshr-12641	76	34	39.19%).15	39.19%).15	NUM
eshr-12641	76	35	the	the	DET
eshr-12641	76	36	gender	gender	NOUN
eshr-12641	76	37	distribution	distribution	NOUN
eshr-12641	76	38	of	of	ADP
eshr-12641	76	39	ms	ms	NOUN
eshr-12641	76	40	prevalence	prevalence	NOUN
eshr-12641	76	41	showed	show	VERB
eshr-12641	76	42	that	that	SCONJ
eshr-12641	76	43	women	woman	NOUN
eshr-12641	76	44	had	have	VERB
eshr-12641	76	45	a	a	DET
eshr-12641	76	46	higher	high	ADJ
eshr-12641	76	47	prevalence	prevalence	NOUN
eshr-12641	76	48	(	(	PUNCT
eshr-12641	76	49	71.08	71.08	NUM
eshr-12641	76	50	%	%	NOUN
eshr-12641	76	51	)	)	PUNCT
eshr-12641	76	52	than	than	ADP
eshr-12641	76	53	men	man	NOUN
eshr-12641	76	54	(	(	PUNCT
eshr-12641	76	55	28.91	28.91	NUM
eshr-12641	76	56	%	%	NOUN
eshr-12641	76	57	)	)	PUNCT
eshr-12641	76	58	(	(	PUNCT
eshr-12641	76	59	table	table	NOUN
eshr-12641	76	60	2	2	NUM
eshr-12641	76	61	)	)	PUNCT
eshr-12641	76	62	.	.	PUNCT
eshr-12641	77	1	previous	previous	ADJ
eshr-12641	77	2	studies	study	NOUN
eshr-12641	77	3	conducted	conduct	VERB
eshr-12641	77	4	on	on	ADP
eshr-12641	77	5	the	the	DET
eshr-12641	77	6	african	african	ADJ
eshr-12641	77	7	continent	continent	NOUN
eshr-12641	77	8	have	have	AUX
eshr-12641	77	9	shown	show	VERB
eshr-12641	77	10	similar	similar	ADJ
eshr-12641	77	11	results.16,17	results.16,17	NOUN
eshr-12641	77	12	this	this	PRON
eshr-12641	77	13	could	could	AUX
eshr-12641	77	14	be	be	AUX
eshr-12641	77	15	explained	explain	VERB
eshr-12641	77	16	by	by	ADP
eshr-12641	77	17	the	the	DET
eshr-12641	77	18	obesity	obesity	NOUN
eshr-12641	77	19	epidemic	epidemic	NOUN
eshr-12641	77	20	,	,	PUNCT
eshr-12641	77	21	which	which	PRON
eshr-12641	77	22	is	be	AUX
eshr-12641	77	23	a	a	DET
eshr-12641	77	24	major	major	ADJ
eshr-12641	77	25	risk	risk	NOUN
eshr-12641	77	26	factor	factor	NOUN
eshr-12641	77	27	for	for	ADP
eshr-12641	77	28	ms	ms	NOUN
eshr-12641	77	29	and	and	CCONJ
eshr-12641	77	30	predominantly	predominantly	ADV
eshr-12641	77	31	affects	affect	VERB
eshr-12641	77	32	women.22	women.22	NOUN
eshr-12641	77	33	menopause	menopause	NOUN
eshr-12641	77	34	,	,	PUNCT
eshr-12641	77	35	polycystic	polycystic	ADJ
eshr-12641	77	36	ovarian	ovarian	ADJ
eshr-12641	77	37	syndrome	syndrome	NOUN
eshr-12641	77	38	,	,	PUNCT
eshr-12641	77	39	and	and	CCONJ
eshr-12641	77	40	low	low	ADJ
eshr-12641	77	41	physical	physical	ADJ
eshr-12641	77	42	activity	activity	NOUN
eshr-12641	77	43	are	be	AUX
eshr-12641	77	44	additional	additional	ADJ
eshr-12641	77	45	risk	risk	NOUN
eshr-12641	77	46	factors	factor	NOUN
eshr-12641	77	47	that	that	PRON
eshr-12641	77	48	could	could	AUX
eshr-12641	77	49	explain	explain	VERB
eshr-12641	77	50	this	this	DET
eshr-12641	77	51	high	high	ADJ
eshr-12641	77	52	prevalence	prevalence	NOUN
eshr-12641	77	53	in	in	ADP
eshr-12641	77	54	this	this	DET
eshr-12641	77	55	population	population	NOUN
eshr-12641	77	56	group	group	NOUN
eshr-12641	77	57	,	,	PUNCT
eshr-12641	77	58	indeed	indeed	ADV
eshr-12641	77	59	in	in	ADP
eshr-12641	77	60	chad	chad	PROPN
eshr-12641	77	61	women	woman	NOUN
eshr-12641	77	62	are	be	AUX
eshr-12641	77	63	faced	face	VERB
eshr-12641	77	64	with	with	ADP
eshr-12641	77	65	multiple	multiple	ADJ
eshr-12641	77	66	challenges	challenge	NOUN
eshr-12641	77	67	,	,	PUNCT
eshr-12641	77	68	particularly	particularly	ADV
eshr-12641	77	69	in	in	ADP
eshr-12641	77	70	terms	term	NOUN
eshr-12641	77	71	of	of	ADP
eshr-12641	77	72	access	access	NOUN
eshr-12641	77	73	to	to	ADP
eshr-12641	77	74	education	education	NOUN
eshr-12641	77	75	,	,	PUNCT
eshr-12641	77	76	physical	physical	ADJ
eshr-12641	77	77	activities	activity	NOUN
eshr-12641	77	78	and	and	CCONJ
eshr-12641	77	79	health	health	NOUN
eshr-12641	77	80	services	service	NOUN
eshr-12641	77	81	(	(	PUNCT
eshr-12641	77	82	unesco	unesco	NOUN
eshr-12641	77	83	2016	2016	NUM
eshr-12641	77	84	)	)	PUNCT
eshr-12641	77	85	.	.	PUNCT
eshr-12641	78	1	this	this	DET
eshr-12641	78	2	result	result	NOUN
eshr-12641	78	3	agrees	agree	VERB
eshr-12641	78	4	with	with	ADP
eshr-12641	78	5	the	the	DET
eshr-12641	78	6	work	work	NOUN
eshr-12641	78	7	of	of	ADP
eshr-12641	78	8	ba	ba	PROPN
eshr-12641	78	9	.	.	PUNCT
eshr-12641	79	1	(	(	PUNCT
eshr-12641	79	2	2012	2012	NUM
eshr-12641	79	3	)	)	PUNCT
eshr-12641	79	4	in	in	ADP
eshr-12641	79	5	senegal	senegal	PROPN
eshr-12641	79	6	who	who	PRON
eshr-12641	79	7	found	find	VERB
eshr-12641	79	8	a	a	DET
eshr-12641	79	9	frequency	frequency	NOUN
eshr-12641	79	10	of	of	ADP
eshr-12641	79	11	58	58	NUM
eshr-12641	79	12	%	%	NOUN
eshr-12641	79	13	in	in	ADP
eshr-12641	79	14	the	the	DET
eshr-12641	79	15	type	type	NOUN
eshr-12641	79	16	2	2	NUM
eshr-12641	79	17	diabetic	diabetic	ADJ
eshr-12641	79	18	population	population	NOUN
eshr-12641	79	19	.	.	PUNCT
eshr-12641	80	1	this	this	DET
eshr-12641	80	2	trend	trend	NOUN
eshr-12641	80	3	has	have	AUX
eshr-12641	80	4	been	be	AUX
eshr-12641	80	5	reported	report	VERB
eshr-12641	80	6	in	in	ADP
eshr-12641	80	7	tunisia.23	tunisia.23	PROPN
eshr-12641	80	8	however	however	ADV
eshr-12641	80	9	,	,	PUNCT
eshr-12641	80	10	a	a	DET
eshr-12641	80	11	higher	high	ADJ
eshr-12641	80	12	prevalence	prevalence	NOUN
eshr-12641	80	13	among	among	ADP
eshr-12641	80	14	men	man	NOUN
eshr-12641	80	15	has	have	AUX
eshr-12641	80	16	been	be	AUX
eshr-12641	80	17	reported	report	VERB
eshr-12641	80	18	in	in	ADP
eshr-12641	80	19	dakar.24	dakar.24	NOUN
eshr-12641	80	20	on	on	ADP
eshr-12641	80	21	the	the	DET
eshr-12641	80	22	other	other	ADJ
eshr-12641	80	23	hand	hand	NOUN
eshr-12641	80	24	,	,	PUNCT
eshr-12641	80	25	no	no	DET
eshr-12641	80	26	significant	significant	ADJ
eshr-12641	80	27	difference	difference	NOUN
eshr-12641	80	28	was	be	AUX
eshr-12641	80	29	observed	observe	VERB
eshr-12641	80	30	between	between	ADP
eshr-12641	80	31	the	the	DET
eshr-12641	80	32	two	two	NUM
eshr-12641	80	33	sexes	sex	NOUN
eshr-12641	80	34	in	in	ADP
eshr-12641	80	35	greece.25	greece.25	NOUN
eshr-12641	80	36	thus	thus	ADV
eshr-12641	80	37	,	,	PUNCT
eshr-12641	80	38	the	the	DET
eshr-12641	80	39	distribution	distribution	NOUN
eshr-12641	80	40	of	of	ADP
eshr-12641	80	41	the	the	DET
eshr-12641	80	42	prevalence	prevalence	NOUN
eshr-12641	80	43	of	of	ADP
eshr-12641	80	44	ms	ms	NOUN
eshr-12641	80	45	according	accord	VERB
eshr-12641	80	46	to	to	ADP
eshr-12641	80	47	sex	sex	NOUN
eshr-12641	80	48	differs	differ	NOUN
eshr-12641	80	49	from	from	ADP
eshr-12641	80	50	one	one	NUM
eshr-12641	80	51	study	study	NOUN
eshr-12641	80	52	to	to	ADP
eshr-12641	80	53	another	another	PRON
eshr-12641	80	54	.	.	PUNCT
eshr-12641	81	1	the	the	DET
eshr-12641	81	2	average	average	ADJ
eshr-12641	81	3	age	age	NOUN
eshr-12641	81	4	of	of	ADP
eshr-12641	81	5	the	the	DET
eshr-12641	81	6	participants	participant	NOUN
eshr-12641	81	7	was	be	AUX
eshr-12641	81	8	60	60	NUM
eshr-12641	81	9	years	year	NOUN
eshr-12641	81	10	old	old	ADJ
eshr-12641	81	11	with	with	ADP
eshr-12641	81	12	extremes	extreme	NOUN
eshr-12641	81	13	ranging	range	VERB
eshr-12641	81	14	from	from	ADP
eshr-12641	81	15	30	30	NUM
eshr-12641	81	16	to	to	PART
eshr-12641	81	17	80	80	NUM
eshr-12641	81	18	years	year	NOUN
eshr-12641	81	19	old	old	ADJ
eshr-12641	81	20	.	.	PUNCT
eshr-12641	82	1	the	the	DET
eshr-12641	82	2	predominant	predominant	ADJ
eshr-12641	82	3	age	age	NOUN
eshr-12641	82	4	group	group	NOUN
eshr-12641	82	5	was	be	AUX
eshr-12641	82	6	50	50	NUM
eshr-12641	82	7	-	-	SYM
eshr-12641	82	8	70	70	NUM
eshr-12641	82	9	years	year	NOUN
eshr-12641	82	10	old	old	ADJ
eshr-12641	82	11	with	with	ADP
eshr-12641	82	12	a	a	DET
eshr-12641	82	13	frequency	frequency	NOUN
eshr-12641	82	14	of	of	ADP
eshr-12641	82	15	67.8	67.8	NUM
eshr-12641	82	16	%	%	NOUN
eshr-12641	82	17	(	(	PUNCT
eshr-12641	82	18	with	with	ADP
eshr-12641	82	19	33.9	33.9	NUM
eshr-12641	82	20	%	%	NOUN
eshr-12641	82	21	from	from	ADP
eshr-12641	82	22	50	50	NUM
eshr-12641	82	23	-	-	SYM
eshr-12641	82	24	60	60	NUM
eshr-12641	82	25	years	year	NOUN
eshr-12641	82	26	old	old	ADJ
eshr-12641	82	27	and	and	CCONJ
eshr-12641	82	28	33.9	33.9	NUM
eshr-12641	82	29	%	%	NOUN
eshr-12641	82	30	from	from	ADP
eshr-12641	82	31	60	60	NUM
eshr-12641	82	32	-	-	SYM
eshr-12641	82	33	70	70	NUM
eshr-12641	82	34	years	year	NOUN
eshr-12641	82	35	old	old	ADJ
eshr-12641	82	36	)	)	PUNCT
eshr-12641	82	37	this	this	PRON
eshr-12641	82	38	could	could	AUX
eshr-12641	82	39	be	be	AUX
eshr-12641	82	40	explained	explain	VERB
eshr-12641	82	41	by	by	ADP
eshr-12641	82	42	aging	aging	NOUN
eshr-12641	82	43	of	of	ADP
eshr-12641	82	44	the	the	DET
eshr-12641	82	45	population	population	NOUN
eshr-12641	82	46	studied	study	VERB
eshr-12641	82	47	.	.	PUNCT
eshr-12641	83	1	this	this	DET
eshr-12641	83	2	increase	increase	NOUN
eshr-12641	83	3	in	in	ADP
eshr-12641	83	4	the	the	DET
eshr-12641	83	5	prevalence	prevalence	NOUN
eshr-12641	83	6	of	of	ADP
eshr-12641	83	7	ms	ms	NOUN
eshr-12641	83	8	with	with	ADP
eshr-12641	83	9	age	age	NOUN
eshr-12641	83	10	is	be	AUX
eshr-12641	83	11	therefore	therefore	ADV
eshr-12641	83	12	in	in	ADP
eshr-12641	83	13	agreement	agreement	NOUN
eshr-12641	83	14	with	with	ADP
eshr-12641	83	15	the	the	DET
eshr-12641	83	16	data	datum	NOUN
eshr-12641	83	17	in	in	ADP
eshr-12641	83	18	the	the	DET
eshr-12641	83	19	literature	literature	NOUN
eshr-12641	83	20	.	.	PUNCT
eshr-12641	84	1	it	it	PRON
eshr-12641	84	2	could	could	AUX
eshr-12641	84	3	be	be	AUX
eshr-12641	84	4	linked	link	VERB
eshr-12641	84	5	to	to	ADP
eshr-12641	84	6	the	the	DET
eshr-12641	84	7	higher	high	ADJ
eshr-12641	84	8	frequency	frequency	NOUN
eshr-12641	84	9	of	of	ADP
eshr-12641	84	10	metabolic	metabolic	NOUN
eshr-12641	84	11	disturbances	disturbance	NOUN
eshr-12641	84	12	in	in	ADP
eshr-12641	84	13	the	the	DET
eshr-12641	84	14	elderly,26	elderly,26	NOUN
eshr-12641	84	15	however	however	ADV
eshr-12641	84	16	,	,	PUNCT
eshr-12641	84	17	the	the	DET
eshr-12641	84	18	emergence	emergence	NOUN
eshr-12641	84	19	of	of	ADP
eshr-12641	84	20	ms	ms	NOUN
eshr-12641	84	21	in	in	ADP
eshr-12641	84	22	adolescents	adolescent	NOUN
eshr-12641	84	23	should	should	AUX
eshr-12641	84	24	be	be	AUX
eshr-12641	84	25	noted	note	VERB
eshr-12641	84	26	,	,	PUNCT
eshr-12641	84	27	as	as	SCONJ
eshr-12641	84	28	evidenced	evidence	VERB
eshr-12641	84	29	by	by	ADP
eshr-12641	84	30	studies	study	NOUN
eshr-12641	84	31	carried	carry	VERB
eshr-12641	84	32	out	out	ADP
eshr-12641	84	33	in	in	ADP
eshr-12641	84	34	the	the	DET
eshr-12641	84	35	united	united	PROPN
eshr-12641	84	36	states,12	states,12	PROPN
eshr-12641	84	37	and	and	CCONJ
eshr-12641	84	38	in	in	ADP
eshr-12641	84	39	canada.23,27	canada.23,27	NOUN
eshr-12641	84	40	according	accord	VERB
eshr-12641	84	41	to	to	ADP
eshr-12641	84	42	these	these	DET
eshr-12641	84	43	authors	author	NOUN
eshr-12641	84	44	,	,	PUNCT
eshr-12641	84	45	obesity	obesity	NOUN
eshr-12641	84	46	would	would	AUX
eshr-12641	84	47	play	play	VERB
eshr-12641	84	48	an	an	DET
eshr-12641	84	49	essential	essential	ADJ
eshr-12641	84	50	role	role	NOUN
eshr-12641	84	51	.	.	PUNCT
eshr-12641	85	1	according	accord	VERB
eshr-12641	85	2	to	to	ADP
eshr-12641	85	3	the	the	DET
eshr-12641	85	4	number	number	NOUN
eshr-12641	85	5	of	of	ADP
eshr-12641	85	6	associated	associated	ADJ
eshr-12641	85	7	criteria	criterion	NOUN
eshr-12641	85	8	,	,	PUNCT
eshr-12641	85	9	we	we	PRON
eshr-12641	85	10	found	find	VERB
eshr-12641	85	11	in	in	ADP
eshr-12641	85	12	most	most	ADJ
eshr-12641	85	13	subjects	subject	NOUN
eshr-12641	85	14	presenting	present	VERB
eshr-12641	85	15	ms	ms	PROPN
eshr-12641	85	16	,	,	PUNCT
eshr-12641	85	17	the	the	DET
eshr-12641	85	18	association	association	NOUN
eshr-12641	85	19	of	of	ADP
eshr-12641	85	20	3	3	NUM
eshr-12641	85	21	criteria	criterion	NOUN
eshr-12641	85	22	(	(	PUNCT
eshr-12641	85	23	34	34	NUM
eshr-12641	85	24	%	%	NOUN
eshr-12641	85	25	)	)	PUNCT
eshr-12641	85	26	(	(	PUNCT
eshr-12641	85	27	table	table	NOUN
eshr-12641	85	28	3	3	NUM
eshr-12641	85	29	)	)	PUNCT
eshr-12641	85	30	.	.	PUNCT
eshr-12641	86	1	these	these	DET
eshr-12641	86	2	results	result	NOUN
eshr-12641	86	3	control	control	VERB
eshr-12641	86	4	the	the	DET
eshr-12641	86	5	data	datum	NOUN
eshr-12641	86	6	from	from	ADP
eshr-12641	86	7	the	the	DET
eshr-12641	86	8	literature	literature	NOUN
eshr-12641	86	9	which	which	PRON
eshr-12641	86	10	shows	show	VERB
eshr-12641	86	11	that	that	SCONJ
eshr-12641	86	12	the	the	DET
eshr-12641	86	13	association	association	NOUN
eshr-12641	86	14	of	of	ADP
eshr-12641	86	15	three	three	NUM
eshr-12641	86	16	components	component	NOUN
eshr-12641	86	17	is	be	AUX
eshr-12641	86	18	always	always	ADV
eshr-12641	86	19	the	the	DET
eshr-12641	86	20	most	most	ADJ
eshr-12641	86	21	frequent.28	frequent.28	NOUN
eshr-12641	86	22	however	however	ADV
eshr-12641	86	23	,	,	PUNCT
eshr-12641	86	24	it	it	PRON
eshr-12641	86	25	is	be	AUX
eshr-12641	86	26	important	important	ADJ
eshr-12641	86	27	to	to	PART
eshr-12641	86	28	note	note	VERB
eshr-12641	86	29	that	that	SCONJ
eshr-12641	86	30	19	19	NUM
eshr-12641	86	31	subjects	subject	NOUN
eshr-12641	86	32	(	(	PUNCT
eshr-12641	86	33	17	17	NUM
eshr-12641	86	34	%	%	NOUN
eshr-12641	86	35	)	)	PUNCT
eshr-12641	86	36	of	of	ADP
eshr-12641	86	37	the	the	DET
eshr-12641	86	38	total	total	ADJ
eshr-12641	86	39	population	population	NOUN
eshr-12641	86	40	already	already	ADV
eshr-12641	86	41	presented	present	VERB
eshr-12641	86	42	2	2	NUM
eshr-12641	86	43	criteria	criterion	NOUN
eshr-12641	86	44	(	(	PUNCT
eshr-12641	86	45	table	table	NOUN
eshr-12641	86	46	3	3	NUM
eshr-12641	86	47	)	)	PUNCT
eshr-12641	86	48	.	.	PUNCT
eshr-12641	87	1	these	these	PRON
eshr-12641	87	2	should	should	AUX
eshr-12641	87	3	be	be	AUX
eshr-12641	87	4	carefully	carefully	ADV
eshr-12641	87	5	monitored	monitor	VERB
eshr-12641	87	6	to	to	PART
eshr-12641	87	7	avoid	avoid	VERB
eshr-12641	87	8	progression	progression	NOUN
eshr-12641	87	9	to	to	ADP
eshr-12641	87	10	metabolic	metabolic	NOUN
eshr-12641	87	11	syndrome	syndrome	NOUN
eshr-12641	87	12	.	.	PUNCT
eshr-12641	88	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	88	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	88	3	noubaramadji	noubaramadji	NOUN
eshr-12641	88	4	yamti	yamti	PROPN
eshr-12641	88	5	et	et	PROPN
eshr-12641	88	6	al	al	PROPN
eshr-12641	88	7	.	.	PUNCT
eshr-12641	89	1	(	(	PUNCT
eshr-12641	89	2	prevalence	prevalence	NOUN
eshr-12641	89	3	of	of	ADP
eshr-12641	89	4	metabolic	metabolic	NOUN
eshr-12641	89	5	syndrome	syndrome	NOUN
eshr-12641	89	6	among	among	ADP
eshr-12641	89	7	patients	patient	NOUN
eshr-12641	89	8	with	with	ADP
eshr-12641	89	9	type	type	NOUN
eshr-12641	89	10	2	2	NUM
eshr-12641	89	11	diabetes	diabetes	NOUN
eshr-12641	89	12	…	…	PUNCT
eshr-12641	89	13	)	)	PUNCT
eshr-12641	89	14	vol	vol	NOUN
eshr-12641	89	15	.	.	PROPN
eshr-12641	90	1	7	7	NUM
eshr-12641	90	2	,	,	PUNCT
eshr-12641	90	3	no	no	INTJ
eshr-12641	90	4	.	.	NOUN
eshr-12641	90	5	2	2	NUM
eshr-12641	90	6	,	,	PUNCT
eshr-12641	90	7	2025	2025	NUM
eshr-12641	90	8	,	,	PUNCT
eshr-12641	90	9	pp	pp	ADJ
eshr-12641	90	10	.	.	PUNCT
eshr-12641	91	1	87	87	NUM
eshr-12641	91	2	-	-	SYM
eshr-12641	91	3	95	95	NUM
eshr-12641	91	4	93	93	NUM
eshr-12641	91	5	10.26555	10.26555	NUM
eshr-12641	91	6	/	/	SYM
eshr-12641	91	7	eshr.v7i2.12641	eshr.v7i2.12641	PROPN
eshr-12641	91	8	nevertheless	nevertheless	ADV
eshr-12641	91	9	,	,	PUNCT
eshr-12641	91	10	our	our	PRON
eshr-12641	91	11	study	study	NOUN
eshr-12641	91	12	had	have	VERB
eshr-12641	91	13	some	some	DET
eshr-12641	91	14	limitations	limitation	NOUN
eshr-12641	91	15	,	,	PUNCT
eshr-12641	91	16	namely	namely	ADV
eshr-12641	91	17	:	:	PUNCT
eshr-12641	91	18	its	its	PRON
eshr-12641	91	19	short	short	ADJ
eshr-12641	91	20	duration	duration	NOUN
eshr-12641	91	21	which	which	PRON
eshr-12641	91	22	did	do	AUX
eshr-12641	91	23	not	not	PART
eshr-12641	91	24	allow	allow	VERB
eshr-12641	91	25	us	we	PRON
eshr-12641	91	26	to	to	PART
eshr-12641	91	27	investigate	investigate	VERB
eshr-12641	91	28	other	other	ADJ
eshr-12641	91	29	possible	possible	ADJ
eshr-12641	91	30	factors	factor	NOUN
eshr-12641	91	31	that	that	PRON
eshr-12641	91	32	could	could	AUX
eshr-12641	91	33	be	be	AUX
eshr-12641	91	34	associated	associate	VERB
eshr-12641	91	35	with	with	ADP
eshr-12641	91	36	the	the	DET
eshr-12641	91	37	metabolic	metabolic	NOUN
eshr-12641	91	38	syndrome	syndrome	NOUN
eshr-12641	91	39	;	;	PUNCT
eshr-12641	91	40	the	the	DET
eshr-12641	91	41	difficulty	difficulty	NOUN
eshr-12641	91	42	of	of	ADP
eshr-12641	91	43	collecting	collect	VERB
eshr-12641	91	44	anthropometric	anthropometric	ADJ
eshr-12641	91	45	data	datum	NOUN
eshr-12641	91	46	in	in	ADP
eshr-12641	91	47	some	some	DET
eshr-12641	91	48	patients	patient	NOUN
eshr-12641	91	49	(	(	PUNCT
eshr-12641	91	50	ethical	ethical	ADJ
eshr-12641	91	51	and	and	CCONJ
eshr-12641	91	52	religious	religious	ADJ
eshr-12641	91	53	problem	problem	NOUN
eshr-12641	91	54	)	)	PUNCT
eshr-12641	91	55	and	and	CCONJ
eshr-12641	91	56	the	the	DET
eshr-12641	91	57	lack	lack	NOUN
eshr-12641	91	58	of	of	ADP
eshr-12641	91	59	additional	additional	ADJ
eshr-12641	91	60	examinations	examination	NOUN
eshr-12641	91	61	(	(	PUNCT
eshr-12641	91	62	lipidogram	lipidogram	NOUN
eshr-12641	91	63	)	)	PUNCT
eshr-12641	91	64	often	often	ADV
eshr-12641	91	65	necessary	necessary	ADJ
eshr-12641	91	66	for	for	ADP
eshr-12641	91	67	diagnosis	diagnosis	NOUN
eshr-12641	91	68	.	.	PUNCT
eshr-12641	92	1	moreover	moreover	ADV
eshr-12641	92	2	,	,	PUNCT
eshr-12641	92	3	our	our	PRON
eshr-12641	92	4	sample	sample	NOUN
eshr-12641	92	5	does	do	AUX
eshr-12641	92	6	not	not	PART
eshr-12641	92	7	reflect	reflect	VERB
eshr-12641	92	8	all	all	DET
eshr-12641	92	9	strata	strata	NOUN
eshr-12641	92	10	of	of	ADP
eshr-12641	92	11	chadian	chadian	ADJ
eshr-12641	92	12	society	society	NOUN
eshr-12641	92	13	.	.	PUNCT
eshr-12641	93	1	a	a	DET
eshr-12641	93	2	multicenter	multicenter	ADJ
eshr-12641	93	3	study	study	NOUN
eshr-12641	93	4	should	should	AUX
eshr-12641	93	5	therefore	therefore	ADV
eshr-12641	93	6	be	be	AUX
eshr-12641	93	7	considered	consider	VERB
eshr-12641	93	8	to	to	PART
eshr-12641	93	9	have	have	VERB
eshr-12641	93	10	exact	exact	ADJ
eshr-12641	93	11	figures	figure	NOUN
eshr-12641	93	12	on	on	ADP
eshr-12641	93	13	the	the	DET
eshr-12641	93	14	prevalence	prevalence	NOUN
eshr-12641	93	15	of	of	ADP
eshr-12641	93	16	ms	ms	PROPN
eshr-12641	93	17	in	in	ADP
eshr-12641	93	18	chad	chad	PROPN
eshr-12641	93	19	.	.	PUNCT
eshr-12641	94	1	conclusion	conclusion	NOUN
eshr-12641	94	2	at	at	ADP
eshr-12641	94	3	the	the	DET
eshr-12641	94	4	end	end	NOUN
eshr-12641	94	5	of	of	ADP
eshr-12641	94	6	this	this	DET
eshr-12641	94	7	study	study	NOUN
eshr-12641	94	8	,	,	PUNCT
eshr-12641	94	9	the	the	DET
eshr-12641	94	10	objective	objective	NOUN
eshr-12641	94	11	of	of	ADP
eshr-12641	94	12	which	which	PRON
eshr-12641	94	13	was	be	AUX
eshr-12641	94	14	to	to	PART
eshr-12641	94	15	assess	assess	VERB
eshr-12641	94	16	the	the	DET
eshr-12641	94	17	prevalence	prevalence	NOUN
eshr-12641	94	18	of	of	ADP
eshr-12641	94	19	the	the	DET
eshr-12641	94	20	metabolic	metabolic	NOUN
eshr-12641	94	21	syndrome	syndrome	NOUN
eshr-12641	94	22	,	,	PUNCT
eshr-12641	94	23	the	the	DET
eshr-12641	94	24	results	result	NOUN
eshr-12641	94	25	show	show	VERB
eshr-12641	94	26	a	a	DET
eshr-12641	94	27	high	high	ADJ
eshr-12641	94	28	prevalence	prevalence	NOUN
eshr-12641	94	29	of	of	ADP
eshr-12641	94	30	ms	ms	NOUN
eshr-12641	94	31	in	in	ADP
eshr-12641	94	32	the	the	DET
eshr-12641	94	33	population	population	NOUN
eshr-12641	94	34	studied	study	VERB
eshr-12641	94	35	,	,	PUNCT
eshr-12641	94	36	particularly	particularly	ADV
eshr-12641	94	37	among	among	ADP
eshr-12641	94	38	women	woman	NOUN
eshr-12641	94	39	.	.	PUNCT
eshr-12641	95	1	the	the	DET
eshr-12641	95	2	metabolic	metabolic	NOUN
eshr-12641	95	3	syndrome	syndrome	NOUN
eshr-12641	95	4	,	,	PUNCT
eshr-12641	95	5	in	in	ADP
eshr-12641	95	6	view	view	NOUN
eshr-12641	95	7	of	of	ADP
eshr-12641	95	8	the	the	DET
eshr-12641	95	9	entities	entity	NOUN
eshr-12641	95	10	that	that	PRON
eshr-12641	95	11	compose	compose	VERB
eshr-12641	95	12	it	it	PRON
eshr-12641	95	13	,	,	PUNCT
eshr-12641	95	14	makes	make	VERB
eshr-12641	95	15	it	it	PRON
eshr-12641	95	16	a	a	DET
eshr-12641	95	17	real	real	ADJ
eshr-12641	95	18	cardiovascular	cardiovascular	ADJ
eshr-12641	95	19	risk	risk	NOUN
eshr-12641	95	20	factor	factor	NOUN
eshr-12641	95	21	and	and	CCONJ
eshr-12641	95	22	therefore	therefore	ADV
eshr-12641	95	23	a	a	DET
eshr-12641	95	24	major	major	ADJ
eshr-12641	95	25	public	public	ADJ
eshr-12641	95	26	health	health	NOUN
eshr-12641	95	27	issue	issue	NOUN
eshr-12641	95	28	.	.	PUNCT
eshr-12641	96	1	the	the	DET
eshr-12641	96	2	management	management	NOUN
eshr-12641	96	3	of	of	ADP
eshr-12641	96	4	this	this	DET
eshr-12641	96	5	metabolic	metabolic	NOUN
eshr-12641	96	6	syndrome	syndrome	NOUN
eshr-12641	96	7	requires	require	VERB
eshr-12641	96	8	emphasizing	emphasize	VERB
eshr-12641	96	9	the	the	DET
eshr-12641	96	10	proper	proper	ADJ
eshr-12641	96	11	monitoring	monitoring	NOUN
eshr-12641	96	12	of	of	ADP
eshr-12641	96	13	diet	diet	NOUN
eshr-12641	96	14	and	and	CCONJ
eshr-12641	96	15	physical	physical	ADJ
eshr-12641	96	16	activity	activity	NOUN
eshr-12641	96	17	in	in	ADP
eshr-12641	96	18	addition	addition	NOUN
eshr-12641	96	19	to	to	ADP
eshr-12641	96	20	drug	drug	NOUN
eshr-12641	96	21	treatment	treatment	NOUN
eshr-12641	96	22	for	for	ADP
eshr-12641	96	23	a	a	DET
eshr-12641	96	24	significant	significant	ADJ
eshr-12641	96	25	improvement	improvement	NOUN
eshr-12641	96	26	in	in	ADP
eshr-12641	96	27	the	the	DET
eshr-12641	96	28	various	various	ADJ
eshr-12641	96	29	parameters	parameter	NOUN
eshr-12641	96	30	.	.	PUNCT
eshr-12641	97	1	acknowledgment	acknowledgment	NOUN
eshr-12641	97	2	we	we	PRON
eshr-12641	97	3	thank	thank	VERB
eshr-12641	97	4	pr	pr	NOUN
eshr-12641	97	5	gatsing	gatse	VERB
eshr-12641	97	6	donatien	donatien	NOUN
eshr-12641	97	7	,	,	PUNCT
eshr-12641	97	8	professor	professor	NOUN
eshr-12641	97	9	at	at	ADP
eshr-12641	97	10	the	the	DET
eshr-12641	97	11	université	université	PROPN
eshr-12641	97	12	evangelique	evangelique	PROPN
eshr-12641	97	13	du	du	PROPN
eshr-12641	97	14	cameroun	cameroun	PROPN
eshr-12641	97	15	,	,	PUNCT
eshr-12641	97	16	for	for	ADP
eshr-12641	97	17	his	his	PRON
eshr-12641	97	18	help	help	NOUN
eshr-12641	97	19	in	in	ADP
eshr-12641	97	20	updating	update	VERB
eshr-12641	97	21	the	the	DET
eshr-12641	97	22	subject	subject	NOUN
eshr-12641	97	23	of	of	ADP
eshr-12641	97	24	study	study	NOUN
eshr-12641	97	25	,	,	PUNCT
eshr-12641	97	26	pr	pr	NOUN
eshr-12641	97	27	tagne	tagne	PROPN
eshr-12641	97	28	simo	simo	PROPN
eshr-12641	97	29	richard	richard	PROPN
eshr-12641	97	30	,	,	PUNCT
eshr-12641	97	31	senior	senior	ADJ
eshr-12641	97	32	lecturer	lecturer	NOUN
eshr-12641	97	33	at	at	ADP
eshr-12641	97	34	the	the	DET
eshr-12641	97	35	university	university	NOUN
eshr-12641	97	36	of	of	ADP
eshr-12641	97	37	ngaoundéré	ngaoundéré	PROPN
eshr-12641	97	38	,	,	PUNCT
eshr-12641	97	39	for	for	ADP
eshr-12641	97	40	his	his	PRON
eshr-12641	97	41	ideas	idea	NOUN
eshr-12641	97	42	and	and	CCONJ
eshr-12641	97	43	above	above	ADP
eshr-12641	97	44	all	all	DET
eshr-12641	97	45	his	his	PRON
eshr-12641	97	46	availability	availability	NOUN
eshr-12641	97	47	during	during	ADP
eshr-12641	97	48	the	the	DET
eshr-12641	97	49	study	study	NOUN
eshr-12641	97	50	;	;	PUNCT
eshr-12641	97	51	the	the	DET
eshr-12641	97	52	director	director	NOUN
eshr-12641	97	53	of	of	ADP
eshr-12641	97	54	the	the	DET
eshr-12641	97	55	chu	chu	PROPN
eshr-12641	97	56	“	"	PUNCT
eshr-12641	97	57	le	le	X
eshr-12641	97	58	bon	bon	PROPN
eshr-12641	97	59	samaritain	samaritain	NOUN
eshr-12641	97	60	”	"	PUNCT
eshr-12641	97	61	for	for	ADP
eshr-12641	97	62	giving	give	VERB
eshr-12641	97	63	us	we	PRON
eshr-12641	97	64	permission	permission	NOUN
eshr-12641	97	65	to	to	PART
eshr-12641	97	66	carry	carry	VERB
eshr-12641	97	67	out	out	ADP
eshr-12641	97	68	the	the	DET
eshr-12641	97	69	study	study	NOUN
eshr-12641	97	70	in	in	ADP
eshr-12641	97	71	his	his	PRON
eshr-12641	97	72	institution	institution	NOUN
eshr-12641	97	73	.	.	PUNCT
eshr-12641	98	1	declarations	declaration	NOUN
eshr-12641	98	2	authors	author	NOUN
eshr-12641	98	3	'	'	PART
eshr-12641	98	4	contribution	contribution	NOUN
eshr-12641	98	5	zan	zan	PROPN
eshr-12641	98	6	,	,	PUNCT
eshr-12641	98	7	bbo	bbo	PROPN
eshr-12641	98	8	and	and	CCONJ
eshr-12641	98	9	vc	vc	AUX
eshr-12641	98	10	designed	design	VERB
eshr-12641	98	11	this	this	DET
eshr-12641	98	12	survey	survey	NOUN
eshr-12641	98	13	.	.	PUNCT
eshr-12641	99	1	sny	sny	PROPN
eshr-12641	99	2	,	,	PUNCT
eshr-12641	99	3	kd	kd	PROPN
eshr-12641	99	4	,	,	PUNCT
eshr-12641	99	5	and	and	CCONJ
eshr-12641	99	6	aa	aa	NOUN
eshr-12641	99	7	,	,	PUNCT
eshr-12641	99	8	collected	collect	VERB
eshr-12641	99	9	the	the	DET
eshr-12641	99	10	original	original	ADJ
eshr-12641	99	11	data	datum	NOUN
eshr-12641	99	12	.	.	PUNCT
eshr-12641	100	1	sny	sny	PROPN
eshr-12641	100	2	,	,	PUNCT
eshr-12641	100	3	add	add	VERB
eshr-12641	100	4	and	and	CCONJ
eshr-12641	100	5	kd	kd	PROPN
eshr-12641	100	6	analyzed	analyze	VERB
eshr-12641	100	7	the	the	DET
eshr-12641	100	8	data	datum	NOUN
eshr-12641	100	9	.	.	PUNCT
eshr-12641	101	1	nys	ny	NOUN
eshr-12641	101	2	,	,	PUNCT
eshr-12641	101	3	aa	aa	NOUN
eshr-12641	101	4	,	,	PUNCT
eshr-12641	101	5	and	and	CCONJ
eshr-12641	101	6	kd	kd	PROPN
eshr-12641	101	7	,	,	PUNCT
eshr-12641	101	8	contributed	contribute	VERB
eshr-12641	101	9	to	to	ADP
eshr-12641	101	10	the	the	DET
eshr-12641	101	11	interpretation	interpretation	NOUN
eshr-12641	101	12	of	of	ADP
eshr-12641	101	13	the	the	DET
eshr-12641	101	14	data	datum	NOUN
eshr-12641	101	15	.	.	PUNCT
eshr-12641	102	1	aldw	aldw	PROPN
eshr-12641	102	2	,	,	PUNCT
eshr-12641	102	3	bbo	bbo	PROPN
eshr-12641	102	4	,	,	PUNCT
eshr-12641	102	5	dda	dda	PROPN
eshr-12641	102	6	,	,	PUNCT
eshr-12641	102	7	gc	gc	PROPN
eshr-12641	102	8	,	,	PUNCT
eshr-12641	102	9	nys	ny	NOUN
eshr-12641	102	10	,	,	PUNCT
eshr-12641	102	11	and	and	CCONJ
eshr-12641	102	12	vc	vc	AUX
eshr-12641	102	13	contributed	contribute	VERB
eshr-12641	102	14	to	to	ADP
eshr-12641	102	15	the	the	DET
eshr-12641	102	16	writing	writing	NOUN
eshr-12641	102	17	of	of	ADP
eshr-12641	102	18	the	the	DET
eshr-12641	102	19	article	article	NOUN
eshr-12641	102	20	.	.	PUNCT
eshr-12641	103	1	sa	sa	PROPN
eshr-12641	103	2	,	,	PUNCT
eshr-12641	103	3	contributed	contribute	VERB
eshr-12641	103	4	equally	equally	ADV
eshr-12641	103	5	to	to	ADP
eshr-12641	103	6	this	this	DET
eshr-12641	103	7	study	study	NOUN
eshr-12641	103	8	.	.	PUNCT
eshr-12641	104	1	all	all	DET
eshr-12641	104	2	the	the	DET
eshr-12641	104	3	authors	author	NOUN
eshr-12641	104	4	have	have	AUX
eshr-12641	104	5	read	read	VERB
eshr-12641	104	6	,	,	PUNCT
eshr-12641	104	7	edited	edit	VERB
eshr-12641	104	8	and	and	CCONJ
eshr-12641	104	9	contributed	contribute	VERB
eshr-12641	104	10	to	to	ADP
eshr-12641	104	11	the	the	DET
eshr-12641	104	12	content	content	NOUN
eshr-12641	104	13	of	of	ADP
eshr-12641	104	14	this	this	DET
eshr-12641	104	15	manuscript	manuscript	NOUN
eshr-12641	104	16	.	.	PUNCT
eshr-12641	105	1	funding	funding	NOUN
eshr-12641	105	2	statement	statement	NOUN
eshr-12641	105	3	this	this	DET
eshr-12641	105	4	research	research	NOUN
eshr-12641	105	5	has	have	AUX
eshr-12641	105	6	not	not	PART
eshr-12641	105	7	received	receive	VERB
eshr-12641	105	8	external	external	ADJ
eshr-12641	105	9	funding	funding	NOUN
eshr-12641	105	10	.	.	PUNCT
eshr-12641	106	1	conflict	conflict	NOUN
eshr-12641	106	2	of	of	ADP
eshr-12641	106	3	interest	interest	NOUN
eshr-12641	106	4	there	there	PRON
eshr-12641	106	5	is	be	VERB
eshr-12641	106	6	no	no	DET
eshr-12641	106	7	conflict	conflict	NOUN
eshr-12641	106	8	of	of	ADP
eshr-12641	106	9	interest	interest	NOUN
eshr-12641	106	10	in	in	ADP
eshr-12641	106	11	this	this	DET
eshr-12641	106	12	research	research	NOUN
eshr-12641	106	13	.	.	PUNCT
eshr-12641	107	1	references	reference	NOUN
eshr-12641	107	2	1	1	NUM
eshr-12641	107	3	.	.	PUNCT
eshr-12641	108	1	punthakee	punthakee	PROPN
eshr-12641	108	2	z	z	PROPN
eshr-12641	108	3	,	,	PUNCT
eshr-12641	108	4	goldenberg	goldenberg	PROPN
eshr-12641	108	5	r	r	PROPN
eshr-12641	108	6	,	,	PUNCT
eshr-12641	108	7	katz	katz	PROPN
eshr-12641	108	8	p.	p.	PROPN
eshr-12641	108	9	definition	definition	NOUN
eshr-12641	108	10	,	,	PUNCT
eshr-12641	108	11	classification	classification	NOUN
eshr-12641	108	12	and	and	CCONJ
eshr-12641	108	13	diagnosis	diagnosis	NOUN
eshr-12641	108	14	of	of	ADP
eshr-12641	108	15	diabetes	diabetes	NOUN
eshr-12641	108	16	,	,	PUNCT
eshr-12641	108	17	prediabetes	prediabete	NOUN
eshr-12641	108	18	and	and	CCONJ
eshr-12641	108	19	metabolic	metabolic	NOUN
eshr-12641	108	20	syndrome	syndrome	NOUN
eshr-12641	108	21	.	.	PUNCT
eshr-12641	109	1	canadian	canadian	ADJ
eshr-12641	109	2	journal	journal	PROPN
eshr-12641	109	3	of	of	ADP
eshr-12641	109	4	diabetes	diabetes	NOUN
eshr-12641	109	5	.	.	PUNCT
eshr-12641	110	1	2018;42	2018;42	NUM
eshr-12641	110	2	:	:	PUNCT
eshr-12641	110	3	s10	s10	NOUN
eshr-12641	110	4	-	-	PUNCT
eshr-12641	110	5	s15	s15	PROPN
eshr-12641	110	6	.	.	PUNCT
eshr-12641	111	1	doi:10.1016	doi:10.1016	PROPN
eshr-12641	111	2	/	/	SYM
eshr-12641	111	3	j.jcjd.2017.10.003	j.jcjd.2017.10.003	PROPN
eshr-12641	111	4	2	2	NUM
eshr-12641	111	5	.	.	PUNCT
eshr-12641	111	6	zampaligré	zampaligré	PROPN
eshr-12641	111	7	i.	i.	PROPN
eshr-12641	111	8	profil	profil	PROPN
eshr-12641	111	9	épidémiologique	épidémiologique	PROPN
eshr-12641	111	10	du	du	PROPN
eshr-12641	111	11	syndrome	syndrome	PROPN
eshr-12641	111	12	métabolique	métabolique	PROPN
eshr-12641	111	13	chez	chez	PROPN
eshr-12641	111	14	les	les	PROPN
eshr-12641	111	15	volontaires	volontaires	PROPN
eshr-12641	111	16	au	au	PROPN
eshr-12641	111	17	dépistage	dépistage	PROPN
eshr-12641	111	18	du	du	PROPN
eshr-12641	111	19	diabète	diabète	PROPN
eshr-12641	111	20	sucré	sucré	NOUN
eshr-12641	111	21	dans	dans	PROPN
eshr-12641	111	22	la	la	X
eshr-12641	111	23	ville	ville	PROPN
eshr-12641	111	24	de	de	X
eshr-12641	111	25	bobo	bobo	PROPN
eshr-12641	111	26	-	-	PUNCT
eshr-12641	111	27	dioulasso	dioulasso	PROPN
eshr-12641	111	28	(	(	PUNCT
eshr-12641	111	29	burkina	burkina	PROPN
eshr-12641	111	30	faso	faso	PROPN
eshr-12641	111	31	)	)	PUNCT
eshr-12641	111	32	.	.	PUNCT
eshr-12641	112	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	112	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	112	3	noubaramadji	noubaramadji	NOUN
eshr-12641	112	4	yamti	yamti	PROPN
eshr-12641	112	5	et	et	PROPN
eshr-12641	112	6	al	al	PROPN
eshr-12641	112	7	.	.	PUNCT
eshr-12641	113	1	(	(	PUNCT
eshr-12641	113	2	prevalence	prevalence	NOUN
eshr-12641	113	3	of	of	ADP
eshr-12641	113	4	metabolic	metabolic	NOUN
eshr-12641	113	5	syndrome	syndrome	NOUN
eshr-12641	113	6	among	among	ADP
eshr-12641	113	7	patients	patient	NOUN
eshr-12641	113	8	with	with	ADP
eshr-12641	113	9	type	type	NOUN
eshr-12641	113	10	2	2	NUM
eshr-12641	113	11	diabetes	diabetes	NOUN
eshr-12641	113	12	…	…	PUNCT
eshr-12641	113	13	)	)	PUNCT
eshr-12641	113	14	vol	vol	NOUN
eshr-12641	113	15	.	.	PROPN
eshr-12641	114	1	7	7	NUM
eshr-12641	114	2	,	,	PUNCT
eshr-12641	114	3	no	no	INTJ
eshr-12641	114	4	.	.	NOUN
eshr-12641	114	5	2	2	NUM
eshr-12641	114	6	,	,	PUNCT
eshr-12641	114	7	2025	2025	NUM
eshr-12641	114	8	,	,	PUNCT
eshr-12641	114	9	pp	pp	ADJ
eshr-12641	114	10	.	.	PUNCT
eshr-12641	115	1	87	87	NUM
eshr-12641	115	2	-	-	SYM
eshr-12641	115	3	95	95	NUM
eshr-12641	115	4	94	94	NUM
eshr-12641	115	5	10.26555	10.26555	NUM
eshr-12641	115	6	/	/	SYM
eshr-12641	115	7	eshr.v7i2.12641	eshr.v7i2.12641	PROPN
eshr-12641	115	8	3	3	NUM
eshr-12641	115	9	.	.	PUNCT
eshr-12641	115	10	gamma	gamma	NOUN
eshr-12641	115	11	-	-	PUNCT
eshr-12641	115	12	glutamyltransferase	glutamyltransferase	NOUN
eshr-12641	115	13	activity	activity	NOUN
eshr-12641	115	14	and	and	CCONJ
eshr-12641	115	15	development	development	NOUN
eshr-12641	115	16	of	of	ADP
eshr-12641	115	17	the	the	DET
eshr-12641	115	18	metabolic	metabolic	NOUN
eshr-12641	115	19	syndrome	syndrome	NOUN
eshr-12641	115	20	(	(	PUNCT
eshr-12641	115	21	international	international	ADJ
eshr-12641	115	22	diabetes	diabetes	NOUN
eshr-12641	115	23	federation	federation	NOUN
eshr-12641	115	24	definition	definition	NOUN
eshr-12641	115	25	)	)	PUNCT
eshr-12641	115	26	in	in	ADP
eshr-12641	115	27	middle	middle	ADJ
eshr-12641	115	28	-	-	PUNCT
eshr-12641	115	29	aged	aged	ADJ
eshr-12641	115	30	men	man	NOUN
eshr-12641	115	31	and	and	CCONJ
eshr-12641	115	32	women	woman	NOUN
eshr-12641	115	33	:	:	PUNCT
eshr-12641	115	34	data	datum	NOUN
eshr-12641	115	35	from	from	ADP
eshr-12641	115	36	the	the	DET
eshr-12641	115	37	epidemiological	epidemiological	ADJ
eshr-12641	115	38	study	study	NOUN
eshr-12641	115	39	on	on	ADP
eshr-12641	115	40	the	the	DET
eshr-12641	115	41	insulin	insulin	NOUN
eshr-12641	115	42	resistance	resistance	NOUN
eshr-12641	115	43	syndrome	syndrome	NOUN
eshr-12641	115	44	(	(	PUNCT
eshr-12641	115	45	desir	desir	PROPN
eshr-12641	115	46	)	)	PUNCT
eshr-12641	115	47	cohort	cohort	NOUN
eshr-12641	115	48	pubmed	pubmed	PROPN
eshr-12641	115	49	.	.	PUNCT
eshr-12641	116	1	accessed	access	VERB
eshr-12641	116	2	may	may	PROPN
eshr-12641	116	3	18	18	NUM
eshr-12641	116	4	,	,	PUNCT
eshr-12641	116	5	2023	2023	NUM
eshr-12641	116	6	.	.	PUNCT
eshr-12641	117	1	4	4	X
eshr-12641	117	2	.	.	X
eshr-12641	117	3	masson	masson	PROPN
eshr-12641	117	4	e.	e.	PROPN
eshr-12641	117	5	nouveaux	nouveaux	PROPN
eshr-12641	117	6	mécanismes	mécanismes	PROPN
eshr-12641	117	7	physiopathologiques	physiopathologique	NOUN
eshr-12641	117	8	du	du	PROPN
eshr-12641	117	9	syndrome	syndrome	PROPN
eshr-12641	117	10	métabolique	métabolique	NOUN
eshr-12641	117	11	 	 	SPACE
eshr-12641	117	12	:	:	PUNCT
eshr-12641	117	13	implication	implication	NOUN
eshr-12641	117	14	des	des	PROPN
eshr-12641	117	15	récepteurs	récepteurs	PROPN
eshr-12641	117	16	nucléaires	nucléaire	VERB
eshr-12641	117	17	orphelins	orphelin	NOUN
eshr-12641	117	18	 	 	SPACE
eshr-12641	117	19	?	?	PUNCT
eshr-12641	118	1	em	em	PROPN
eshr-12641	118	2	-	-	PUNCT
eshr-12641	118	3	consulte	consulte	PROPN
eshr-12641	118	4	.	.	PROPN
eshr-12641	119	1	accessed	access	VERB
eshr-12641	119	2	march	march	PROPN
eshr-12641	119	3	1	1	NUM
eshr-12641	119	4	,	,	PUNCT
eshr-12641	119	5	2025	2025	NUM
eshr-12641	119	6	.	.	PUNCT
eshr-12641	120	1	5	5	NUM
eshr-12641	120	2	.	.	X
eshr-12641	120	3	the	the	DET
eshr-12641	120	4	metabolic	metabolic	NOUN
eshr-12641	120	5	syndrome	syndrome	NOUN
eshr-12641	120	6	:	:	PUNCT
eshr-12641	120	7	time	time	NOUN
eshr-12641	120	8	for	for	ADP
eshr-12641	120	9	a	a	DET
eshr-12641	120	10	critical	critical	ADJ
eshr-12641	120	11	appraisal	appraisal	NOUN
eshr-12641	120	12	:	:	PUNCT
eshr-12641	120	13	joint	joint	ADJ
eshr-12641	120	14	statement	statement	NOUN
eshr-12641	120	15	from	from	ADP
eshr-12641	120	16	the	the	DET
eshr-12641	120	17	american	american	ADJ
eshr-12641	120	18	diabetes	diabetes	PROPN
eshr-12641	120	19	association	association	PROPN
eshr-12641	120	20	and	and	CCONJ
eshr-12641	120	21	the	the	DET
eshr-12641	120	22	european	european	PROPN
eshr-12641	120	23	association	association	PROPN
eshr-12641	120	24	for	for	ADP
eshr-12641	120	25	the	the	DET
eshr-12641	120	26	study	study	NOUN
eshr-12641	120	27	of	of	ADP
eshr-12641	120	28	diabetes	diabetes	NOUN
eshr-12641	120	29	pubmed	pubmed	PROPN
eshr-12641	120	30	.	.	PUNCT
eshr-12641	121	1	accessed	access	VERB
eshr-12641	121	2	march	march	PROPN
eshr-12641	121	3	1	1	NUM
eshr-12641	121	4	,	,	PUNCT
eshr-12641	121	5	2025	2025	NUM
eshr-12641	121	6	.	.	PUNCT
eshr-12641	122	1	6	6	NUM
eshr-12641	122	2	.	.	X
eshr-12641	122	3	diabetes	diabetes	NOUN
eshr-12641	122	4	mellitus	mellitus	NOUN
eshr-12641	122	5	type	type	VERB
eshr-12641	122	6	2	2	NUM
eshr-12641	122	7	in	in	ADP
eshr-12641	122	8	urban	urban	ADJ
eshr-12641	122	9	ghana	ghana	PROPN
eshr-12641	122	10	:	:	PUNCT
eshr-12641	122	11	characteristics	characteristic	NOUN
eshr-12641	122	12	and	and	CCONJ
eshr-12641	122	13	associated	associated	ADJ
eshr-12641	122	14	factors	factor	NOUN
eshr-12641	122	15	|	|	ADV
eshr-12641	122	16	bmc	bmc	VERB
eshr-12641	122	17	public	public	ADJ
eshr-12641	122	18	health	health	NOUN
eshr-12641	122	19	|	|	ADP
eshr-12641	122	20	full	full	ADJ
eshr-12641	122	21	text	text	NOUN
eshr-12641	122	22	.	.	PUNCT
eshr-12641	123	1	accessed	access	VERB
eshr-12641	123	2	march	march	PROPN
eshr-12641	123	3	1	1	NUM
eshr-12641	123	4	,	,	PUNCT
eshr-12641	123	5	2025	2025	NUM
eshr-12641	123	6	.	.	PUNCT
eshr-12641	124	1	7	7	X
eshr-12641	124	2	.	.	X
eshr-12641	124	3	nsiah	nsiah	PROPN
eshr-12641	124	4	k	k	PROPN
eshr-12641	124	5	,	,	PUNCT
eshr-12641	124	6	shang	shang	PROPN
eshr-12641	124	7	vo	vo	PROPN
eshr-12641	124	8	,	,	PUNCT
eshr-12641	124	9	boateng	boateng	PROPN
eshr-12641	124	10	ka	ka	PROPN
eshr-12641	124	11	,	,	PUNCT
eshr-12641	124	12	mensah	mensah	PROPN
eshr-12641	124	13	f.	f.	PROPN
eshr-12641	124	14	prevalence	prevalence	PROPN
eshr-12641	124	15	of	of	ADP
eshr-12641	124	16	metabolic	metabolic	NOUN
eshr-12641	124	17	syndrome	syndrome	NOUN
eshr-12641	124	18	in	in	ADP
eshr-12641	124	19	type	type	NOUN
eshr-12641	124	20	2	2	NUM
eshr-12641	124	21	diabetes	diabetes	NOUN
eshr-12641	124	22	mellitus	mellitus	NOUN
eshr-12641	124	23	patients	patient	NOUN
eshr-12641	124	24	.	.	PUNCT
eshr-12641	125	1	int	int	PROPN
eshr-12641	126	1	j	j	PROPN
eshr-12641	126	2	app	app	PROPN
eshr-12641	126	3	basic	basic	ADJ
eshr-12641	126	4	med	med	ADJ
eshr-12641	126	5	res	re	NOUN
eshr-12641	126	6	.	.	PUNCT
eshr-12641	127	1	2015;5(2):133	2015;5(2):133	X
eshr-12641	127	2	.	.	PUNCT
eshr-12641	128	1	doi:10.4103/2229516x.157170	doi:10.4103/2229516x.157170	NUM
eshr-12641	128	2	8	8	NUM
eshr-12641	128	3	.	.	PUNCT
eshr-12641	129	1	ferrannini	ferrannini	PROPN
eshr-12641	129	2	e.	e.	PROPN
eshr-12641	129	3	physiological	physiological	PROPN
eshr-12641	129	4	and	and	CCONJ
eshr-12641	129	5	metabolic	metabolic	NOUN
eshr-12641	129	6	consequences	consequence	NOUN
eshr-12641	129	7	of	of	ADP
eshr-12641	129	8	obesity	obesity	NOUN
eshr-12641	129	9	.	.	PUNCT
eshr-12641	130	1	metabolism	metabolism	NOUN
eshr-12641	130	2	.	.	PUNCT
eshr-12641	131	1	1995;44(9	1995;44(9	NUM
eshr-12641	131	2	suppl	suppl	ADJ
eshr-12641	131	3	3):15	3):15	NUM
eshr-12641	131	4	-	-	PUNCT
eshr-12641	131	5	17	17	NUM
eshr-12641	131	6	.	.	PUNCT
eshr-12641	132	1	doi:10.1016/0026	doi:10.1016/0026	PROPN
eshr-12641	132	2	-	-	PUNCT
eshr-12641	132	3	0495(95)90313	0495(95)90313	NUM
eshr-12641	132	4	-	-	PUNCT
eshr-12641	132	5	5	5	NUM
eshr-12641	132	6	9	9	NUM
eshr-12641	132	7	.	.	PUNCT
eshr-12641	132	8	protéine	protéine	NOUN
eshr-12641	132	9	c	c	NOUN
eshr-12641	132	10	-	-	PUNCT
eshr-12641	132	11	réactive	réactive	ADJ
eshr-12641	132	12	,	,	PUNCT
eshr-12641	132	13	syndrome	syndrome	NOUN
eshr-12641	132	14	métabolique	métabolique	PROPN
eshr-12641	132	15	et	et	PROPN
eshr-12641	132	16	risque	risque	PROPN
eshr-12641	132	17	d’événements	d’événements	PROPN
eshr-12641	132	18	cardiovasculaires	cardiovasculaire	NOUN
eshr-12641	132	19	incidents	incident	NOUN
eshr-12641	132	20	 	 	SPACE
eshr-12641	132	21	:	:	PUNCT
eshr-12641	132	22	suivi	suivi	PROPN
eshr-12641	132	23	de	de	PROPN
eshr-12641	132	24	8	8	NUM
eshr-12641	132	25	ans	ans	X
eshr-12641	132	26	de	de	X
eshr-12641	132	27	14	14	NUM
eshr-12641	132	28	719	719	NUM
eshr-12641	132	29	femmes	femme	NOUN
eshr-12641	132	30	américaines	américaines	PROPN
eshr-12641	132	31	initialement	initialement	PROPN
eshr-12641	132	32	en	en	PROPN
eshr-12641	132	33	bonne	bonne	PROPN
eshr-12641	132	34	santé	santé	PROPN
eshr-12641	132	35	pubmed	pubmed	PROPN
eshr-12641	132	36	.	.	PROPN
eshr-12641	133	1	accessed	access	VERB
eshr-12641	133	2	march	march	PROPN
eshr-12641	133	3	1	1	NUM
eshr-12641	133	4	,	,	PUNCT
eshr-12641	133	5	2025	2025	NUM
eshr-12641	133	6	.	.	PUNCT
eshr-12641	134	1	10	10	NUM
eshr-12641	134	2	.	.	PUNCT
eshr-12641	135	1	ford	ford	PROPN
eshr-12641	135	2	es	es	PROPN
eshr-12641	135	3	,	,	PUNCT
eshr-12641	135	4	giles	giles	PROPN
eshr-12641	135	5	wh	wh	PROPN
eshr-12641	135	6	,	,	PUNCT
eshr-12641	135	7	dietz	dietz	PROPN
eshr-12641	135	8	wh	wh	PROPN
eshr-12641	135	9	.	.	PUNCT
eshr-12641	136	1	prevalence	prevalence	NOUN
eshr-12641	136	2	of	of	ADP
eshr-12641	136	3	the	the	DET
eshr-12641	136	4	metabolic	metabolic	NOUN
eshr-12641	136	5	syndrome	syndrome	NOUN
eshr-12641	136	6	among	among	ADP
eshr-12641	136	7	us	us	PROPN
eshr-12641	136	8	adults	adult	NOUN
eshr-12641	136	9	:	:	PUNCT
eshr-12641	136	10	findings	finding	NOUN
eshr-12641	136	11	from	from	ADP
eshr-12641	136	12	the	the	DET
eshr-12641	136	13	third	third	ADJ
eshr-12641	136	14	national	national	PROPN
eshr-12641	136	15	health	health	NOUN
eshr-12641	136	16	and	and	CCONJ
eshr-12641	136	17	nutrition	nutrition	NOUN
eshr-12641	136	18	examination	examination	NOUN
eshr-12641	136	19	survey	survey	NOUN
eshr-12641	136	20	.	.	PUNCT
eshr-12641	137	1	jama	jama	PROPN
eshr-12641	137	2	.	.	PUNCT
eshr-12641	138	1	2002;287(3):356	2002;287(3):356	X
eshr-12641	138	2	-	-	SYM
eshr-12641	138	3	359	359	NUM
eshr-12641	138	4	.	.	PUNCT
eshr-12641	139	1	doi:10.1001	doi:10.1001	PROPN
eshr-12641	139	2	/	/	SYM
eshr-12641	139	3	jama.287.3.356	jama.287.3.356	PROPN
eshr-12641	139	4	11	11	NUM
eshr-12641	139	5	.	.	PUNCT
eshr-12641	140	1	pietzsch	pietzsch	PROPN
eshr-12641	140	2	j	j	PROPN
eshr-12641	140	3	,	,	PUNCT
eshr-12641	140	4	julius	julius	PROPN
eshr-12641	140	5	u	u	PROPN
eshr-12641	140	6	,	,	PUNCT
eshr-12641	140	7	nitzsche	nitzsche	NOUN
eshr-12641	140	8	s	s	PROPN
eshr-12641	140	9	,	,	PUNCT
eshr-12641	140	10	hanefeld	hanefeld	ADJ
eshr-12641	140	11	m.	m.	NOUN
eshr-12641	140	12	in	in	ADP
eshr-12641	140	13	vivo	vivo	ADJ
eshr-12641	140	14	evidence	evidence	NOUN
eshr-12641	140	15	for	for	ADP
eshr-12641	140	16	increased	increased	ADJ
eshr-12641	140	17	apolipoprotein	apolipoprotein	ADJ
eshr-12641	140	18	a	a	PRON
eshr-12641	140	19	-	-	PUNCT
eshr-12641	140	20	i	i	PRON
eshr-12641	140	21	catabolism	catabolism	NOUN
eshr-12641	140	22	in	in	ADP
eshr-12641	140	23	subjects	subject	NOUN
eshr-12641	140	24	with	with	ADP
eshr-12641	140	25	impaired	impaired	ADJ
eshr-12641	140	26	glucose	glucose	NOUN
eshr-12641	140	27	tolerance	tolerance	NOUN
eshr-12641	140	28	.	.	PUNCT
eshr-12641	141	1	diabetes	diabetes	NOUN
eshr-12641	141	2	.	.	PUNCT
eshr-12641	142	1	1998;47(12):1928	1998;47(12):1928	NUM
eshr-12641	142	2	-	-	SYM
eshr-12641	142	3	1934	1934	NUM
eshr-12641	142	4	.	.	PUNCT
eshr-12641	143	1	doi:10.2337	doi:10.2337	NOUN
eshr-12641	143	2	/	/	SYM
eshr-12641	143	3	diabetes.47.12.1928	diabetes.47.12.1928	PROPN
eshr-12641	143	4	12	12	NUM
eshr-12641	143	5	.	.	PUNCT
eshr-12641	144	1	impact	impact	NOUN
eshr-12641	144	2	de	de	ADP
eshr-12641	144	3	4	4	NUM
eshr-12641	144	4	définitions	définition	NOUN
eshr-12641	144	5	différentes	différentes	PROPN
eshr-12641	144	6	utilisées	utilisées	PROPN
eshr-12641	144	7	pour	pour	PROPN
eshr-12641	144	8	l’évaluation	l’évaluation	PROPN
eshr-12641	144	9	de	de	X
eshr-12641	144	10	la	la	X
eshr-12641	144	11	prévalence	prévalence	NOUN
eshr-12641	144	12	du	du	PROPN
eshr-12641	144	13	syndrome	syndrome	PROPN
eshr-12641	144	14	métabolique	métabolique	PROPN
eshr-12641	144	15	dans	dans	PROPN
eshr-12641	144	16	les	les	X
eshr-12641	144	17	soins	soins	X
eshr-12641	144	18	de	de	X
eshr-12641	144	19	santé	santé	X
eshr-12641	144	20	primaires	primaires	PROPN
eshr-12641	144	21	 	 	SPACE
eshr-12641	144	22	:	:	PUNCT
eshr-12641	144	23	projet	projet	PROPN
eshr-12641	144	24	allemand	allemand	PROPN
eshr-12641	144	25	sur	sur	PROPN
eshr-12641	144	26	les	les	PROPN
eshr-12641	144	27	risques	risques	PROPN
eshr-12641	144	28	métaboliques	métabolique	NOUN
eshr-12641	144	29	et	et	NOUN
eshr-12641	144	30	cardiovasculaires	cardiovasculaire	NOUN
eshr-12641	144	31	(	(	PUNCT
eshr-12641	144	32	gemcas	gemcas	PROPN
eshr-12641	144	33	)	)	PUNCT
eshr-12641	144	34	pmc	pmc	PROPN
eshr-12641	144	35	.	.	PROPN
eshr-12641	145	1	accessed	access	VERB
eshr-12641	145	2	march	march	PROPN
eshr-12641	145	3	1	1	NUM
eshr-12641	145	4	,	,	PUNCT
eshr-12641	145	5	2025	2025	NUM
eshr-12641	145	6	.	.	PUNCT
eshr-12641	146	1	13	13	NUM
eshr-12641	146	2	.	.	X
eshr-12641	146	3	osuji	osuji	PROPN
eshr-12641	146	4	cu	cu	PROPN
eshr-12641	146	5	,	,	PUNCT
eshr-12641	146	6	nzerem	nzerem	PROPN
eshr-12641	146	7	ba	ba	PROPN
eshr-12641	146	8	,	,	PUNCT
eshr-12641	146	9	dioka	dioka	PROPN
eshr-12641	146	10	ce	ce	PROPN
eshr-12641	146	11	,	,	PUNCT
eshr-12641	146	12	onwubuya	onwubuya	PROPN
eshr-12641	146	13	ei	ei	PROPN
eshr-12641	146	14	.	.	PROPN
eshr-12641	146	15	metabolic	metabolic	PROPN
eshr-12641	146	16	syndrome	syndrome	NOUN
eshr-12641	146	17	in	in	ADP
eshr-12641	146	18	newly	newly	ADV
eshr-12641	146	19	diagnosed	diagnose	VERB
eshr-12641	146	20	type	type	NOUN
eshr-12641	146	21	2	2	NUM
eshr-12641	146	22	diabetes	diabetes	NOUN
eshr-12641	146	23	mellitus	mellitus	NOUN
eshr-12641	146	24	using	use	VERB
eshr-12641	146	25	ncep	ncep	PROPN
eshr-12641	146	26	-	-	PUNCT
eshr-12641	146	27	atp	atp	PROPN
eshr-12641	146	28	iii	iii	PROPN
eshr-12641	146	29	,	,	PUNCT
eshr-12641	146	30	the	the	DET
eshr-12641	146	31	nnewi	nnewi	NOUN
eshr-12641	146	32	experience	experience	NOUN
eshr-12641	146	33	.	.	PUNCT
eshr-12641	147	1	nigerian	nigerian	ADJ
eshr-12641	147	2	journal	journal	PROPN
eshr-12641	147	3	of	of	ADP
eshr-12641	147	4	clinical	clinical	ADJ
eshr-12641	147	5	practice	practice	NOUN
eshr-12641	147	6	.	.	PUNCT
eshr-12641	148	1	2012;15(4):475	2012;15(4):475	NUM
eshr-12641	148	2	.	.	PUNCT
eshr-12641	149	1	doi:10.4103/1119	doi:10.4103/1119	PROPN
eshr-12641	149	2	-	-	PUNCT
eshr-12641	149	3	3077.104530	3077.104530	NUM
eshr-12641	149	4	14	14	NUM
eshr-12641	149	5	.	.	PUNCT
eshr-12641	150	1	islam	islam	PROPN
eshr-12641	150	2	mds	mds	PROPN
eshr-12641	150	3	,	,	PUNCT
eshr-12641	150	4	wei	wei	PROPN
eshr-12641	150	5	p	p	PROPN
eshr-12641	150	6	,	,	PUNCT
eshr-12641	150	7	suzauddula	suzauddula	NOUN
eshr-12641	150	8	m	m	PROPN
eshr-12641	150	9	,	,	PUNCT
eshr-12641	150	10	et	et	PROPN
eshr-12641	150	11	al	al	PROPN
eshr-12641	150	12	.	.	PUNCT
eshr-12641	151	1	the	the	DET
eshr-12641	151	2	interplay	interplay	NOUN
eshr-12641	151	3	of	of	ADP
eshr-12641	151	4	factors	factor	NOUN
eshr-12641	151	5	in	in	ADP
eshr-12641	151	6	metabolic	metabolic	NOUN
eshr-12641	151	7	syndrome	syndrome	NOUN
eshr-12641	151	8	:	:	PUNCT
eshr-12641	151	9	understanding	understand	VERB
eshr-12641	151	10	its	its	PRON
eshr-12641	151	11	roots	root	NOUN
eshr-12641	151	12	and	and	CCONJ
eshr-12641	151	13	complexity	complexity	NOUN
eshr-12641	151	14	.	.	PUNCT
eshr-12641	152	1	molecular	molecular	ADJ
eshr-12641	152	2	medicine	medicine	NOUN
eshr-12641	152	3	.	.	PUNCT
eshr-12641	153	1	2024;30(1):279	2024;30(1):279	NOUN
eshr-12641	153	2	.	.	PUNCT
eshr-12641	154	1	doi:10.1186	doi:10.1186	PROPN
eshr-12641	154	2	/	/	SYM
eshr-12641	154	3	s10020	s10020	PROPN
eshr-12641	154	4	-	-	PUNCT
eshr-12641	154	5	024	024	NUM
eshr-12641	154	6	-	-	PUNCT
eshr-12641	154	7	01019	01019	NUM
eshr-12641	154	8	-	-	PUNCT
eshr-12641	154	9	y	y	PROPN
eshr-12641	154	10	15	15	NUM
eshr-12641	154	11	.	.	PUNCT
eshr-12641	155	1	kahn	kahn	PROPN
eshr-12641	155	2	r	r	PROPN
eshr-12641	155	3	,	,	PUNCT
eshr-12641	155	4	buse	buse	PROPN
eshr-12641	155	5	j	j	PROPN
eshr-12641	155	6	,	,	PUNCT
eshr-12641	155	7	ferrannini	ferrannini	NOUN
eshr-12641	155	8	e	e	NOUN
eshr-12641	155	9	,	,	PUNCT
eshr-12641	155	10	stern	stern	ADJ
eshr-12641	155	11	m.	m.	NOUN
eshr-12641	155	12	the	the	DET
eshr-12641	155	13	metabolic	metabolic	NOUN
eshr-12641	155	14	syndrome	syndrome	NOUN
eshr-12641	155	15	:	:	PUNCT
eshr-12641	155	16	time	time	NOUN
eshr-12641	155	17	for	for	ADP
eshr-12641	155	18	a	a	DET
eshr-12641	155	19	critical	critical	ADJ
eshr-12641	155	20	appraisal	appraisal	NOUN
eshr-12641	155	21	:	:	PUNCT
eshr-12641	155	22	joint	joint	ADJ
eshr-12641	155	23	statement	statement	NOUN
eshr-12641	155	24	from	from	ADP
eshr-12641	155	25	the	the	DET
eshr-12641	155	26	american	american	ADJ
eshr-12641	155	27	diabetes	diabetes	PROPN
eshr-12641	155	28	association	association	PROPN
eshr-12641	155	29	and	and	CCONJ
eshr-12641	155	30	the	the	DET
eshr-12641	155	31	european	european	PROPN
eshr-12641	155	32	association	association	PROPN
eshr-12641	155	33	for	for	ADP
eshr-12641	155	34	the	the	DET
eshr-12641	155	35	study	study	NOUN
eshr-12641	155	36	of	of	ADP
eshr-12641	155	37	diabetes	diabetes	NOUN
eshr-12641	155	38	.	.	PUNCT
eshr-12641	156	1	diabetes	diabetes	NOUN
eshr-12641	156	2	care	care	NOUN
eshr-12641	156	3	.	.	PUNCT
eshr-12641	157	1	2005;28(9):2289	2005;28(9):2289	NUM
eshr-12641	157	2	-	-	SYM
eshr-12641	157	3	2304	2304	NUM
eshr-12641	157	4	.	.	PUNCT
eshr-12641	158	1	doi:10.2337	doi:10.2337	NOUN
eshr-12641	158	2	/	/	SYM
eshr-12641	158	3	diacare.28.9.2289	diacare.28.9.2289	PROPN
eshr-12641	158	4	16	16	NUM
eshr-12641	158	5	.	.	PUNCT
eshr-12641	159	1	jaspers	jasper	NOUN
eshr-12641	159	2	faijer	faijer	NOUN
eshr-12641	159	3	-	-	PUNCT
eshr-12641	159	4	westerink	westerink	NOUN
eshr-12641	159	5	h	h	NOUN
eshr-12641	159	6	,	,	PUNCT
eshr-12641	159	7	kengne	kengne	PROPN
eshr-12641	159	8	ap	ap	PROPN
eshr-12641	159	9	,	,	PUNCT
eshr-12641	159	10	meeks	meeks	PROPN
eshr-12641	159	11	kac	kac	PROPN
eshr-12641	159	12	,	,	PUNCT
eshr-12641	159	13	agyemang	agyemang	PROPN
eshr-12641	160	1	c.	c.	PROPN
eshr-12641	160	2	prevalence	prevalence	NOUN
eshr-12641	160	3	of	of	ADP
eshr-12641	160	4	metabolic	metabolic	NOUN
eshr-12641	160	5	syndrome	syndrome	NOUN
eshr-12641	160	6	in	in	ADP
eshr-12641	160	7	sub	sub	ADJ
eshr-12641	160	8	-	-	ADJ
eshr-12641	160	9	saharan	saharan	ADJ
eshr-12641	160	10	africa	africa	PROPN
eshr-12641	160	11	:	:	PUNCT
eshr-12641	160	12	a	a	DET
eshr-12641	160	13	systematic	systematic	ADJ
eshr-12641	160	14	review	review	NOUN
eshr-12641	160	15	and	and	CCONJ
eshr-12641	160	16	meta	meta	ADJ
eshr-12641	160	17	-	-	PUNCT
eshr-12641	160	18	analysis	analysis	NOUN
eshr-12641	160	19	.	.	PUNCT
eshr-12641	161	1	nutr	nutr	PROPN
eshr-12641	161	2	metab	metab	PROPN
eshr-12641	161	3	cardiovasc	cardiovasc	PROPN
eshr-12641	161	4	dis	dis	PROPN
eshr-12641	161	5	.	.	PUNCT
eshr-12641	162	1	2020;30(4):547	2020;30(4):547	NUM
eshr-12641	162	2	-	-	SYM
eshr-12641	162	3	565	565	NUM
eshr-12641	162	4	.	.	PUNCT
eshr-12641	162	5	doi:10.1016	doi:10.1016	PROPN
eshr-12641	162	6	/	/	SYM
eshr-12641	162	7	j.numecd.2019.12.012	j.numecd.2019.12.012	PROPN
eshr-12641	162	8	17	17	NUM
eshr-12641	162	9	.	.	PUNCT
eshr-12641	163	1	paramètre	paramètre	ADJ
eshr-12641	163	2	anthropométrique	anthropométrique	NOUN
eshr-12641	163	3	permettant	permettant	X
eshr-12641	163	4	de	de	X
eshr-12641	163	5	mieux	mieux	X
eshr-12641	163	6	prédire	prédire	PROPN
eshr-12641	163	7	le	le	PROPN
eshr-12641	163	8	syndrome	syndrome	PROPN
eshr-12641	163	9	métabolique	métabolique	PROPN
eshr-12641	163	10	dans	dans	PROPN
eshr-12641	163	11	le	le	X
eshr-12641	163	12	sud	sud	PROPN
eshr-12641	163	13	-	-	PUNCT
eshr-12641	163	14	ouest	ouest	PROPN
eshr-12641	163	15	du	du	PROPN
eshr-12641	163	16	nigéria	nigéria	PROPN
eshr-12641	163	17	pubmed	pubmed	PROPN
eshr-12641	163	18	.	.	PUNCT
eshr-12641	164	1	accessed	access	VERB
eshr-12641	164	2	january	january	PROPN
eshr-12641	164	3	16	16	NUM
eshr-12641	164	4	,	,	PUNCT
eshr-12641	164	5	2025	2025	NUM
eshr-12641	164	6	.	.	PUNCT
eshr-12641	165	1	18	18	NUM
eshr-12641	165	2	.	.	X
eshr-12641	165	3	annani	annani	NOUN
eshr-12641	165	4	-	-	PUNCT
eshr-12641	165	5	akollor	akollor	NOUN
eshr-12641	165	6	me	me	PROPN
eshr-12641	165	7	,	,	PUNCT
eshr-12641	165	8	laing	laing	PROPN
eshr-12641	165	9	ef	ef	PROPN
eshr-12641	165	10	,	,	PUNCT
eshr-12641	165	11	addai	addai	PROPN
eshr-12641	165	12	-	-	PUNCT
eshr-12641	165	13	mensah	mensah	PROPN
eshr-12641	165	14	o	o	PROPN
eshr-12641	165	15	,	,	PUNCT
eshr-12641	165	16	fondjo	fondjo	PROPN
eshr-12641	165	17	la	la	PROPN
eshr-12641	165	18	,	,	PUNCT
eshr-12641	165	19	adu	adu	PROPN
eshr-12641	165	20	ea	ea	PROPN
eshr-12641	165	21	,	,	PUNCT
eshr-12641	165	22	owiredu	owiredu	PROPN
eshr-12641	165	23	ew	ew	PROPN
eshr-12641	165	24	.	.	PUNCT
eshr-12641	165	25	population	population	NOUN
eshr-12641	165	26	-	-	PUNCT
eshr-12641	165	27	derived	derive	VERB
eshr-12641	165	28	cut	cut	NOUN
eshr-12641	165	29	-	-	PUNCT
eshr-12641	165	30	off	off	NOUN
eshr-12641	165	31	for	for	ADP
eshr-12641	165	32	hba1c	hba1c	NOUN
eshr-12641	165	33	could	could	AUX
eshr-12641	165	34	enhance	enhance	VERB
eshr-12641	165	35	the	the	DET
eshr-12641	165	36	identification	identification	NOUN
eshr-12641	165	37	of	of	ADP
eshr-12641	165	38	metabolic	metabolic	NOUN
eshr-12641	165	39	syndrome	syndrome	NOUN
eshr-12641	165	40	among	among	ADP
eshr-12641	165	41	non	non	ADJ
eshr-12641	165	42	-	-	ADJ
eshr-12641	165	43	diabetic	diabetic	ADJ
eshr-12641	165	44	population	population	NOUN
eshr-12641	165	45	.	.	PUNCT
eshr-12641	166	1	heliyon	heliyon	NOUN
eshr-12641	166	2	.	.	PUNCT
eshr-12641	167	1	2020;6(8):e04583	2020;6(8):e04583	NUM
eshr-12641	167	2	.	.	PUNCT
eshr-12641	168	1	doi:10.1016	doi:10.1016	PROPN
eshr-12641	168	2	/	/	SYM
eshr-12641	168	3	j.heliyon.2020.e04583	j.heliyon.2020.e04583	PROPN
eshr-12641	168	4	19	19	NUM
eshr-12641	168	5	.	.	PUNCT
eshr-12641	169	1	ménopause	ménopause	PROPN
eshr-12641	169	2	et	et	PROPN
eshr-12641	169	3	syndrome	syndrome	PROPN
eshr-12641	169	4	métabolique	métabolique	PROPN
eshr-12641	169	5	chez	chez	PROPN
eshr-12641	169	6	la	la	PROPN
eshr-12641	169	7	femme	femme	PROPN
eshr-12641	169	8	tunisienne	tunisienne	PROPN
eshr-12641	169	9	ben	ben	PROPN
eshr-12641	169	10	ali	ali	PROPN
eshr-12641	169	11	2014	2014	NUM
eshr-12641	169	12	biomed	biome	VERB
eshr-12641	169	13	research	research	NOUN
eshr-12641	169	14	international	international	PROPN
eshr-12641	169	15	wiley	wiley	PROPN
eshr-12641	169	16	online	online	PROPN
eshr-12641	169	17	library	library	PROPN
eshr-12641	169	18	.	.	PUNCT
eshr-12641	170	1	accessed	access	VERB
eshr-12641	170	2	january	january	PROPN
eshr-12641	170	3	16	16	NUM
eshr-12641	170	4	,	,	PUNCT
eshr-12641	170	5	2025	2025	NUM
eshr-12641	170	6	.	.	PUNCT
eshr-12641	171	1	20	20	NUM
eshr-12641	171	2	.	.	PUNCT
eshr-12641	171	3	abourazzak	abourazzak	PROPN
eshr-12641	171	4	f	f	PROPN
eshr-12641	171	5	,	,	PUNCT
eshr-12641	171	6	talbi	talbi	PROPN
eshr-12641	171	7	s	s	PART
eshr-12641	171	8	,	,	PUNCT
eshr-12641	171	9	lazrak	lazrak	PROPN
eshr-12641	171	10	f	f	PROPN
eshr-12641	171	11	,	,	PUNCT
eshr-12641	171	12	et	et	PROPN
eshr-12641	171	13	al	al	PROPN
eshr-12641	171	14	.	.	PROPN
eshr-12641	171	15	does	do	AUX
eshr-12641	171	16	metabolic	metabolic	NOUN
eshr-12641	171	17	syndrome	syndrome	NOUN
eshr-12641	171	18	or	or	CCONJ
eshr-12641	171	19	its	its	PRON
eshr-12641	171	20	individual	individual	ADJ
eshr-12641	171	21	components	component	NOUN
eshr-12641	171	22	affect	affect	VERB
eshr-12641	171	23	pain	pain	NOUN
eshr-12641	171	24	and	and	CCONJ
eshr-12641	171	25	function	function	NOUN
eshr-12641	171	26	in	in	ADP
eshr-12641	171	27	knee	knee	NOUN
eshr-12641	171	28	osteoarthritis	osteoarthritis	NOUN
eshr-12641	171	29	women	woman	NOUN
eshr-12641	171	30	?	?	PUNCT
eshr-12641	172	1	curr	curr	PROPN
eshr-12641	172	2	rheumatol	rheumatol	PROPN
eshr-12641	172	3	rev	rev	PROPN
eshr-12641	172	4	.	.	PROPN
eshr-12641	172	5	published	publish	VERB
eshr-12641	172	6	online	online	ADV
eshr-12641	172	7	may	may	PROPN
eshr-12641	172	8	21	21	NUM
eshr-12641	172	9	,	,	PUNCT
eshr-12641	172	10	2015	2015	NUM
eshr-12641	172	11	.	.	PUNCT
eshr-12641	173	1	21	21	NUM
eshr-12641	173	2	.	.	X
eshr-12641	174	1	okafor	okafor	PROPN
eshr-12641	174	2	ci	ci	PROPN
eshr-12641	174	3	.	.	PUNCT
eshr-12641	175	1	the	the	DET
eshr-12641	175	2	metabolic	metabolic	NOUN
eshr-12641	175	3	syndrome	syndrome	NOUN
eshr-12641	175	4	in	in	ADP
eshr-12641	175	5	africa	africa	PROPN
eshr-12641	175	6	:	:	PUNCT
eshr-12641	175	7	current	current	ADJ
eshr-12641	175	8	trends	trend	NOUN
eshr-12641	175	9	.	.	PUNCT
eshr-12641	176	1	indian	indian	PROPN
eshr-12641	176	2	j	j	PROPN
eshr-12641	176	3	endocrinol	endocrinol	NOUN
eshr-12641	176	4	metab	metab	NOUN
eshr-12641	176	5	.	.	PUNCT
eshr-12641	177	1	2012;16(1):56	2012;16(1):56	PROPN
eshr-12641	177	2	-	-	SYM
eshr-12641	177	3	66	66	NUM
eshr-12641	177	4	.	.	PUNCT
eshr-12641	178	1	doi:10.4103/2230	doi:10.4103/2230	VERB
eshr-12641	178	2	-	-	PROPN
eshr-12641	178	3	8210.91191	8210.91191	NUM
eshr-12641	178	4	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	179	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	179	2	noubaramadji	noubaramadji	NOUN
eshr-12641	179	3	yamti	yamti	PROPN
eshr-12641	179	4	et	et	PROPN
eshr-12641	179	5	al	al	PROPN
eshr-12641	179	6	.	.	PUNCT
eshr-12641	180	1	(	(	PUNCT
eshr-12641	180	2	prevalence	prevalence	NOUN
eshr-12641	180	3	of	of	ADP
eshr-12641	180	4	metabolic	metabolic	NOUN
eshr-12641	180	5	syndrome	syndrome	NOUN
eshr-12641	180	6	among	among	ADP
eshr-12641	180	7	patients	patient	NOUN
eshr-12641	180	8	with	with	ADP
eshr-12641	180	9	type	type	NOUN
eshr-12641	180	10	2	2	NUM
eshr-12641	180	11	diabetes	diabetes	NOUN
eshr-12641	180	12	…	…	PUNCT
eshr-12641	180	13	)	)	PUNCT
eshr-12641	180	14	vol	vol	NOUN
eshr-12641	180	15	.	.	PROPN
eshr-12641	181	1	7	7	NUM
eshr-12641	181	2	,	,	PUNCT
eshr-12641	181	3	no	no	INTJ
eshr-12641	181	4	.	.	NOUN
eshr-12641	181	5	2	2	NUM
eshr-12641	181	6	,	,	PUNCT
eshr-12641	181	7	2025	2025	NUM
eshr-12641	181	8	,	,	PUNCT
eshr-12641	181	9	pp	pp	ADJ
eshr-12641	181	10	.	.	PUNCT
eshr-12641	182	1	87	87	NUM
eshr-12641	182	2	-	-	SYM
eshr-12641	182	3	95	95	NUM
eshr-12641	182	4	95	95	NUM
eshr-12641	182	5	10.26555	10.26555	NUM
eshr-12641	182	6	/	/	SYM
eshr-12641	182	7	eshr.v7i2.12641	eshr.v7i2.12641	NUM
eshr-12641	182	8	22	22	NUM
eshr-12641	182	9	.	.	PUNCT
eshr-12641	183	1	prévalence	prévalence	NOUN
eshr-12641	183	2	du	du	PROPN
eshr-12641	183	3	syndrome	syndrome	PROPN
eshr-12641	183	4	métabolique	métabolique	NOUN
eshr-12641	183	5	et	et	PROPN
eshr-12641	183	6	différences	différence	VERB
eshr-12641	183	7	entre	entre	PROPN
eshr-12641	183	8	les	les	PROPN
eshr-12641	183	9	sexes	sexes	PROPN
eshr-12641	183	10	pubmed	pubmed	PROPN
eshr-12641	183	11	.	.	PUNCT
eshr-12641	184	1	accessed	access	VERB
eshr-12641	184	2	march	march	PROPN
eshr-12641	184	3	1	1	NUM
eshr-12641	184	4	,	,	PUNCT
eshr-12641	184	5	2025	2025	NUM
eshr-12641	184	6	.	.	PUNCT
eshr-12641	185	1	23	23	NUM
eshr-12641	185	2	.	.	PUNCT
eshr-12641	186	1	w	w	PROPN
eshr-12641	186	2	z	z	PROPN
eshr-12641	186	3	,	,	PUNCT
eshr-12641	186	4	m	m	VERB
eshr-12641	186	5	ae	ae	PROPN
eshr-12641	186	6	,	,	PUNCT
eshr-12641	186	7	y	y	PROPN
eshr-12641	186	8	z	z	PROPN
eshr-12641	186	9	,	,	PUNCT
eshr-12641	186	10	et	et	PROPN
eshr-12641	186	11	al	al	PROPN
eshr-12641	186	12	.	.	PROPN
eshr-12641	186	13	metabolic	metabolic	PROPN
eshr-12641	186	14	syndrome	syndrome	PROPN
eshr-12641	186	15	,	,	PUNCT
eshr-12641	186	16	independent	independent	ADJ
eshr-12641	186	17	predictor	predictor	NOUN
eshr-12641	186	18	for	for	ADP
eshr-12641	186	19	coronary	coronary	ADJ
eshr-12641	186	20	artery	artery	NOUN
eshr-12641	186	21	disease	disease	NOUN
eshr-12641	186	22	.	.	PUNCT
eshr-12641	187	1	clinical	clinical	ADJ
eshr-12641	187	2	laboratory	laboratory	NOUN
eshr-12641	187	3	.	.	PUNCT
eshr-12641	188	1	2015;61(10	2015;61(10	NUM
eshr-12641	188	2	)	)	PUNCT
eshr-12641	188	3	.	.	PUNCT
eshr-12641	189	1	doi:10.7754	doi:10.7754	PROPN
eshr-12641	189	2	/	/	SYM
eshr-12641	189	3	clin.lab.2015.150219	clin.lab.2015.150219	NOUN
eshr-12641	189	4	24	24	NUM
eshr-12641	189	5	.	.	PUNCT
eshr-12641	190	1	acidocétose	acidocétose	PROPN
eshr-12641	190	2	chez	chez	PROPN
eshr-12641	190	3	les	les	PROPN
eshr-12641	190	4	diabétiques	diabétique	NOUN
eshr-12641	190	5	de	de	X
eshr-12641	190	6	type	type	NOUN
eshr-12641	190	7	1	1	NUM
eshr-12641	190	8	 	 	SPACE
eshr-12641	190	9	:	:	PUNCT
eshr-12641	190	10	73	73	NUM
eshr-12641	190	11	cas	cas	X
eshr-12641	190	12	à	à	X
eshr-12641	190	13	dakar	dakar	PROPN
eshr-12641	190	14	pubmed	pubmed	PROPN
eshr-12641	190	15	.	.	PUNCT
eshr-12641	191	1	accessed	access	VERB
eshr-12641	191	2	march	march	PROPN
eshr-12641	191	3	1	1	NUM
eshr-12641	191	4	,	,	PUNCT
eshr-12641	191	5	2025	2025	NUM
eshr-12641	191	6	.	.	PUNCT
eshr-12641	192	1	25	25	NUM
eshr-12641	192	2	.	.	PUNCT
eshr-12641	193	1	vg	vg	ADP
eshr-12641	193	2	a	a	DET
eshr-12641	193	3	,	,	PUNCT
eshr-12641	193	4	vi	vi	PROPN
eshr-12641	193	5	b	b	PROPN
eshr-12641	193	6	,	,	PUNCT
eshr-12641	193	7	an	an	DET
eshr-12641	193	8	p	p	X
eshr-12641	193	9	,	,	PUNCT
eshr-12641	193	10	et	et	PROPN
eshr-12641	193	11	al	al	PROPN
eshr-12641	193	12	.	.	PUNCT
eshr-12641	194	1	the	the	DET
eshr-12641	194	2	prevalence	prevalence	NOUN
eshr-12641	194	3	of	of	ADP
eshr-12641	194	4	the	the	DET
eshr-12641	194	5	metabolic	metabolic	NOUN
eshr-12641	194	6	syndrome	syndrome	NOUN
eshr-12641	194	7	in	in	ADP
eshr-12641	194	8	greece	greece	PROPN
eshr-12641	194	9	:	:	PUNCT
eshr-12641	194	10	the	the	DET
eshr-12641	194	11	metsgreece	metsgreece	PROPN
eshr-12641	194	12	multicentre	multicentre	PROPN
eshr-12641	194	13	study	study	NOUN
eshr-12641	194	14	.	.	PUNCT
eshr-12641	195	1	diabetes	diabetes	NOUN
eshr-12641	195	2	,	,	PUNCT
eshr-12641	195	3	obesity	obesity	NOUN
eshr-12641	195	4	&	&	CCONJ
eshr-12641	195	5	metabolism	metabolism	NOUN
eshr-12641	195	6	.	.	PUNCT
eshr-12641	196	1	2005;7(4	2005;7(4	NUM
eshr-12641	196	2	)	)	PUNCT
eshr-12641	196	3	.	.	PUNCT
eshr-12641	197	1	doi:10.1111	doi:10.1111	PROPN
eshr-12641	197	2	/	/	SYM
eshr-12641	197	3	j.1463	j.1463	PROPN
eshr-12641	197	4	-	-	PUNCT
eshr-12641	197	5	1326.2004.00409.x	1326.2004.00409.x	NUM
eshr-12641	197	6	26	26	NUM
eshr-12641	197	7	.	.	PUNCT
eshr-12641	198	1	acidocétose	acidocétose	PROPN
eshr-12641	198	2	chez	chez	PROPN
eshr-12641	198	3	les	les	PROPN
eshr-12641	198	4	diabétiques	diabétique	NOUN
eshr-12641	198	5	de	de	X
eshr-12641	198	6	type	type	NOUN
eshr-12641	198	7	1	1	NUM
eshr-12641	198	8	 	 	SPACE
eshr-12641	198	9	:	:	PUNCT
eshr-12641	198	10	73	73	NUM
eshr-12641	198	11	cas	cas	X
eshr-12641	198	12	à	à	X
eshr-12641	198	13	dakar	dakar	PROPN
eshr-12641	198	14	pubmed	pubmed	PROPN
eshr-12641	198	15	.	.	PUNCT
eshr-12641	199	1	accessed	access	VERB
eshr-12641	199	2	march	march	PROPN
eshr-12641	199	3	1	1	NUM
eshr-12641	199	4	,	,	PUNCT
eshr-12641	199	5	2025	2025	NUM
eshr-12641	199	6	.	.	PUNCT
eshr-12641	200	1	27	27	NUM
eshr-12641	200	2	.	.	X
eshr-12641	201	1	khadilkar	khadilkar	PROPN
eshr-12641	201	2	a	a	PROPN
eshr-12641	201	3	,	,	PUNCT
eshr-12641	201	4	oza	oza	PROPN
eshr-12641	201	5	c	c	NOUN
eshr-12641	201	6	,	,	PUNCT
eshr-12641	201	7	mondkar	mondkar	PROPN
eshr-12641	201	8	sa	sa	PROPN
eshr-12641	201	9	.	.	PUNCT
eshr-12641	202	1	insulin	insulin	NOUN
eshr-12641	202	2	resistance	resistance	NOUN
eshr-12641	202	3	in	in	ADP
eshr-12641	202	4	adolescents	adolescent	NOUN
eshr-12641	202	5	and	and	CCONJ
eshr-12641	202	6	youth	youth	NOUN
eshr-12641	202	7	with	with	ADP
eshr-12641	202	8	type	type	NOUN
eshr-12641	202	9	1	1	NUM
eshr-12641	202	10	diabetes	diabetes	NOUN
eshr-12641	202	11	:	:	PUNCT
eshr-12641	202	12	a	a	DET
eshr-12641	202	13	review	review	NOUN
eshr-12641	202	14	of	of	ADP
eshr-12641	202	15	problems	problem	NOUN
eshr-12641	202	16	and	and	CCONJ
eshr-12641	202	17	solutions	solution	NOUN
eshr-12641	202	18	.	.	PUNCT
eshr-12641	203	1	clinical	clinical	ADJ
eshr-12641	203	2	medicine	medicine	NOUN
eshr-12641	203	3	insights	insight	VERB
eshr-12641	203	4	endocrinology	endocrinology	NOUN
eshr-12641	203	5	and	and	CCONJ
eshr-12641	203	6	diabetes	diabetes	NOUN
eshr-12641	203	7	.	.	PUNCT
eshr-12641	204	1	2023;16:11795514231206730	2023;16:11795514231206730	X
eshr-12641	204	2	.	.	PUNCT
eshr-12641	204	3	doi:10.1177/11795514231206730	doi:10.1177/11795514231206730	ADJ
eshr-12641	204	4	28	28	NUM
eshr-12641	204	5	.	.	PUNCT
eshr-12641	205	1	cisse	cisse	PROPN
eshr-12641	205	2	f	f	PROPN
eshr-12641	205	3	,	,	PUNCT
eshr-12641	205	4	mehreza	mehreza	ADV
eshr-12641	205	5	a	a	X
eshr-12641	205	6	,	,	PUNCT
eshr-12641	205	7	thiam	thiam	PROPN
eshr-12641	205	8	s	s	PROPN
eshr-12641	205	9	,	,	PUNCT
eshr-12641	205	10	lamkinsi	lamkinsi	PROPN
eshr-12641	205	11	t	t	PROPN
eshr-12641	205	12	,	,	PUNCT
eshr-12641	205	13	ndiaye	ndiaye	VERB
eshr-12641	205	14	a	a	PRON
eshr-12641	205	15	,	,	PUNCT
eshr-12641	205	16	samba	samba	NOUN
eshr-12641	205	17	a	a	PRON
eshr-12641	205	18	,	,	PUNCT
eshr-12641	205	19	coly	coly	ADJ
eshr-12641	205	20	nf	nf	NOUN
eshr-12641	205	21	,	,	PUNCT
eshr-12641	205	22	soumah	soumah	PROPN
eshr-12641	205	23	iy	iy	PROPN
eshr-12641	205	24	,	,	PUNCT
eshr-12641	205	25	diedhiou	diedhiou	VERB
eshr-12641	205	26	f	f	PROPN
eshr-12641	205	27	,	,	PUNCT
eshr-12641	205	28	agossou	agossou	PROPN
eshr-12641	205	29	hhm	hhm	PROPN
eshr-12641	205	30	,	,	PUNCT
eshr-12641	205	31	diallo	diallo	PROPN
eshr-12641	205	32	-	-	PUNCT
eshr-12641	205	33	agne	agne	PROPN
eshr-12641	205	34	f	f	PROPN
eshr-12641	205	35	,	,	PUNCT
eshr-12641	205	36	diatta	diatta	VERB
eshr-12641	205	37	a	a	DET
eshr-12641	205	38	,	,	PUNCT
eshr-12641	205	39	&	&	CCONJ
eshr-12641	205	40	sall	sall	PROPN
eshr-12641	205	41	nd	nd	PROPN
eshr-12641	205	42	.	.	PUNCT
eshr-12641	205	43	(	(	PUNCT
eshr-12641	205	44	2020	2020	NUM
eshr-12641	205	45	)	)	PUNCT
eshr-12641	205	46	.	.	PUNCT
eshr-12641	206	1	etude	etude	PROPN
eshr-12641	206	2	de	de	PROPN
eshr-12641	206	3	la	la	PROPN
eshr-12641	206	4	prevalence	prevalence	NOUN
eshr-12641	206	5	du	du	PROPN
eshr-12641	206	6	syndrome	syndrome	PROPN
eshr-12641	206	7	metabolique	metabolique	ADJ
eshr-12641	206	8	dans	dan	NOUN
eshr-12641	206	9	une	une	PROPN
eshr-12641	206	10	population	population	PROPN
eshr-12641	206	11	adulte	adulte	PROPN
eshr-12641	206	12	senegalaise	senegalaise	PROPN
eshr-12641	206	13	/	/	SYM
eshr-12641	206	14	study	study	NOUN
eshr-12641	206	15	of	of	ADP
eshr-12641	206	16	the	the	DET
eshr-12641	206	17	prevalence	prevalence	NOUN
eshr-12641	206	18	of	of	ADP
eshr-12641	206	19	metabolic	metabolic	NOUN
eshr-12641	206	20	syndrome	syndrome	NOUN
eshr-12641	206	21	in	in	ADP
eshr-12641	206	22	senegalese	senegalese	ADJ
eshr-12641	206	23	population	population	NOUN
eshr-12641	206	24	.	.	PUNCT
eshr-12641	207	1	ramres2s	ramres2s	PROPN
eshr-12641	207	2	crufaoci	crufaoci	PROPN
eshr-12641	207	3	,	,	PUNCT
eshr-12641	207	4	2(2	2(2	NUM
eshr-12641	207	5	)	)	PUNCT
eshr-12641	207	6	,	,	PUNCT
eshr-12641	207	7	1–7	1–7	X
eshr-12641	207	8	.	.	PUNCT
eshr-12641	208	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-12641	208	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	NOUN